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ABSTRACT
This PhD consisted of a series of studies aiming at detecting genetic risk factors for 
Aggressive Periodontitis (AgP). AgP is a destructive disease of the periodontium 
affecting around 1% of the population and leading to early tooth loss. Microbiological 
and environmental factors are thought to act on a genetically susceptible host to 
determine AgP.
We conducted a case- control association study on 224 AgP patients (both Generalised 
AgP and Localised AgP) and 231 healthy controls to detect differences in genotype 
distributions of 13 single nucleotide polymorphisms (SNPs). The selected SNPs 
included FcR and FPR, NADPH oxidase, IL-6, TNF-a and VDR polymorphisms. 
Further studies on subsets of patients were conducted to detect associations between 
these SNPs and classical features of AgP: disease severity, familial aggregation, 
presence of periodontopathogenic bacteria and neutrophil hyperactivity.
The NADPH p22phox 242 polymorphism was associated with the AgP trait and with 
disease severity. The IL-6 -174 SNP was associated with LAgP and with increased 
detection o f periodontopathogenic bacteria. The FcyRIIIb NA polymorphism was 
associated with GAgP, while FcyR haplotypes were linked with AgP in Blacks and 
FcyRIIa was associated with familial aggregation of the AgP phenotype. The VDR Taq-I 
polymorphism showed a trend for association with AgP in smokers.
The overall results of the study provide two possible pathogenic pathways leading to 
AgP: one is mediated through an excessive inflammatory response triggered by the 
presence of specific bacteria in individuals with hyper-responsive genotypes (NADPH 
p22phox 242 T allele, FcyRIIIb NA1 homozygosity, IL-6 -174 G homozygosity); the 
second is initiated by an increased susceptibility to bacterial colonization (FcyRIIa R 
homozygosity).
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In conclusion, this study supports the importance of genetic factors in Aggressive 
Periodontitis and hypothesizes possible pathogenic mechanisms.
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CHAPTER 1
1. INTRODUCTION
1.1. Definition of Aggressive Periodontitis
In 1971 Baer (1971) described a form of periodontal disease affecting young individuals. 
At the time this pathological entity was called ‘Periodontosis’, and was not considered 
an inflammatory, but a degenerative process of the periodontium. In his paper Baer 
defines the criteria for the classification of Periodontosis as: 
occurring in healthy individuals
characterized by rapid loss of alveolar bone affecting more than one tooth of the 
permanent dentition
amount of destruction not commensurate with amount of local irritants present.
Baer also reports the strong familial association of these cases and suggests the possible 
importance of a genetic predisposition.
More than 30 years on, while the concept of periodontitis as a non-inflammatory process 
seems now prehistoric, it is necessary to credit Baer with having identified and described 
the main characteristics of this clinical entity which has subsequently been called ‘Early 
onset Periodontitis’ and which we now call ‘Aggressive Periodontitis’.
The term ‘Aggressive Periodontitis’ (AgP) was introduced in the classification by the 
1999 Consensus Report on Classification of Periodontal Diseases by the American 
Academy of Periodontology (Armitage 1999). The group discussing the classification 
concluded that AgP is a specific type of periodontitis with clearly identifiable clinical 
and laboratory findings which make it sufficiently different from Chronic Periodontitis 
(CP), which is the most common form of periodontal diseases. The consensus report also 
distinguishes common and secondary features that render AgP a distinct entity.
The common features of AgP are:
Except for the presence of periodontitis, patients are otherwise clinically healthy 
Rapid attachment loss and bone destruction 
Familial aggregation
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The secondary features are:
Amounts of microbial deposits are inconsistent with the severity of periodontal 
tissue destruction
Elevated proportions of Actinobacillus actinomycetemcomitans and, in some 
populations, Porphyromonas gingivalis 
Phagocyte abnormalities
Hyper-responsive macrophage phenotype, including elevated levels of PGE2 and IL- 
10
Progression of attachment loss and bone loss may be self-arresting
Not all these features, however, must be present to assign a diagnosis of AgP. The 
emphasis of this new classification is on the fact that it is not considered correct to use 
the term ‘Early Onset’ because it is too restrictive, since not all cases of this form of 
disease occur in very young individuals.
Curiously, despite the substantial understanding of AgP as an inflammatory process, the 
hinges of our classification are still those described by Baer: health, rapid progression, 
familial aggregation and a small amount of supra- and sub-gingival deposits. However, 
it has to be admitted that the new classification is not universally accepted, and in some 
cases the differences between AgP and CP are not so clear-cut, and leave scope for 
individual interpretations. This is due to the difficulty of establishing the rate of 
progression of the disease (hardly possible without having previous clinical records of 
the patient), of establishing the familial aggregation (which makes examining relatives 
necessary), and to the fact that the secondary characteristics are not always present nor 
are they easily detected.
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1.1.1. SUBCLASSIFICATION
AgP cases are sub classified into Localised (LAgP) and Generalised (GAgP). The first 
includes patients with a molar/incisor pattern of bone and attachment loss, previously 
classified as Localised Juvenile Periodontitis (LJP) or Localised Early Onset 
Periodontitis (LEOP). GAgP roughly merges the old terms of Generalised Juvenile 
Periodontitis (GJP), Generalised Early Onset Periodontitis (GEOP), post-juvenile 
Periodontitis and rapidly progressive Periodontitis (RPP). Throughout this thesis, we 
will preferably refer to LAgP and GAgP even with regards to old studies. It is also 
worthy of mention that most of the literature in this field relates to LAgP, rather than the 
generalised form.
In more detail, the characteristics of LAgP and GAgP following the current 
classification are as follows:
• LAgP
circumpubertal onset
robust serum antibody response to infecting agents
localized first molar/incisor presentation with interproximal attachment loss on at 
least two permanent teeth, one of which is a first molar, and involving no more than 
two teeth other than first molars and incisors
• GAgP
usually affecting persons under 30 years of age 
poor serum antibody response to infecting agents
pronounced episodic nature of the destruction of attachment and alveolar bone 
generalized interproximal attachment loss affecting at least three permanent teeth 
other than first molars and incisors
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This thesis focuses on the genetic aspects of AgP, but in order to understand the 
importance of genetics, it is necessary to understand the evidence of the role that the 
other factors play in its onset and development.
1.2. Epidemiology
A few epidemiologic studies have been conducted throughout the world, trying to 
establish the incidence rate of AgP. Drawing conclusions from these surveys is not very 
easy because of several factors:
1. Classification bias: the classifications of disease used by the different studies are 
very heterogeneous (Baer’s criteria, Early Onset, AgP, or even non standard 
individual devised classifications are used)
2. Selection bias: due to the lack of random selection of samples in some surveys
3. Screening bias: different methods of screening are used and some can lead to 
underestimation of the disease
4. Age criteria: most studies focused on adolescents (15-16 years old), which leaves 
us very little understanding of the disease prevalence in other age groups
5. Population differences: very variable rates are described in developed vs. 
undeveloped countries and in populations of different ethnic backgrounds
6. Lack of power: most of the studies are based on a very small number of subjects.
The biggest published survey is from Loe & Brown (1991) on 11007 adolescents in the 
United States of America, and reports a total prevalence of about 0.66%, with 0.17% of 
Caucasians and 2.64% of Blacks affected. The overall prevalence of LAgP and GAgP 
was 0.53% and 0.13% respectively. Saxby (1987), in an UK survey, found a prevalence 
of 0.1% in the age range from 15 to 19 years old. The prevalence was higher for Blacks 
(0.8%) and Asians (0.2%) than for Caucasians (0.01%). Higher prevalence is reported 
in studies conducted in developing countries (Albandar et al. 2002, Albandar & Tinoco 
2002).
Whilst we should be aware of the limitations of past studies, we can conclude from these 
that AgP seems to affect about 0.1% of Caucasian, and 1-2.5% of Black adolescents.
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The reported sex ratios vary greatly between different studies and different populations, 
but the supposed higher prevalence in females does not seem to be proven (Hart et al. 
1991). As emphasised above, we can only guess that AgP prevalence in young adults (in 
their twenties or early thirties) is somehow higher than these figures.
1.3. Pathogenesis
Periodontal disease is an infectious disease, with a multifactorial aetiopathogenesis. It 
affects the surrounding and supporting apparatus of the teeth, including periodontal 
ligament and alveolar bone. The destruction of the periodontal structures leaves the teeth 
with reduced support, causing mobility and eventually tooth exfoliation. Understanding 
the reason why this happens has always represented a challenge for any clinician who 
comes across such cases, especially when this occurs, as in the case of AgP, during 
adolescence or early adulthood (Tonetti & Mombelli 1999).
The complex interaction of a variety of microbial, environmental, behavioural, and 
systemic factors with innate and acquired host factors determines the outcome of 
periodontal destruction. In healthy conditions, a balance exists between oral bacteria, 
host response and local factors. If this balance is somehow disturbed and shifted by one 
of these factors or by a combination of them, the net result is severe destruction of the 
supporting apparatus of the teeth. The attention o f periodontal research is therefore 
directed towards the study of highly virulent periodontal pathogens, interfering local and 
environmental factors and, of course, host response (Komman et al. 1997a).
From an aetiopathogenetic standpoint, AgP has been distinguished from CP because of 
the supposed different importance that the various factors play in their onset and 
development. In fact, CP is believed to be due mainly to the cumulative effect of local 
and environmental factors, such as defective plaque control, smoking, in combination 
with pathogenic bacteria and a degree of genetic susceptibility. On the other hand, in 
AgP the effect of genetic and probably microbiological factors, seems to be prevalent, 
and this causes a very early onset and a rapid progression of disease in the absence of 
clear local or environmental factors (Tonetti & Mombelli 1999).
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1.3.1. MICROBIOLOGICAL FACTORS
Periodontal disease is an infectious disease, so it is naturally important to underline the 
importance of microbiological factors. Going back to the 1999 classification, the 
presence of “elevated proportions of Actinobacillus actinomycetemcomitans (A.a.) and, 
in some populations, of Porphyromonas gingivalis (P.g .)”, is mentioned within the 
secondary features which can help distinguish AgP from CP cases (Armitage 1999).
The first studies looking at the microbiological factors in AgP are from Newman et al. 
(1976) and Listgarten (1976). The lack of grossly noticeable tooth surface deposits in 
AgP cases was widely recognized at the time. Electron microscopy studies of plaque 
samples collected from early-onset cases revealed the presence of a cuticle covering the 
root surfaces, composed of “globules of amorphous material, forming an irregular­
shaped covering containing small clumps of Gram-negative coccoid bacteria and 
polymorphonuclear leukocytes (PMN) in varying stages of disintegration” (Listgarten 
1976). Fewer morphologic forms were detected as compared to CP samples, and 
Newman at el. (1976) distinguished 5 groups of Gram-negative anaerobic rods 
associated with early-onset lesions. Many studies based on new techniques which allow 
detection and counts of periodontal pathogens collected from periodontal pockets have 
followed. A metanalysis of all the different studies is very difficult, because of the 
heterogeneity o f classification systems and the methodologies used (PCR, cultures, 
DNA probes, immunofluorescence, antibodies).
Mombelli et al. (2002) recently studied the evidence produced by numerous bacterial 
association studies for AgP and CP. They concluded that the presence or absence of 
known or supposed periodontal pathogens could not discriminate between subjects with 
AgP from those with CP. A trend of association was present between AgP and certain 
periodontal bacteria, such as Actinobacillus actinomycetemcomitans (A.a.), 
Porphyromonas gingivalis (P.g.), Tannerella forsythensis (T .f), Prevotella intermedia 
(.P.i.), Treponema denticola (T.d.), Campylobacter rectus (C.r.), Fusobacterium
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nucleatum (F.n .). The first three were designated as periodontal pathogens in the World 
Workshop in Periodontology in 1996 (Consensus Report 1996) and deserve more 
detailed discussion in this context.
1.3.1.1. Actinobacillus actinomycetemcomitans (A.a.)
A.actinomycetemcomitans is a small, non motile, Gram-negative, saccharolytic, 
capnophilic, round- ended rod. It is considered particularly important in LAgP 
(Socransky & Haffajee 1992), where its detection in different studies varies form 20- 
25% up to 90%, which was consistently more than the percentage of detection in GAgP 
and CP lesions. It has been demonstrated that most localized early-onset cases produce 
antibodies locally and have elevated serum antibodies against A. actinomycetemcomitans 
(Listgarten et al. 1981, Tew et al. 1985). Among its virulence factors, leukotoxins, 
collagenases and endotoxins have been described as heavily involved in periodontal 
disease pathogenesis (Haffajee & Socransky 1994). A. actinomycetemcomitans has also 
been shown to stimulate cytokine production and neutrophil response (Belibasakis et al. 
2005). Furthermore, its elimination from infected periodontal pockets has been 
associated with a good response to treatment (Komman & Robertson 1985). However, 
A. actinomycetemcomitans has also been detected in relatively high prevalence in CP 
and healthy subjects (Mcnabb et al. 1992), while cases o f AgP, even localized, where A. 
actinomycetemcomitans was not detected, are often reported (Ishikawa et al. 2002). 
Contrasting results come from serotype studies. A highly leukotoxic variant (JP2) has 
been implicated in a small percentage of subjects with AgP and especially in some 
ethnic subgroups (Haubek et al. 2004). There also seems to be a relation between age 
and presence of A. actinomycetemcomitans, the highly leukotoxic variant being detected 
mainly at a very early age with carriage at a later age restricted to less virulent serotypes 
(Haraszthy et al. 2000).
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1.3.1.2. Porphyromonas gingivalis (P.g.)
P.gingivalis is a Gram-negative, anaerobic, non-motile, asaccharolytic rod. It belongs to 
the family of the black- pigmented Bacteroides and is one of the most prevalent bacteria 
in AgP lesions, detected in a range of about 60-90% of generalized cases, and 
consistently less in LAgP and CP cases (Mombelli et al. 2002). Porphyromonas 
gingivalis produces virulence factors including proteases, collagenases, endotoxins and 
is able to determine a strong immune response in the host both locally and systemically 
(Haffajee & Socransky 1994). Moreover, P.gingivalis seems to have the ability to affect 
and influence the phagocytic response in humans (Wilton et al. 1992) and it has been 
shown to be capable of invading the host’s epithelial cells in vitro (Papapanou et al. 
1994). In addition, clinical studies have observed a persistence of P.gingivalis in 
periodontal lesions which did not respond well to treatment (Van Winkelhoff et al. 
1988).
1.3.1.3. Tannerella forsythensis (T.f.)
Previously known as Bacteroides forsythus, T. forsythensis is a Gram-negative, 
anaerobic rod, detected in about 70-100% of AgP cases, both in Generalised and in 
Localised cases (Mullally et al. 2000, Mombelli et al. 2002). T. forsythensis was shown 
to be detected more frequently in ‘active’ periodontal lesions (Dzink et al. 1988) and in 
sites showing breakdown after periodontal therapy (Shiloah et al. 1998). Individuals 
affected by refractory forms of periodontitis have been shown to have elevated detection 
rates and elevated antibodies against T. forsythensis (Taubman et al. 1992).
Summarizing, we have evidence of an increased prevalence of certain bacteria in AgP 
cases when compared with healthy subjects. However, we don’t know how much of the 
difference can be due to the fact that some of the suspected pathogens may be a 
consequence rather than a cause of the disease. This difference is less marked when we 
compare AgP to CP, and not enough to distinguish between these two forms of 
periodontitis (Mombelli et al. 2002). Further studies on the presence of toxic strains of 
A.actinomycetemcomitans and P.gingivalis may give increased evidence for their 
pathogenic effects.
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We can hence conclude that, with our present knowledge, microbiological factors alone 
are not enough to explain the difference between AgP and CP and indeed between health 
and disease.
1.3.2. GENETIC FACTORS
In the last 10-15 years the focus of research in the field of periodontitis has shifted more 
towards a genetic approach in an attempt to identify individual risk factors for the onset 
and development of periodontal diseases. This section will discuss the evidence of the 
importance of genetics for AgP and explore the ways genetic markers can be identified 
and confirmed as risk factors.
13.2.1. Identification o f  genetic markers fo r disease
There are up to 50,000 different genes in the human genome (Parra et al. 2003). Genes 
can be polymorphic at several sites, meaning that they can exist in different forms 
(alleles). When an allele is expressed in at least 1% of the population it is conventionally 
called a polymorphism. If, on the other hand, the frequency is lower, it is called a 
mutation. Some mutations or polymorphisms are ‘silent’ or ‘synonymous’, which means 
the variation in the allele does not change the coded amino acid. Others are functional, 
and they change the coded amino acid and subsequently the resulting protein (Collins et 
al. 1999). If the affected protein is involved in a biological process, that mutation or 
polymorphism can therefore change the predisposition to a specific phenotype or disease 
through the effect of the coded protein. In addition to this, other polymorphisms located 
in the promoter region of the gene exert a functional effect by changing the 
transcriptional levels of the gene itself, therefore increasing the numbers of the coded 
protein.
The power of these effects can either be deterministic or just predisposing to a disease. 
In this latter case, it is the interaction between the genetic predisposition and other 
environmental factors which may cause the onset of the disease.
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There are just few examples of diseases caused by either a genetic or by an 
environmental factor alone (haematophilia A, for example, is caused by a mutation in a 
gene coding for a coagulation factor). For many diseases, such as for example cancer or 
cardiovascular disease, the human population show different susceptibilities, determined 
by the combination of both genetic and environmental components (Kinane et al. 2005).
Recent studies on periodontitis suggest a cumulative high-susceptibility profile model, 
given by the combination of the effects resulting from a variety of high- susceptibility 
genotypes. The contribution of an allelic variant can either be deterministic or subtle, 
with only a modifying effect on aetiology (Kinane & Hart, 2003). Increasing evidence 
suggests that periodontitis may be a complex genetic disease, meaning that its traits are 
the result o f the interaction of multiple different loci. The genetic variants etiologically 
important are not rare mutations, but common polymorphisms, which occur in 
unaffected as well as affected individuals (Kinane & Hart, 2003). A combination of 
polymorphisms or their association with environmental factors can give rise to an 
increased susceptibility to periodontitis.
Several approaches are available in order to detect genes responsible for disease 
susceptibility:
1. Familial aggregation. The study of the relatives of the affected patient can 
show a genetic predisposition to the disease. However, environmental factors 
will still contribute to disease susceptibility.
2. Twin studies. Especially studying monozygous twins reared apart, enormous 
insight into the relevance of genetic factors to disease predisposition can be 
gained.
3. Segregation analyses. Allows studying the pattern of transmission of a 
disease, by means of examining relatives o f the affected patients.
4. Linkage analyses. It is a complex genetic analysis which aims at identifying a 
specific chromosomal location where the suspected gene responsible for the 
disease predisposition is situated.
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5. Association studies. The aim of this kind of study is to identify possible 
predisposing genotypes, by a case-control design. Genetic polymorphism 
analysis is performed in a group of patients and in a group of healthy subjects 
for specific suspected genes and the distributions of the studied genotypes are 
compared between the two groups (Kinane & Hart 2003).
1.3.2.2. Evidence for genetic factors in Aggressive Periodontitis
Back in 1971 Baer suspected a possible role for genetic factors in the predisposition to 
early onset periodontitis. Several reports have followed, showing increased rates of 
diagnosis of periodontitis in families with at least one individual affected by AgP (Butler 
et al. 1969, Melnick et al. 1976, Spektor et al. 1985, Stabholz et al. 1998).
Michalowicz et al. (1991, 2000) studied a group of monozygous and dizygous twins, 
both reared apart and reared together. They concluded, trying to adjust for 
environmental factors, that approximately half of the variance in periodontitis in the 
population is attributable to genetic factors.
Different theories have been hypothesized about the transmission of the AgP trait. A 
pattern of transmission consistent with Mendelian inheritance of a gene of major effect 
has been suggested (Beaty et al. 1987, Marazita et al. 1994). Segregation analyses have 
shown conflicting results, with some studies, mainly in Black African populations, 
suggesting a possible autosomal dominant mode of inheritance (Marazita et al. 1994), 
and other studies suggesting a recessive mode of inheritance (Boughman et al. 1988). 
Even reports of an X-linked transmission exist (Melnick et al. 1976). The biggest study 
so far available in the literature was performed in the United States (Marazita et al. 
1994) on 104 affected individuals and their families. They performed a segregation 
analysis on these subjects and proposed a dominant mode of inheritance with 70% of 
penetrance. Thus there is a lack of agreement regarding the transmission of periodontal 
diseases and there may be differences between the results seen in a black North 
American populations and white Caucasian populations. These differences may be due 
to the fact that periodontitis in general and AgP in particular, are probably
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heterogeneous pathogenically and genetically, and therefore there may be different 
defects and different genes predisposing to AgP in different families. These genes may 
be of major effect or just predisposing, and this may vary depending on the cases. 
Therefore, AgP may be transmitted in different ways in each family, and different loci 
may be capable of causing the disease in both dominant and recessive manners.
A few studies have reported linkage analyses on AgP families. Boughman et al. (1987) 
suspected linkage to chromosome 4 in a large family where LAgP and dentinogenesis 
imperfecta were segregating as dominant traits. Wang et al. (1996) suggested two 
chromosome loci, respectively located on chromosome 6 and 9, to be of interest for 
AgP, while Li et al. (2004) identified by linkage analysis of 4 LAgP families, an AgP 
locus on chromosome lq25.
1.3.2.2.1 Association studies
This approach is the best to study modifying genes, which exert a limited effect on 
disease predisposition and may not be detected in linkage analyses. Therefore, 
association mapping is the method of choice to study complex- trait loci (Risch & 
Merikangas 1996). It also allows for study of the interaction between different genetic 
markers and environmental factors.
In association studies, the distribution of a suspected predisposing allele or genotype is 
studied in a group of diseased and a group of healthy subjects (Pritchard & Rosenberg 
1999). If differences in the allelic or genotypic distribution emerge, there are at least 
four possible explanations: i) the allele is predisposing to the disease; ii) the allele is in 
linkage-disequilibrium with the real predisposing allele; iii) the association is due to 
population stratification, iv) the association is due to a statistical artefact. In order to 
reduce the risk of falling into one of the last three categories, an accurate choice of the 
control group has to be made, and functional studies of the suspected genotype should be 
performed (Hodge 1994).
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Several aspects have to be considered in relation to genetic association studies for 
periodontitis:
1. Selection of controls
• Definition of healthy status. Periodontitis is a relatively common human 
disease and usually affects people late in life. Therefore, association studies 
on Chronic Periodontitis should not include patients younger than at least 
40- 50 years of age. Without doing so, the risk of including individuals 
susceptible to develop CP later in life may dilute or mask any possible 
association. With regards to AgP, patients are usually affected in their teens, 
twenties or early thirties. Hence, the age limit for controls can be 
significantly lowered. The definition of periodontal health is also 
particularly difficult to set, and it may vary with age and in relation to local 
factors.
• Stratification bias. Controls, as well as patients, should represent the ‘normal 
population’ as much as possible and they should not be recruited from a 
restricted subgroup of subjects. Moreover, confounders such as ethnic 
origin, known environmental and socioeconomic factors have to be 
controlled in the two groups of subjects (cases and controls). This is due to 
the powerful effect of factors such as smoking and ethnicity in the 
predisposition to periodontitis. Ethnic factors, which have strong 
associations with genetic SNPs, have to be controlled for in order to avoid 
stratification bias. Otherwise, spurious associations may emerge due to 
linkage of a SNP with a difference in ethnicity rather than with a difference 
in disease susceptibility (Pritchard & Rosenberg 1999). Socioeconomic 
factors are probably slightly less important in AgP than in CP. This is 
because of the supposed stronger genetic background and weaker relation to 
local factors, such as oral hygiene, which might be influenced by belonging 
to different socioeconomic groups.
2. Power. Large numbers of subjects have to be included in order to test hypotheses of 
association, and to verify the possible interactions between genes and environmental
factors. This is particularly difficult in the case of AgP, considering its low 
prevalence (Loe & Brown 1991).
3. External validity. Apparently significant associations may reflect the choice of the 
patient group, and may not be generalised to other populations, different for 
ethnicity or environmental characteristics.
4. Definition of disease. Considerable confusion took place in the past with regards to 
the definition of early onset cases, and an attempt has been made to homogenize it 
through the introduction of the new classification (Armitage 1999). However, this is 
far from being ideal, and still leaves some scope for individual interpretation.
5. Choice of genetic marker. Association studies should be based on functional 
evidence to support the possible linkage of a certain gene with the disease (Hodge 
1994). In reality, this very rarely happens, and most of the time a hypothesis of 
association leads to a study to test the hypothesis. If the association is confirmed, 
then an effort is made to try and understand the functional mechanism behind it.
These are just some of the possible reasons why, despite several association studies having 
been conducted in recent years in relation to CP and AgP, most studies report contrasting 
results.
1.3.2.3. Evidence for risk assessment
The confirmation of a genetic, microbiological, systemic or environmental factor as a 
true risk factor requires the fulfilment of a series of requisites (Beck et al. 1994): 
Identification, i.e. odds ratio >1.0 in cross- sectional investigations 
Retention of significance and direction of effect in a multi-factorial model 
including other exposures as confounders
Assessment, meaning external validation through studies on independent 
populations
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Targeting step, i.e. proof of reduced incidence of the disease after intervention 
strategies targeted at the factor.
Genetic polymorphisms, which are currently non-modifiable, cannot fulfil the last step. 
The 5th European workshop in periodontology recently concluded that, out of an 
overabundance o f putative risk factor, only three have currently been shown to fulfil all 
criteria: smoking, diabetes and certain bacteria (Tonetti & Claffey 2005).
1.3.2.4. Putative genetic risk factors
A range of different genetic deficiencies or variations in the host response have been 
studied as potential modifiers of the response to bacterial plaque, and therefore are among 
the plethora of putative predisposing factors to periodontitis. Several genetic 
polymorphisms have been analyzed and associated to susceptibility to infections, to 
inflammatory diseases and especially to periodontitis (Kinane et al. 2005). Restricting our 
considerations to AgP, because of the several contrasting results as mentioned earlier, we 
have little evidence to confirm with certainty any genetic polymorphisms as clear risk 
factors for AgP. Three different broad categories of candidate gene modifiers for 
periodontitis exist:
1. Innate response : cytokine markers and neutrophil markers
2. Adaptive response: immunological markers
3. Structural factors of periodontal tissues
The main attention of AgP genetic research so far has been focused mainly on the first 
category. The next chapter will include a brief discussion about the pathogenic mechanisms 
of the innate response and will present an overview of the most important known candidate 
genetic risk factors for AgP.
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CHAPTER 2
2. INNATE RESPONSE IN PERIODONTAL DISEASE
Healthy gingiva features a protein-rich inflammatory infiltrate, which exudes through 
the vessels and creates the gingival crevicular fluid (Brill & Krasse 1958). In normal 
healthy gingiva, this inflammatory infiltrate contributes to maintaining the balance with 
the microbial challenge, through specific and non-specific mechanisms, thus preserving 
the physiological homeostasis between bacterial presence and host response (Griffiths 
2003). When the normal balance is somehow disrupted by bacterial overload due to 
plaque accumulation and/or by impaired host response, the first signs of gingival 
inflammation appear and the innate response is activated. The innate (or non-specific) 
response includes mechanisms that operate without any previous contact with the 
disease-causing organism. The activation of the innate response leads to inflammation, 
which may lead to resolution of the infection or to establishment of a chronic lesion. The 
classical cardinal points, which characterize the inflammatory lesion, are rubor, tumor, 
calor, dolor and functio lesa, which mean the area becomes red, swollen, hot, painful 
and loses its function. These factors are common in periodontal lesions, which present 
with gingival redness and swelling due to vasodilatation and vascular permeability; the 
heat is less easy to evaluate and the pain less common in the periodontium, while loss of 
function caused by tooth mobility is common in advanced periodontitis. Thus, in 
gingivitis, alterations in the vascular network occur, many capillaries dilate, and the 
inflammatory infiltrate is produced in increased quantity. This infiltrate is initially 
characterized by the presence of monocytes/macrophages, lymphocytes and neutrophils. 
The junctional epithelium proliferates, and the immune (specific) response also gets 
activated, with the release in the infiltrate of increasing number of plasma cells. When 
this overall host response is not able to effectively oppose the microbial challenge, 
gingivitis may evolve into periodontitis, with destruction of periodontal fibers and 
connective tissue and apical migration of the junctional epithelium. Both the plaque and 
the inflammatory infiltrate subsequently move apically (Bosshardt & Lang 2005).
In this process, the inflammatory response is crucial and the inability to successfully 
deal with the bacterial challenge and therefore the persistence of the inflammatory
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infiltrate can represent the basis for the pathogenesis of periodontitis (Van Dyke et al.
2003).
As anticipated, the cells involved in the inflammatory process are mainly 
monocytes/macrophages, lymphocytes and neutrophils (PMN). These cells are activated 
and regulated thanks to a complex network of interactions o f cytokines. Cytokines are 
soluble proteins, secreted by cells, which act as messengers transmitting signals to other 
cells. A member of the cytokine group is the interleukin subclass, responsible for 
regulation of immune and inflammatory responses. Cytokines, depending on their 
function, can be divided into proinflammatory (such as interleukin-1 and 6 and tumor 
necrosis factor), chemotactic (such as interleukin-8) and lymphocyte signaling cytokines 
(such as interleukin-4, 5, 10 and 13). Each of these cytokines is coded by a specific 
gene, and several genetic variants (polymorphisms) have been identified in these genes. 
Some of these polymorphisms are probably responsible for gain or loss of function of 
the coded cytokines, and therefore may determine a change in the capacity and 
effectiveness of the inflammatory response. This theory has led to the hypothesis that 
polymorphisms of some of these cytokines may predispose to chronic inflammatory 
diseases, such as periodontitis (Kinane et al. 2005).
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2.1. INTERLEUKIN 1
2.1.1. Function
Interleukin 1 (IL-1) is one of the main pro-inflammatory cytokines. It is synthesized by 
a variety of cells including activated macrophages, keratinocytes, stimulated B 
lymphocytes and fibroblasts, and it elicits a wide range of biological activities that 
initiate and promote the host response to injury and infection (Kinane et al. 2005). There 
are two different structural forms of IL-1: IL la, which is the acidic form, and IL-1 (3, 
which is the neutral form. Both have very similar activities. Lord et al. (1991) 
demonstrated that IL-1 a, and to an even greater extent IL-1 (3, are transcribed in PMN 
stimulated with bacterial lypopolysaccharide. Furthermore, both forms stimulate 
osteoclast activity and are potent bone resorbing factors in vivo. These processes are 
mediated through stimulation of the production of IL-1 itself, IL-6, TNFa, prostaglandin 
E2 and matrix metalloproteinases (MMPs). There are two primary cell surface receptors 
for IL-1. The IL-1 type I receptor transduces a signal, whereas the type II receptor binds 
IL-1 without transducing a signal.
2.1.2. Polymorphisms
The genes for IL-1 (IL-A, IL-B, IL-RN) are located on chromosome 2ql4, and encode 
respectively for IL-1 a, IL-1 (3 and IL-1 Ra (receptor antagonist). The latter is structurally 
similar to IL-1 [3, but lacks agonist activity, being a competitive inhibitor of the IL-1B 
effect. Danis et al. (1995) supported the theory that polymorphisms in regions of 
cytokine genes that affect transcription may contribute to interindividual variations in 
cytokine production. Therefore, it is possible to speculate on an increased IL-1 
production followed by an increased risk of developing chronic inflammatory conditions 
depending on IL-1 polymorphisms. Particular attention has been attracted by an ILIA - 
889 polymorphism, by two ILB polymorphisms (-511 and +3954) and by a VNTR 86- 
pair repeat IL1 RN polymorphism. Pociot et al. (1992) revealed that the presence of the 
uncommon allele (’2’) of ILB +3954 polymorphism was associated with increased 
monocyte production of IL(3 in vitro. Contrasting results have been obtained more 
recently by Santtila et al. (1998) and Mark et al. (2000). Shirodaria et al. (2000) found 
that allele 2 of ILIA -889 was associated with a 4-fold increase in IL-1 a.
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Linkage of genes of the IL-1 cluster has been suggested for rheumatoid arthritis and 
Alzheimer disease (McGeer et al. 2001).
2.1.3. Relation to periodontitis
Because of its proinflammatory function and its ability to induce bone resorption, a role 
for IL-1 in periodontal disease has been suspected. Stashenko et al. (1991) reported 
higher levels of ILp in periodontitis; moreover, increased IL-1 in gingival crevicular 
fluid has been correlated with onset of gingivitis and severe periodontal disease (Kinane 
et al. 1992, Ebersole 1993). Ishihara et al. (1997) suggested that the amounts of 
crevicular IL-1 are closely associated with periodontal disease severity, while Masada et 
al. (1990) showed reduction of IL-1 in gingival tissues after periodontal treatment. 
Komman et al. (1997b) identified an increased risk of developing periodontitis in non 
smokers aged 40 to 60 who carried the ‘2 ’ allele for IL-1A -889 and IL-1B +3954 
(defined as ‘IL-1 combined genotype’). Gore et al. (1998) and Rogers et al. (2002) also 
found increased prevalence of IL-1B+3954 allele 2 in advanced Chronic Periodontitis 
patients compared to healthy or mild diseased subjects. Studies from Papapanou et al.
(2001) and Meisel et al. (2003), however, did not confirm these results. Recently, we 
observed an increased tendency for periodontal progression in Chronic Periodontitis 
patients heterozygous for IL-1B +3954 (Nibali et al. 2005). Diehl et al. (1999) obtained 
evidence of linkage disequilibrium for Generalised Early Onset Periodontitis and ILIA - 
889 and IL1B +3954 polymorphisms, suspecting a predisposing role for allele ‘1’ of 
ILip +3954. However, they were not able to attribute it a major effect. Conversely, 
Quappe et al. (2004) in a Chilean population, observed an association between 
heterozygosity for IL1B +3954 and AgP, while Parkhill et al. (2000) found an increased 
prevalence of allele 2 in Caucasian AgP patients. Hodge et al. (2001), in a group of 56 
Caucasians with Generalized Early Onset Periodontitis, observed no associations for any 
of the described IL-1 polymorphisms. Walker et al. (2000), examining a population of 
37 African Americans with Early Onset Periodontitis, concluded that, given the high 
prevalence of allele 1 in this population, the +3954 polymorphism would provide little 
diagnostic or predictive information on the disease. Danis et al. (1995) associated a
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VNTR 86- pair repeat IL-1 RN polymorphism with increased production of IL-1 RN 
protein, and reduced production of ILla by monocytes. This polymorphism was later 
associated by Langdhal et al. (2000) with increased risk of osteoporotic fractures. Tai et 
al. (2002), in a case-control study on 47 Japanese Generalised Early Onset Periodontitis 
and 97 healthy individuals, observed an association between this IL-1 RN polymorphism 
and the periodontitis group, while no differences in IL-1 A -889 and IL-1B +3954 
polymorphisms were detected.
Kinane & Hart (2003) recently stated that in the context of the high redundancy in the 
cytokine system, IL-1 is so highly regulated that any polymorphism coding for increased 
production of this molecule could be controlled by feedback mechanisms associated 
with its regulation, therefore excluding a major contribution to periodontal disease 
pathogenesis.
We can conclude that there is inconclusive evidence of a role for IL-1 polymorphisms in 
AgP. If a relation exists, it may be limited and variable depending on different 
populations.
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2.2. INTERLEUKIN 6
2.2.1. Function
Interleukin 6 (IL-6) is a multifunctional cytokine with a central role in host defence 
(Terry et al. 2000). It exerts its functions activating a cell-surface signaling assembly 
composed of IL-6, IL-6RA, and the shared signaling receptor gp 130. Its functions vary 
from stimulation of the hepatic acute phase response to infection and injury, to 
stimulation of osteoclasts, differentiation and activation of macrophages and T cells 
(Lotz et al. 1988), stimulation of neutrophils, growth and differentiation of B cells and 
stimulation of hematopoiesis (Revel 1989). Its great importance in the acute phase 
response, partially induced by regulation of fibrinogen, is proven by the compromised 
response to infections and tissue damage in IL-6 knockout mice (Fattori et al. 1994). IL- 
6 is not constitutively expressed, but its production is induced by a number of 
inflammatory stimuli such as IL-1, platelet-derived growth factor, tumor necrosis factor 
a (TNF-a), bacterial products such as endotoxin, and viral infections (Terry et al. 2000). 
Many cells are able to produce IL-6; among them monocytes/macrophages, fibroblasts, 
neutrophils, endothelial cells, adipocytes, T cells and mast cells. Aberrant production of 
IL-6 by neoplastic cells has been implicated as a contributory factor to the growth of B 
cell dyscrasias, T-cell lymphoma, renal and ovarian cell carcinomas, and Kaposi 
sarcoma (Kawano et al. 1988, Foster et al. 2000). Dysregulation of IL-6 production has 
also been associated with a number of systemic diseases such as plasmacytosis, juvenile 
chronic arthritis, cardiovascular disease, rheumatoid arthritis, osteoporosis, Paget disease 
and Alzheimer disease (Terry et al. 2000, Shibata et al. 2002, Antonicelli et al. 2005). 
Furthermore, serum IL-6 levels are considered to be a predictor of postmenopausal bone 
loss (Scheidt- Nave 2001).
2.2.2. Polymorphisms
The IL-6 gene is located on chromosome 7 (locus 7p21). The IL-6 locus showed 
evidence of linkage to osteopenia (Ota et al. 1999) and association with bone mineral 
density (Gamero et al. 2002, Nordstrom et al. 2004). Several polymorphisms have been 
detected on this gene, among which the following substitutions exist: -597 G to A, -572 
G to C, -373 An to Tn and -174 G to C. There is increasing evidence about
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interindividual variation in transcription and expression of the IL-6 gene due to the 
haplotype determined by combinations of these polymorphisms (Terry et al. 2000, Fife 
et al. 2005). Fishman et al. (1998) reported a statistically lower frequency of allele C at 
position -174 in 92 patients with systemic juvenile rheumatoid arthritis, compared to 383 
healthy subjects. In the same study, the C allele was also associated with significantly 
lower levels of plasma IL-6: after stimulation with LPS or IL-1, only the -174G 
construct expression significantly increased compared with the unstimulated levels. On 
the other hand, expression from the -174C construct did not change after 24 hours 
(Fishman et al. 1998). Homozygosity for -174G has been associated with increased IL-6 
production, Kaposi sarcoma in HIV-infected men (Foster et al. 2000) and with mortality 
rates after acute coronary syndrome (Antonicelli et al. 2005).
2.2.3. Relation to periodontitis
Reports showing a link between IL-6 levels and periodontal infections are becoming 
more and more frequent. Takahashi et al. (1994) showed the presence of IL-6 in 
endothelial cells, fibroblasts and macrophages of subjects affected by periodontitis, 
while they did not detect it in cells from healthy individuals. Increased levels of IL-6 in 
gingival crevicular fluid have been demonstrated in AgP patients (Kamma 2004). 
Moreover, we showed a sharp increase in serum IL-6 levels at day 1 after intensive 
periodontal treatment of patients with advanced Chronic Periodontitis (D’Aiuto et al.
2004). We also observed in a group of severe Chronic Periodontitis patients treated with 
intensive treatment plus locally-delivered tetracyclines, reduction at 2 months post­
treatment of serum IL-6 levels compared to untreated controls (D’Aiuto et al. 2005).
A few investigators have tried to evaluate the distribution of polymorphisms in the IL-6 
gene in periodontitis patients: Trevilatto et al. (2003) showed an association between - 
174 G allele and susceptibility to chronic periodontitis in Brazilian Caucasians; Holla et 
al. (2004) studying 148 chronic periodontitis patients and 107 healthy controls, did not 
detect any associations for the -174 polymorphism, while they did detect significant 
differences in the -572 polymorphism, with increased presence o f allele C in the 
controls; in a study of 112 Japanese chronic periodontitis and 77 healthy subjects, all
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individuals (patients and controls) were homozygous for -174 G, while a significant 
association with periodontal health was noted for the -373 A9T11 genotype (Komatsu et 
al. 2005). Although the association between allele G and increased levels of IL-6 seems 
consistent in most studies, Terry et al. (2000) recently concluded that more than one of 
the IL-6 polymorphic sites are functional, and IL-6 transcription is influenced not only 
by a simple additive mechanism but rather through complex interactions determined by 
the haplotype.
From these preliminary data, although no association studies have been published 
looking at the distribution of IL-6 polymorphisms in AgP, we can conclude that there is 
a functional basis for a possible association.
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2.3. TUMOR NECROSIS FACTOR (TNF)
2.3.1. Function
TNF is a multifunctional pro inflammatory cytokine, with effects on lipid metabolism, 
coagulation, insulin resistance, and endothelial function. Two forms of TNF exist (TNF- 
a and TNF-(3), which have similar biologic activities and share 30% amino acid 
homology (Aggarwal et al. 1985). Numerous cells can produce TNF, mainly activated 
macrophages, but also monocytes, natural killer (NK) cells, B and T cells, basophils, 
eosinophils, neutrophils (PMN), fibroblast and osteoclasts (Vassalli 1992). TNF 
production by macrophages is stimulated by lipopolysaccharide (LPS), and suppressed 
by PGE2, Interferon-a and -(3, IL-4, IL-6 and IL-10. The effects of TNF production 
include induction of acute phase proteins, mobilization of PMN, release of antibody and 
complement, T and B cell activation, stimulation of bone resorption, increased platelet 
adhesion to blood vessel walls, increased extravascularization of lymphocytes and 
macrophages (Ruuls & Sedgwick 1999). The sum of these effects stimulates 
phagocytosis; however, excessive levels of TNF may cause alterations of cellular 
metabolism and harmful effects for the host, such as systemic oedema, hypoproteinemia 
and neutropenia. Overproduction of TNF has been implicated in the onset of 
autoimmune diseases, Crohn’s disease, as well as cancer (Mocellin et al. 2005, Russo & 
Polosa 2005).
2.3.2. Polymorphisms
The TNF-a gene is located on chromosome 6 (locus 6p21). The TNF-a locus showed 
evidence for linkage with osteoporosis (Ota et al. 2000). The possible functional effect 
may be due to its effect on bone resorption. Other reports suggest a possible association 
of this locus with systemic lupus erythematosus, Crohn’s disease and rheumatoid 
arthritis (Mulcahi et al. 1996, Fowler et al. 2005). Several TNF-a polymorphisms have 
been identified and studied. TNF-a production seems to be affected by a -308 A-G 
polymorphism. Wilson et al. (1997) and Kroeger et al. (1997) showed higher 
transcriptional levels in the presence of allele A rather than G at this position. Koss et al. 
(2000) and Sashio et al. (2002) found an association between -308 G-A genotype and 
ulcerative colitis.
38
2.3.3. Relation to periodontitis
The information related to TNF-a polymorphisms and periodontitis is limited: Kinane et 
al. (1999a) found no association between TNF -308 polymorphism and AgP; Galbraith 
et al. (1998) found an increased prevalence of G homozygosity at position -308 in 20 
severe CP patients in a small case-control study; while Craandjiik et al. (2002) found no 
associations between periodontitis and any of the studied TNF polymorphisms (-238, - 
308, -376, +489). Likewise, Donati et al. (2005) reported a lack of association between 
TNF- a -308 polymorphism and severe Chronic Periodontitis in a population consisting 
of 60 affected individuals and 39 controls. Conversely, Soga et al. (2003) studied the 
distribution of polymorphisms at -238, -308, -857, -863 and -1031 in 64 CP and 64 
healthy Japanese subjects. They concluded that carriers o f at least one variant allele of 
TNF-a -1031, -863 and -857 tended to have higher production of TNF-a from 
circulating monocytes/macrophages and appeared to have higher risk of having CP.
We can therefore conclude that there are very limited results available to allow 
conclusions to be made regarding the relevance of a relationship between TNF-a 
polymorphisms and AgP.
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2.4. VITAMIN D RECEPTOR (VDR)
2.4.1. Function
The vitamin D receptor (VDR) is part of the vitamin D endocrine system, along with the 
active form of vitamin D and its metabolizing enzymes. It is a nuclear receptor, and 
modulates gene expression once complexed with the active form of vitamin D. The 
vitamin D system is involved in several endocrine pathways such as calcium 
metabolism, immune modulation, regulation of cell growth and differentiation and 
induction of apoptosis of osteoblasts, keratinocytes, T-cells and cancer cells (Dusso et al.
2005). Animal studies suggest a pivotal role for VDR in growth, bone formation and 
immune functions (Yoshizawa 1997). The synthesis of osteocalcin, the most abundant 
non collageneous protein in bone, is induced by calcitriol, the active hormonal form of 
vitamin D. This occurs through VDR and a specific VDR-responsive element in the 
osteocalcin gene promoter.
2.4.2. Polymorphisms
The VDR gene is located on chromosome 12 (locus 12 q l2-14). Three allelic variants in 
the VDR gene, which are recognized by the restriction enzymes BsmI, Apal and TaqI, 
have been identified and showed to predict differences in bone density, accounting for 
normal physiologic variations in osteocalcin levels and up to 75% of the total genetic 
effect on bone density in healthy persons (Morrison et al. 1994, 1995, 2004). Other more 
recent reports show conflicting results in the different populations studied (Eisman et al. 
1996, Zee et al. 2000), and calcium and vitamin D intake have been suggested to play a 
role in the relation between genotype and function (Ferrari et al. 1998). Moreover, the 
VDR gene has been found to be associated with osteoarthritis, hyperparathyroidism, 
cancer and Crohn’s disease, but with conflicting results (Uitterlinden et al. 2004). 
Recently, the TaqI- T allele of VDR polymorphisms has been linked to susceptibility to 
tuberculosis and hepatitis B (Bellamy et al. 1999).
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2.4.3. Relation to periodontitis
Tachi et al. (2003) found VDR Taq-I TT genotype to be associated with CP. No 
association was found from other investigators (Yoshihara et al. 2001, Sun et al. 2002), 
but their control groups included younger subjects, that could develop CP as they grow 
older. Inagaki et al. (2003) reported an association between the VDR Apa-I AA 
genotype to periodontal disease progression over 23 years in a group of healthy or mild 
periodontitis subjects, while no association was found for Taq-I polymorphism. We 
recently showed an association of the TaqI T homozygosis with extent of CP and an 
effect on periodontal disease progression attributable to the interaction between this 
polymorphism and smoking (Nibali et al. 2005).
Hennig et al. (1999) reported increased risk of developing L-AgP in t allele carriers in a 
small case-control study, while no association was observed for G-AgP. It is worthy of 
mention that this restriction fragment length polymorphism (RFLP) of the VDR gene, 
called Taq-I, is present in the coding sequence (exon 9) but is ‘synonymous’: its 
variation does not change the amino acid sequence of the encoded protein. Nonetheless, 
it may be in linkage disequilibrium with an unknown functional sequence elsewhere in 
the gene.
Speculations about the effect of VDR on AgP interaction may involve a combinatory 
effect on the immune response and/or on the bone metabolism, but this needs to be 
elucidated further.
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2.5. NEUTROPHILS
Phagocytes such as neutrophils (polymorphonuclear leukocytes, PMN) and 
monocyte/macrophages are the first part of the cellular defence in host resistance to 
bacterial invasion. PMN are produced in the bone marrow and released into the 
bloodstream, where they respond to a variety of stimuli via nonspecific and specific 
interactions (Van Dyke et al. 2003). A series of chemoattractans and environmental 
factors modulate PMN margination, adhesion, diapedesis and then migration from the 
vessel walls to the extravascular spaces. PMN directional migration is called 
chemotaxis, and is activated by chemoattractans like IL-8, platelet-activating factor, 
leukotrienes and N-formyl-methionine-leucyl-phenylalanine (FMLP). All these ligands 
interact with PMN through specific surface receptors, and activate signal transduction 
through a complex mechanism of cytoskeleton organization. In the extracellular spaces 
PMN are ready to exert their killing activity following bacterial phagocytosis. 
Compelling evidence gives PMN a prominent role in periodontal tissues defence against 
microbial pathogens, with particular regards to AgP (Hart et al. 1994, Van Dyke et al 
2003). It is widely recognized that whenever this first PMN defensive step is somehow 
defective, the net result is a shift in the physiologic homeostasis between bacteria and 
host response, resulting in periodontal disease. Support for this comes from the finding 
of severe destructive periodontitis as a common secondary feature in subjects affected 
by PMN deficiencies or malfunctions, such as neutropenia or Chediak-Higaghi 
syndrome (Deas et al. 2003).
Studies conducted in the past two decades (Suzuki et al. 1984, Van Dyke et al. 1986, 
Gronert et al. 2004) demonstrated chemotactic and phagocytic defects in AgP patients. 
Conversely with what these reports suggest, more recent research supports the 
hypothesis that it is the excess of activity and the release of toxic products from PMNs, 
and not their deficiency, that is responsible for the tissue destruction seen in AgP 
(Kantarci et al. 2003). PMNs of AgP patients, especially of Localized AgP, have been 
shown to be hyper reactive (Leino et al. 1994, Gronert et al. 2004) and there is now 
increasing evidence to suggest that periodontal lesions characteristic of AgP are
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determined by the nature of PMN and immune response (Gemmell et al. 2002, Van 
Dyke et al. 2003).
PMN biological activities and bacterial killing potentials are due to two different 
pathways: non-oxidative, through the release of proteases, and oxidative, through the so 
called ‘oxidative burst’. The role of the oxidative burst in inducing bacterial killing, but 
also tissue damage, has been widely recognized for many years (Henson et al. 1987, 
Weiss et al. 1989), and implicated in the pathogenesis of rheumatoid arthritis, diabetes, 
reperfusion injury, ulcerative colitis, pre-eclampsia, haemorrhagic shock (Kantarci et al. 
2003, Abdelrahman et al. 2005). This pathogenic potential due to the PMN activity is 
also evident on human periodontal ligament in vitro (Deguchi 1990). Altman et al. 
(1992) demonstrated the specific tissue damaging effect of the release of reactive 
oxygen species (ROS) on gingival epithelial cells. ROS have been shown to be 
biologically active and involved in bacterial killing both directly and indirectly, thanks 
to the following mechanisms: i) production of a cascade of anti-microbial reactive 
oxygen metabolites, such as hydrogen peroxide, hypoclorous acid and chloramines 
(Dahlgren et al. 1999, Van Dyke et al. 2003, Rada et al. 2004), both in the intracellular 
and extracellular milieu, ii) activation of proteases through a depolarization 
compensatory mechanism mediated by K+ flux subsequent to the reduction of O2 
(Reeves et al. 2002, Rada et al. 2004).
It has been widely demonstrated that the oxidative burst which leads to ROS production 
is increased in many LAgP cases compared with healthy controls (Leino et al. 1994, 
Gronert et al. 2004), even if the underlying defect leading to it has escaped 
understanding so far. Gronert et al. (2004) suspected a role o f PMN diacylglycerol- 
kinase a signalling in the pathogenesis of LAgP.
The research which forms the basis for this PhD has focused on two aspects of PMN 
function: bacterial recognition through specific receptors and superoxide production 
through NADPH oxidase activity.
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2.5.1. BACTERIAL RECOGNITION
Bacterial recognition is an important step towards PMN activation. PMN recognise 
bacteria opsonised to immunoglobulins (Ig) through specific Fc receptors. They are also 
able to recognise bacteria which are not bound to Ig through formyl-peptide receptors 
(FPR), which bind bacterial formyl peptide. These two different classes of receptors will 
be treated separately in the next sections.
2.5.1.1. Fc receptors
2.5.1.1.1 Function
PMN receptors for the Fc, or constant part of Immunoglobulins are considered to act as 
a bridge between cellular and humoral immunity through their binding to bacterial- 
bound Ig, which activates important effector functions. The Fc receptors expressed on 
PMN consist of a heterogeneous family of membrane bound and soluble proteins, 
differing in structure and ligand affinity and specific receptors exist for IgA, IgD, IgE, 
IgG and IgM (Ravetch & Bolland 2001, van Sorge et al. 2003). Particular interest has 
been attracted by Fc-a and Fc-y receptors, which bind respectively IgA and IgG. 
Increased concentrations of both these Ig antibodies against periodontopathic bacteria 
have been detected in gingival crevicular fluid and in the periodontal pocket epithelium 
of periodontitis patients (Tew et al. 1985, Yuan et al. 2000).
Fc-a receptors (CD89) are present on PMN, monocytes/macrophages and eosinophils. 
Once they interact with IgA coated on the surface of invading bacteria, they mediate 
several immunologic defense processes such as phagocytosis, antibody-dependent cell- 
mediated cytotoxicity, and release of inflammatory mediators (Monteiro & van de 
Winkel 2003).
Fc-y receptors are expressed in leukocytes and interact with bacteria-bound IgG, 
triggering phagocytosis, superoxide production, cellular cytotoxicity, antigen 
presentation, cytokine release, degranulation and regulation of antibody synthesis (van 
der Pol & van de Winkel 1998). They fall into three categories: Fc-yRI (CD64), Fc-yRII 
(CD32) and Fc-yRIII (CD16). Fc-yRI has been shown to be particularly effective in
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antigen presentation, while Fc-yRII is more effective in inducing phagocytosis, and 
FcyRIII is involved in phagocytosis and superoxide production by PMN (van Sorge et 
al. 2003). A diagram showing activation mechanisms for FcyRIII is represented in figure
2.1. There seems to be a very high redundancy in the Fc receptor functions, meaning that 
their overlapping functions are usually able to guarantee compensation for diminished or 
absent function of one of these receptors. It has been shown that Fc-yRI and Fc-yRIII 
deficient individuals do not have higher incidence of infectious or autoimmune diseases. 
Nonetheless, interindividual differences in Fc-y receptor genes may affect receptor 
functions at a more subtle level (van der Pol & Van de Winkel 1998).
FcyRIII
}  common ligand binding
Aggregation
Activation
Figure 2.1. Representation of an FcRIIIB with activation functions (taken from Ravetch & Bolland 
2001). A cytoplasmic IT AM sequence is associated with the receptor and allows signal transduction.
2.5.1.1.2 Polymorphisms
Fc-a receptor gene is located on chromosome 19 (locus 19ql3.4). Two polymorphisms 
have been identified in its functional promoter region (Shimokawa et al.2000) and one 
coding for an IgG-binding domain (Kaneko et al. 2004).
Fc-y receptor genes are located on the long arm of chromosome 1 (locus lq21-24). A 
schematic representation of chromosome 1 is presented in figure 2.2. Fc-yRI class is 
encoded by three genes (Fc-yRIa, Fc-yRIb and Fc-yRIc). Three genes also encode for
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Fc-yRII (a, b and c), while two encode for Fc-yRIII (a and b). Mutations and 
polymorphisms in the Fc-yRII and Fc-yRIII are suspected to affect ligand ability and 
effector functions, such as phagocytosis and killing of bacteria (van Sorge et al. 2003).
Z GC 
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Figure 2.2. Schematic representation of chromosome 1, indicating the regions rich in genes and SNPs 
within the chromosome. The FcyR genes are located in one o f these regions (1 q21.24, indicated by the 
arrow) (image taken from the Human Genome Project at the Sanger Institute website).
Fc-yRIIa is polymorphic in at least two sites, one of which (at position 494 in the gene) 
codifies for amino acids (at position 131) located in spots involved in IgG-binding. The 
histidine (H) at position 131 has been shown to increase receptor affinity and specificity, 
while the presence of an arginine (R) results in PMN with reduced ability to 
phagocytose IgG2-opsonized particles in humans (Bredius et al. 1994). Eleven 
polymorphisms, three of which have been shown to be non synonymous, have been 
detected in the Fc-yRIIb gene in a population of Japanese subjects (Yasuda et al. 2003).
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^7649550981330740558^275
8429^6 277657207338^77416649016579^
16914^16 79773620^^3308^
Fc-yRIII is the only PMN receptor without an intracellular part (see figure 2.1). It is 
anchored in the outer leaflet of the membrane via a glycosyl-phosphatidylinositol 
molecule. Both a and b genes are polymorphic. A G-T substitution at nucleotide 559 in 
the gene results in a valine (V) instead of a phenylalanine (F) at position 176. The V 
allotype exhibits higher affinity for IgGl, 3 and 4 than does the F allotype (Koene et al. 
1997). This may translate to an increased ability of phagocytosis and killing of bacteria.
The Fc-yRIIIb bears the neutrophil antigen (NA) polymorphism, implicated in 
autoimmune neutropenia and transfusion reactions. Five nucleotide substitutions result 
in two isoforms (NA1 and NA2) differing by 4 amino acids (at position 36, 65, 82 and 
106) in an Ig domain. NA1 and NA2 have been shown to have different glycosilation 
and therefore different ligand affinity. The NA1 allotype exhibits higher affinity for 
immune-complexed IgG3, and therefore increased phagocytosis (Salmon et al. 1990). 
Kobayashi et al. (2000b) showed that, in the presence of CD32-blocking antibody 
fragments, Fc-yRIIIbNA2-carrying PMN from both patients with CP and healthy 
controls were less efficient in phagocytosis and induction of oxidative burst upon 
interaction with IgGl- and IgG3-opsonized P.gingivalis. Furthermore, Bux et al. (1997) 
identified another antigen (SH) located on the Fc-yRIIIb, determined by a single base C- 
A mutation at nucleotide 266, which results in an Ala78Asp amino acid substitution. 
SH+ individuals are rare (usually <5%) and seem to be always accompanied by presence 
of the NA2 allotype, either because of close homology or because of linkage. This new 
antigen may have functional influences, still to be elucidated (Koene et al. 1998).
Considering the supposed importance of Fc-y receptors in handling bacterial infections, 
the possible role of FcyR polymorphism in relation to disease susceptibility has been the 
subject of several studies. In particular, the ability to interact with IgG2 conferred by the 
Fc-yRIIa H I 31 allotype has caused speculation about its possible clinical significance. 
The 131 Fc-yRIIa polymorphism has been associated with risk of upper respiratory tract 
infections and meningococcal septic shock (Bredius et al. 1994, Sanders et al. 1994). 
Homozygosity for R131 was also reported to increase the susceptibility to immune- 
complexed autoimmune diseases such as systemic lupus erythematosus (SLE) (Blasini et
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al. 1993). A combined Fc-yRIIa-R/R131- Fc-yRIIIb-NA2/NA2 genotype has been 
associated with increased frequency of meningococcal disease (Fijen et al. 1999, 
Platonov et al. 1998).
2.5.1.13 Relation to periodontitis
Dense infiltrates of neutrophils with high expression of Fc-a receptors have been 
detected in the apical part of diseased periodontal pockets (Yuan et al. 2000). Kaneko et 
al. (2004) investigated a population of 46 AgP patients and 90 healthy Japanese controls 
for the distribution o f a -324 A-G transition. They found a statistically significant 
increase in prevalence of allele A in the patient group. This polymorphism does not 
change the coded amino acid, therefore the supposed effect might be due to another 
polymorphism in linkage disequilibrium with the -324 (Kaneko et al. 2004). PMN from 
allele A homozygous individuals also exhibited decreased phagocytosis of 
Porphyromonas gingivalis.
Periodontitis is among the most widely studied bacterial diseases in relation to Fc 
receptor polymorphisms. Kobayashi et al. (1997) suggested some years ago the possible 
role of Fc-yRIIIb NA2 allotype in inducing recurrence of periodontitis in a group of CP 
patients. They then extended their observation to Early Onset periodontitis and proposed 
the importance of the same allele in disease susceptibility (Kobayashi et al. 2000a). 
Yoshihara et al. (2001) confirmed this result analyzing Fc-yRIIIb genotype distribution 
in a Japanese population, albeit with small numbers of subjects (only 42 AgP). Fu et al.
(2002), studying 48 LAgP and 67 controls, all of Afro-American descent, gave support 
to the previous findings, identifying the NA2 allele as a risk susceptibility factor. Chung 
et al. (2003) could not confirm this finding in 30 GAgP patients from Taiwan, and 
neither could studies performed on Caucasians with CP (Colombo et al. 1998, Loos et al. 
2003). Loos et al. (2003), performing a study of 12 GAgP, 56 CP and 61 Caucasian 
controls, concluded that homozygosity for Fc-yRIIa 131H may be a risk factor for AgP. 
Yamamoto et al. (2004), in a study of 422 Caucasian adults observed an increase in the 
HH genotype in CP patients. Yasuda et al. (2003) found increased prevalence of allele T 
at nucleotide 232 of Fc-yRIIb in a Japanese AgP population. Looking at all these reports
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as a whole, the evident lack of a study including large numbers of subjects reduces the 
external validity of these results. Nonetheless, AgP seems to be consistently associated 
to the Fc-yRIIIb NA2 allotype in Japanese populations. Furthermore, this finding is 
supported by the functional results in relation to handling of periodontal bacteria 
(Kobayashi et al. 2000b). However, data on AgP Caucasians are lacking. Association 
with other Fc-yR polymorphism has shown conflicting results, maybe because of the 
different populations studied.
2.5.1.2. FPR receptors
2.5.1.2.1 Function
The formyl peptide receptor (FPR) is a transmembrane receptor expressed in PMN and 
monocytes. The FPR has 7 transmembrane domains, connected by intra- and extra­
cellular loops, which are coupled to intracellular effectors through guanine nucleotide 
regulatory proteins (G proteins) (Quehenberger et al. 1993, Seifert et al. 2001). It 
recognizes and binds N-formyl peptide, a chemotactic factor derived from human 
mitochondrial proteins and bacterial products, such as FMLP. When recognition occurs, 
PMN are driven to sites of bacterial invasion or tissue damage. Signaling events include 
cell adhesion, phagocytosis, stimulation of oxidative burst and production of 
inflammatory cytokines (Cui et al. 2002). Multiple domains of the FPR seem to be 
required for high-affinity ligand binding. Major determinants are probably located on the 
first extracellular loop and its adjacent transmembrane domain. An additional important 
site for determination of ability to bind the ligands is located in the second extracellular 
loop. Its substitution, as well as substitutions of the fourth and fifth transmembrane 
domains, has been associated with a 27-fold decrease in ligand binding affinity 
(Quehenberger et al. 1993). An FPR variant with lower affinity is called FPR-like 1, and 
interacts with high concentrations of FMLP.
2.5.1.2.2 Polymorphisms
FPR is encoded by the FPR1 gene, located on chromosome 19 and organized into 3 
exons and 2 introns. Several gene polymorphisms in the gene encoding for different 
components of the receptor have been detected (Zhang et al. 2003).
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2.5.1.2.3 Relation to periodontitis
Reduced chemotaxis of PMN is now a confirmed feature o f LAgP (Cianciola et al. 
1977, Genco et al. 1980, VanDyke et al. 1985). Given the importance of FPR in 
stimulating chemotaxis, several investigators have suspected the FPR1 gene as being 
responsible for chemotactic defects in AgP. Gwinn et al. (1999), in a study of 30 LAgP, 
5 GAgP, 30 CP patients and 20 healthy controls, found a remarkable association 
between two single base substitutions at position 329 (C to T) and 378 (C to G) and the 
presence of LAgP: 29 out of 30 African American LAgP patients, and none of the other 
subjects included in the study exhibited at least one of these two substitutions. Both 
these polymorphisms result in amino acid changes in the second intracellular loop of the 
receptor and may be linked to difference in ligand affinity (Seifert et al. 2001). Further 
research, however, has not supported these findings and what looked like a remarkable 
association, may actually be due to population stratification. Zhang et al. (2003) 
performed sequencing analysis of the FPR1 gene spanning from nucleotides 250 to 615, 
on 111 AgP patients and 115 healthy controls of mixed ethnicity. None of these subjects 
presented any of the nucleotide substitutions reported by Gwinn et al (1999). 
Nonetheless, they identified six single nucleotide polymorphisms (301 G-C, 306 T-C, 
348 T-C, 546 C-A, 568 A-T and 576 T-C-G), two of which were associated with the 
AgP phenotype in their study group of African Americans. These two polymorphisms 
(at nucleotide 568 and 576) are non-synonymous, determining a change in the coded 
amino acid in the second extracellular loop of the receptor. In particular, the 568 T to A 
substitution determines a change from a basic to an acid amino acid (arginine to tripsine) 
at codon 190 (Zhang et al. 2003). Considering the above mentioned importance of this 
second extracellular loop in ligand affinity, this change may have a reflection on 
receptor function. The polymorphism at position 301 is also functional, although 
affecting a site not shown to be important for ligand affinity. Maney et al. (2005) 
studying the FPR-1 genetic profile of 12 African American AgP patients and 12 
controls, identified the 348 polymorphism as a possible risk indicator for AgP, and 
found only weak associations for the other polymorphisms described by Zhang et al.
(2003). They also did not find any of the polymorphisms described by Gwinn et al.
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(1999). Therefore, the basis for a possible association between FPR polymorphisms and 
AgP exists and deserves further study.
2.5.2. SUPEROXIDE PRODUCTION
2.5.2.1. NADPH oxidase
2.5.2.1.1 Function
The NADPH (nicotinamide adenine dinucleotide phosphate) oxidase is the enzyme 
responsible for the activation of the oxidative cascade in PMN, which through the 
release of superoxide (O2 ) and hydrogen peroxide (H2O2) leads to the production of 
reactive oxygen species (ROS). The NADPH oxidase (also known as phagocyte oxidase 
or respiratory burst oxidase) is a terminal electron carrier from NADPH to molecular 
oxygen (Robinson et al. 2004). The resulting electrons are moved and delivered to 
produce O2" both in the phagosome and in the extracellular environment (Dahlgren & 
Karlsson 1999) with the following stoichiometry:
NADPH+ 2 0 2 —> NADP+ + 2 0 2 + H+.
Then superoxide undergoes a dismutation reaction to form peroxide:
O2 + O2 + 2H+ —► H2O2+ O2 .
The NADPH system is a multicomponent enzyme consisting of six subunits (see figure 
2.3). Two of them, gp91phox and p22phox, located in the membrane, form 
flavocytochrome b558, the catalytic core of the enzyme. The gp91phox (also termed Nox2 
or subunit p) contains the NADPH-binding site, a flavin adenine dinucleotide (FAD) and 
two haeme groups coordinated by two pairs of histidine residues (Werner et al. 2004). 
The 22-kDa a  subunit (p22phox) has a regulatory role and is essential for oxidase 
activation and recruitment of cytosolic factors. Three o f the other subunits, p47phox, 
p67phox and p40phox form a complex located in the cytosolic component of resting 
neutrophils. The fourth component is the small GTP-binding protein known as Rac2 
(p21rac), also located in the cytoplasm.
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Figure 2.3. Schematic representation o f the neutrophil NADPH oxidase. Upon stimulation by bacterial 
products or pro- inflammatory cytokines, the four cytosolic components (p40phox, p47phox, p67phox 
and Rac) migrate towards the membrane. In the membrane they interact with the two membrane 
components (p22phox and gp91phox) thus activating the enzymatic functions and determining 
production and release of 0 2 both in the phagosomes and in the extracellular environment (images 
adapted from Dahlgren & Karlsson 1999 and Takeya & Sumimoto 2003).
The NADPH oxidase is normally dormant. Upon stimulation by bacterial products, pro- 
inflammatory cytokines or by appropriate agents such as the protein kinase C activator 
PMA (4B-phorbol 12-mystrate 13-acetate), the cytosolic components migrate to the 
membrane, where they interact with cytochrome b558, and thus activate the enzymatic 
reactions. In more detail, stimulation of the neutrophils activates p40phox, which 
regulates the recruitment to the membrane of p67phox and p47phox. Simultaneously, upon 
activation p47phox becomes phosphorylated at multiple serine sites, and its SH3 domains 
become accessible to a proline-rich region of p22phox, which activates gp91phox. In 
addition, Rac2 is independently activated and binds to p67phox and gp91phox. As
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represented in figure 2.3, this system of interactions leads to the activation of the 
enzyme, and subsequently to the release of superoxide (Takeya & Sumimoto 2003).
Therefore, oxidative activity is strictly regulated by a complex network of interactions, 
and it is never present in resting cells. Moreover, gene expression of gp91phox, p47phox 
and p67phox is restricted to mature phagocytes (Price et al. 2002).
In recent years, the production of reactive oxygen species (ROS) has been implicated in 
numerous physiological and pathological processes and their importance as second 
messengers is now emerging. ROS are thought to coordinate extracellular signals 
received through membrane receptors with intracellular activation of mitogenesis, cell 
adhesion, gene expression and cell survival (Werner et al. 2004). Seven different 
NADPH oxidases (also known as Nox) have now been identified: Nox 1 is present in the 
colon, Nox 2 is the phagocyte oxidase, Nox 3 in the inner ear, Nox 4 is expressed in 
kidney, vascular cells and osteoclasts, Nox 5 in lymphoid tissues, Duoxl in the thyroid 
and in the respiratory epithelia, Duox2 is involved in hormone synthesis.
The possible role of the osteoclastic Nox 4 in relation to periodontal disease is 
particularly intriguing. Several studies suggest that it is involved in activation and 
formation of osteoclasts, and is responsible for osteoclastic superoxide production, 
therefore playing a role in bone resorption (Yang et al. 2001). Osteoclasts have been 
shown to secrete hydrogen ions, proteinases and superoxide in order to excavate a 
resorption pit or lacuna in the bone surface. Superoxide may stimulate bone resorption 
by activating collagenases and by participating in fragmentation of matrix proteins. 
Yang et al. (2001) showed a decrease in bone resorption following inhibition of the 
superoxide production by the oxidase. Furthermore, defects in superoxide generation 
have been found in patients suffering from osteopetrosis, a disease characterized by 
excessive bone formation. In this context, it is necessary to underline the importance of 
the p22phox subunit, shown to be indispensable in the osteoclastic Nox 4 superoxide 
production (Yang et al. 2004).
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2.5.2.2. Polym orphisms
The gene encoding for the p22phox subunit of flavocytochrome b558 is located on 
chromosome 16 and known as CYBA (for subunit a  or p22phox). Defects in this gene, as 
well as in the genes coding for gp91phox, p47phox and p67phox, are associated with chronic 
granulomatous disease (CGD), an inherited disorder characterized by a severe defect in 
host defense against bacteria and fungi (Dinauer et al. 1993). In CGD, the activity of the 
NADPH oxidase enzyme is greatly diminished or absent. In myeloid cells, the absence 
o f p22phox protein because of genetic defects also results in the loss of gp91phox 
expression and vice versa, indicating that each of these proteins requires the other for 
mutual stability (Rae et al. 2000). Furthermore, UshioFukai et al. (1996) provided 
evidence that the p22phox is critical for the function of the NADPH oxidase. They 
showed that the transfection of antisense p22phox cDNA decreased superoxide production 
in rats.
Parkos et al. (1988) described a 242C-T polymorphism o f the CYBA gene causing a 
histidine to tyrosine change at position 72. This substitution involves a potential haem- 
binding site, which can have as a consequence an increase or decrease of superoxide 
production. Several groups have studied the possible relation between this 
polymorphism and the risk of developing cardiovascular disease, intracranial aneurysm 
and diabetes, with conflicting results. The T allele has first been linked to a protective 
role on coronary risk (Inoue et al. 1998). However, this result was not confirmed by 
subsequent studies, which either found no associations (Li et al. 1999, Gardemann et al. 
1999, Renner et al. 2000), or tendency to increased cardiovascular risk in young 
Caucasians (Cai et al. 1999) and progression of coronary atherosclerosis (Cahilly et al. 
2000). Existing data suggest that the vascular and phagocytic p22phox are very similar, 
even though the latter has much higher activity (De Keulenaer et al.1998). In order to 
investigate the functional importance of this amino acid substitution, Shimo-Nakanishi 
et al. (2004) measured the PMN oxidative burst on a subset o f Japanese patients with 
thrombotic cerebral infarction, and related it to the C242T p22phox polymorphism. They 
showed that, although basal superoxide production was not different, subjects with the T 
allele had significantly higher oxidative burst than CC subjects under stimulation by
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PMA. In contrast, Wyche et al. (2004) in a study on 90 healthy Caucasians detected an 
increase in superoxide production in CC positive individuals.
2.5.2.3. Relation to periodontitis
There are no published studies in the literature investigating a possible role of any 
NADPH oxidase polymorphisms in periodontal disease. However, we can hypothesize 
that given the importance of superoxide production in the defense against bacterial 
infections, its tissue-damaging potential and considering the tight regulation of the 
NADPH oxidase activity, a variation in its activity, due to genetic polymorphisms, may 
predispose to the onset of AgP. The increased superoxide production seen in AgP 
patients may therefore be linked with polymorphism in the p22phox component of 
NADPH oxidase, both in PMNs and osteoclasts, and could account for the considerable 
destruction of periodontal attachment and alveolar bone.
Further element for speculation about the possible role of NADPH oxidase in 
periodontitis is given by a study on gene expression signatures in chronic and aggressive 
periodontitis (Papapanou et al. 2004). They found up-regulated expression in 
periodontitis patients of a cluster of genes including NAD, including the PBEF gene, 
involved in its biosynthesis, and the NAD+ isocitrate dehydrogenase (3, NDUFB8, 
NDUFC1 and NDUFB2 genes, involved in NADH dehydrogenization.
55
CHAPTER 3
3. AIMS OF THE STUDY
The overall main points outlined in the preceding chapters, may be summarized as 
follows:
• AgP affects a small but significant percentage of the population (at least around 1%) 
and leads to tooth loss at a young age
• It is an infectious disease, associated with specific bacteria
• Genetically determined host response affects susceptibility to AgP by modifying the 
response to bacterial plaque
However, despite the conspicuous amount of knowledge developed in recent years, we 
are still a long way from having a complete understanding of AgP aetiopathogenesis. 
Furthermore, patients are often not very well informed about the characteristics and 
consequences of AgP, and the same applies to some general dentists. This is due to the 
fact that periodontitis is not usually accompanied by painful symptoms: this means that 
the patients are not always able to imagine that the bleeding they see when they brush 
their teeth is the manifestation of a severe gingival disease, which if  not treated early 
may put the future of their teeth at risk. All these aspects taken together mean that when 
such a patient gets to the attention of a periodontist, the disease is usually at an advanced 
stage.
The management of AgP patients is therefore extremely difficult and delicate, 
considering the young age of the patients and the advanced degree of periodontal 
destruction. The treatment usually consists of oral hygiene instruction, supra- and sub­
gingival debridement, which may also involve the use of antimicrobials, and extraction 
of the hopeless teeth. These are the teeth whose attachment and bone loss is too 
advanced and therefore cannot respond adequately to the treatment. This first phase of 
treatment is usually followed by sessions of surgical treatment, aimed at correcting the 
tissue damage provoked by AgP. The loss o f a number o f teeth, usually first molars and 
incisors, at a young age means that AgP patients face a lifetime of complex dentistry in 
order to replace them, over 50 years or more.
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Several improvements have recently been made in the ability to treat AgP patients, and 
to replace missing teeth, by means o f bridges or osseointegrated implants. However, a 
better understanding of the disease process is still needed, in order to inform more 
specific and more effective prevention and treatment regimes. A specific area which 
requires further research is the genetically determined host response of AgP patients. As 
mentioned in the previous chapter, several studies have been conducted in the last 5-10 
years but, because of lack of power or other problems, have left us with more doubts 
than certainties.
The aim of my PhD has been to take advantage of the large number of AgP patients 
referred to our Department to gain a better insight into the genetic susceptibility factors 
leading to AgP. General aims are:
• Detecting genetic polymorphisms which are risk factors for the onset of AgP
• Exploring the familial aggregation of AgP
• Correlating genetic risk factors with the severity o f AgP
• Exploring possible mechanisms of association between genetic risk factors and 
onset o f AgP
Specific aims will be discussed within each individual chapter. The next chapter will 
describe the general materials and methods and the procedures adopted in order to 
achieve these aims.
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CHAPTER 4
4. GENERAL MATERIALS AND METHODS
The research on which this PhD is based took place entirely at the Eastman Dental 
Institute and Hospital (EDI/EDH). Patient examinations were performed at the main 
clinic of the Department of Periodontology and at the Eastman Clinical Investigation 
Centre (ECIC). Control subjects were examined at the Departments of Oral Surgery, 
Conservation, Endodontics and ECIC. The laboratory work was performed in the 
laboratories o f the Eastman Dental Institute and Hospital.
The EDH receives referrals for specialist consultations and treatment from general 
dental practitioners (GDPs). Referrals regarding periodontal problems are directed to the 
Department of Periodontology, and several consultants are responsible for screening the 
patients through an initial consultation. Once a patient is examined clinically and 
radiographically, provisional diagnosis is made and patients are either discharged back 
to their GDP or allocated for treatment within the Hospital.
In the last 8 years, a special clinic has been arranged for patients suffering from Early 
Onset forms o f Periodontitis (EOP, now AgP). Therefore, patients with a suspect 
diagnosis o f AgP are referred by the examining consultant to this clinic, where a more 
detailed examination will allow the diagnosis to be confirmed (see flow chart in figure 
4.1). Examination in the ‘Early Onset clinic’ consists of full mouth periodontal clinical 
measurements, full mouth long cone periapical radiographs with parallel technique, 
discussion about medical and family history, clinical photographs and case presentation 
to the patient.
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General Dental Practitioners
Referral letter
EDH
Department of Periodontology 
SCREENING CLINIC
Suspect 
diagnosis of 
AgP
EOP CLINIC:
• Family history
• Medical history
• Full mouth periodontal measurements 
• Full mouth periapical radiographs
Confirmed 
diagnosis of AgP
Discussion about research study 
Consent 
Examination and blood sample
Allocation for 
treatment
Figure 4.1. Chart showing the flow o f patients 
from their General Dental Practice 
to inclusion in the study.
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4.1. Anamnesis
All examined individuals are normally given a medical history questionnaire to fill at 
their first visit in the Hospital. Every questionnaire was checked by the examiner and the 
answers confirmed by the patient. Long term past or present usage of medications was 
recorded.
Ethnicity and family history of periodontal disease were recorded in a specific 
questionnaire, given to the patients at the specific examination visit in the ‘Early Onset 
clinic’. Patients were asked to describe the ethnic origin of their parents, and to write the 
details and age of their first degree relatives (parents, siblings and children); specific 
questions investigated whether any of the relatives had any missing teeth, loose teeth, 
bleeding gums or if they had been treated for periodontal disease. Patients were also 
invited to investigate whether their relatives were willing to be examined at the EDH. 
The patients were divided into 3 main ethnic groups: Caucasian, Black (including Black- 
Africans and Black-Caribbeans) and Asian (including all different Asian ethnic groups, 
such as Indian, Pakistani, Chinese, Japanese etc.). All other subjects and subjects who 
had at least one grandparent of dissimilar ethnic origin than the other three were 
classified as ‘others’.
The dental and periodontal history of the patients was also investigated. They were 
asked to describe their symptoms, when they had started, and if they had any periodontal 
treatment provided in the past. Whenever possible, a letter was sent to their GDPs asking 
to provide patients’ old records (probing pocket depths, radiographs).
4.2. Periodontal examination
Single pass, whole mouth measures of the distance from the free gingival margin to the 
base of the sulcus (probing pocket depth, PPD, rounded up to the next millimetre), the 
distance from the cement-enamel junction (CEJ) to the free gingival margin (FGM) and 
bleeding on probing (BOP, positive or negative) were collected using a manual, 
incremental UNC-15 periodontal probe. Both PPD and recessions (REC= CEJ-FGM) 
measurements were used to determine the lifetime cumulative attachment loss (LCAL=
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PPD+ REC). Six sites were measured for each natural tooth, one each at the 
mesiobuccal, buccal, distobuccal, distolingual, lingual and mesiolingual sites encircling 
the tooth. The measurements were made at the corresponding contact points or their 
equivalent in case o f a missing tooth, and at the midpoint of buccal and lingual surfaces. 
An example of a probing sheet used for the study is presented in appendix I.
Scores of full mouth bleeding on probing (FMBS) and plaque (FMPS) were also 
recorded. Both were measured as dichotomous variables: if  a site bled within 15 seconds 
after probing the score was positive (1), otherwise it was negative (0). FMBS represents 
the percentage o f bleeding sites in the whole mouth. FMPS was calculated as the 
percentage of sites with plaque detected by moving a periodontal probe around the 
cement-enamel junction of each tooth.
4.3. Diagnosis
Anamnestic, radiographic and clinical data collected were studied in order to confirm a 
diagnosis of AgP. Diagnosis of AgP was based on the 1999 Consensus Classification of 
Periodontal Diseases (see chapter 1). Our diagnostic criteria took into consideration only 
clinical, and not laboratory, evidence. A single experienced clinician confirmed the 
diagnosis. Patients were classified as having AgP when they had evidence of:
•  Healthy status, except for the presence of periodontitis. All patients with possible 
contributory medical history, such as specific recognized genetic diseases with 
periodontal manifestations (i.e. Papillon-Lefevre syndrome), diabetes, or 
prolonged use of anti-inflammatory or immunosuppressive medications were 
excluded.
•  Rapid attachment loss and bone destruction, proven by X-rays obtained at a few 
years distance. When this was not possible, severe disease at a young age was 
used, with patients < 35 at the time of the initial diagnosis.
•  Familial aggregation. Patients were preferably included in the study if they had 
positive family history. However, given the difficulty of ascertaining accurate 
family history and of examining all their first- degree relatives, patients showing
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clear clinical signs of AgP were still included even without a proven positive 
family history.
• Clinical and radiographic diagnosis. All individuals who fulfilled the above 
mentioned criteria, but who had retentive factors or high plaque scores, 
proportionate to the amount of periodontal destruction present, were excluded. 
Such a measure was used to take advantage of the lee-way space the new 
classification leaves to personal interpretation, in order to exclude patients 
belonging to the ‘grey area’ between AgP and Chronic periodontitis. Patients 
were classified accordingly to the 1999 classification of Aggressive Periodontitis 
(Armitage et al. 1999) with Localised AgP (LAgP) when presenting with 
interproximal PPD and LCAL > 5 mm and radiographic bone loss of > 30% of 
root length on at least two permanent teeth, of which at least one was a first 
molar or incisor, and including no more than two teeth other than first molars or 
incisors. Patients were diagnosed with Generalised AgP (GAgP) when presenting 
with generalised interproximal PPD and LCAL > 5 mm and radiographic bone 
loss of > 30% of root length affecting at least three permanent teeth other than 
first molars and incisors.
4.4. Blood sampling
Once a diagnosis of Aggressive Periodontitis was confirmed, patients were asked to give 
their consent to have a blood sample taken for routine testing and genetic investigation. 
The blood samples were drawn by the examiner from the antecubital vein of the patient 
sitting in the dental chair in a semi-reclined position. After applying a tourniquet on the 
bicep area and disinfecting with an alcohol swab, a vacutainer tube system with a 19 or 
21 gauge butterfly needle was used. The first blood sample was used to measure full 
blood count (purple tube). Two EDTA tubes (7ml- pink) were then used for storage of 
blood for DNA extraction. A vacutainer tube (3.5ml - gold) containing serum separator 
gel additive was used for cholesterol and lipids screening; a fluoride oxalate tube (light 
grey) was used to quantify glucose levels. Additionally a red cup vacutainer for serum 
collection, and a citrate vacutainer (light blue) for plasma separation were used. Within 
one hour of collection these samples were centrifuged at 3000 rpm for 15 minutes.
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Serum and plasma collected were then placed into aliquots of 1ml in plastic cryovials 
and stored at -70°C.
The next chapters will describe one by one the different studies which, taken together, 
form this PhD. In the first one (chapter 5), the clinical data collected in our patient 
sample will be analyzed and discussed. The following chapter (6) reports the methods 
and results of a genetic association study performed on our AgP patients and on 231 
healthy controls. Chapter 7 describes the relations detected between genetic markers and 
disease severity. The eighth chapter relates to the family study performed by examining 
the relatives of our AgP patients. The ninth chapter describes a study we have performed 
on a subset of our patient sample, in order to investigate the prevalence of specific 
bacterial pathogens and the microbe-genetic interactions. The tenth chapter reports about 
a functional study performed on the neutrophils (PMN) of a subset of our patients.
All the results of these different studies will then be discussed as a whole and 
conclusions will be drawn in the last chapter.
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CHAPTER 5
5. CLINICAL DATA
5.1. BACKGROUND
Early onset forms of periodontitis have always been broadly distinguished into Localised 
and Generalised, with the Localised characterised by an incisor-molar pattern of bone 
loss, and the Generalised affecting a larger number of teeth. Several attempts have been 
made to identify different patterns of disease within these two broad categories. Manson 
and Lehner (1974) subdivided the Localised form into typical and atypical. The first was 
symmetrical with involvement of incisors and first molars in both jaws; the atypical 
form was asymmetrical, with one arch involved to a greater extent than the other. 
Another sub classification identified three forms of disease: class I, involving first 
molars and/or incisors; class II, involving first molars, incisors and some other teeth, 
with a total of fewer than 14 other teeth affected; class III, with generalised involvement 
o f more than 14 teeth (Bial & Mellonig 1987). The current classification distinguishes 
just LAgP and GAgP (see chapter 1). The clinical differential diagnosis is based on the 
number of teeth affected other than first molars and incisors: in LAgP no more than two 
other teeth are affected. If more teeth are affected, the case falls into the GAgP 
classification. LAgP usually has an earlier onset, around puberty, but cases of primary 
dentition involvement have also been described (Sjodin et al. 1993, Hilgers et al. 2004). 
Some investigators reported progression from LAgP to GAgP (Brown et al. 1996), so 
doubts remain whether some cases of GAgP may represent the evolution of untreated 
LAgP cases.
LAgP cases classically consist of vertical bone loss affecting first molars and incisors 
symmetrically in both sides. The lesions usually present radiographically as an arch­
shaped image of radiolucency surrounding maxillary or mandibular first molars and 
incisors. The reason for increased susceptibility of these teeth to LAgP is not clear. One 
possible explanation is that first molars and incisors are the first teeth to erupt in the 
permanent dentition. Therefore, they reflect more than other teeth the cumulative effect 
o f disease pathogenesis, being present in the mouth for longer. An alternative 
explanation is that the disease may be the manifestation of an aetiologic factor present in
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the early phases of puberty or before that, when these are the only teeth fully erupted 
(Lindskog & Blomlof 1983).
GAgP usually presents a more widespread pattern of bone loss with multiple teeth 
affected in both jaws and both arches.
The aim o f this chapter was to:
1. Describe the clinical characteristics of the AgP patients described in this thesis
2. Examine the subgroups of Localised and Generalised Aggressive Periodontitis 
to determine differences in clinical presentation, some of which would be 
predetermined by the definitions set in the classification
3. Examine the effect of patient factors such as age, gender, ethnicity and smoking 
on the clinical parameters
5.2. MATERIALS AND METHODS
Clinical data from 224 consecutive AgP patients referred for care to the Department of 
Periodontology were studied. The data collected included probing pocket depths (PPD), 
recessions (REC), lifetime cumulative attachment loss (LCAL), full mouth plaque 
scores (FMPS) and full mouth bleeding on probing scores (FMBS) (see paragraph 4.2 
for details). Recession and therefore LCAL measure were recorded only in 184 patients. 
Three different examiners collected the clinical measurements throughout the study. 
Although they underwent exercises of intraexaminer calibration and they had been 
trained to perform clinical measurements with the same technique, no interexaminer 
calibration was performed between them. Radiographic records, including long cone 
periapical radiographs with parallel technique and/or orthopantomograph were available 
for all subjects. Clinical and radiographic data and clinical photographs are presented 
for two example cases for both GAgP and LAgP.
5.2.1. CASE 1 Generalised Aggressive Periodontitis
This patient was referred by her General Dental Practitioner (GDP), who thought she 
might be affected by Early Onset Periodontitis. She presented as a 31-year old
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Caucasian, with clear medical history and a past history of smoking (15 cigarettes/day 
for 10 years, had given up for 1 year). She was complaining about mobility and bleeding 
on brushing, which started a few years before and got worse recently. She reported a
family history of periodontal problems and tooth loss at a young age in her parents.
Clinical examination revealed good oral hygiene, 28 teeth fully erupted plus two lower 
third molars partially erupted, localised recessions with localised loss of interdental 
papillae and no evident marginal inflammation (see figure 5.1). Clinical measurements 
revealed:
• Full mouth plaque score of 23%
• Full mouth bleeding score of 82%
• 158 probing pocket depths > 5 mm (94% of all sites)
• Average probing pocket depth of 7.34 mm
• Average recessions of 0.72 mm
• Average lifetime cumulative attachment loss of 8.06 mm
Figure 5.1. Frontal intraoral view of the 31-year old Caucasian former smoker female patient described 
in paragraph 5.2.1. Localised recessions and loss of interdental papillae are evident. Small amounts of
localised deposits of plaque are also present.
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Radiographic examination revealed:
• Generalised horizontal bone loss > 30% of root length on all teeth (ranging 
from 30 to 80%)
• Localised vertical bone loss (see figure 5.2)
Figure 5.2. Orthopantomograph of the patient described in paragraph 5.2.1. Generalised bone loss is 
present, with localised vertical defects. The mandibular canines are the only teeth still preserving at 
least half of the original alveolar bone radiographic length.
All the characteristic features for a diagnosis of Generalised Aggressive Periodontitis 
were present: clear medical history, rapid progression (testified by the very advanced 
attachment loss and bone destruction compared to her age), possible family history and 
amount of local factors not proportionate with the periodontal destruction present. No 
laboratory diagnostic criteria had been obtained at the time of first diagnosis.
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5.2.2. CASE 2 Localised Aggressive Periodontitis
This patient presented as a Black Caribbean 14-year old, referred by her GDP, 
complaining of occasional bleeding on brushing and soreness around some of the back 
teeth. She was a student, bom in Jamaica, and had recently moved to London. Her 
medical history was clear and she was not a smoker. She referred to a positive family 
history of gum disease; she had 5 brothers and sisters; only one sister lived in the UK 
and she had some gum problems. Clinical examination revealed a moderate standard of 
oral hygiene, with a lack of gross deposits of plaque and calculus, and a minimally 
restored dentition (see figure 5.3). All teeth were present, with the exception of third 
molars which were still unerupted. Clinical measurements revealed:
• Full mouth plaque score of 25%
• Full mouth bleeding score of 15%
• 10 probing pocket depths of > 5 mm (6% of all sites)
• Average probing pocket depth of 3.01 mm
• No recessions
Figure 5.3. Frontal intraoral view of the 14-year old Black Caribbean female patient described in 
paragraph 5.2.2. Localised marginal inflammation is present, with very small amounts of local
deposits.
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Radiographic examination revealed:
• Localised vertical bone loss affecting all first molars and upper right central 
incisor (see figures 5.4 and 5.5).
Figure 5.4. Orthopantomograph of the patient described in paragraph 5.2.2. Localised bone loss is 
present around 16 (UR6), 11 (UR1), 26 (UL6), 36 (LL6) and 46 (LR6).
Figure 5.5. Long cone periapical radiographs showing the localised periodontal vertical defects o f the
patient described in chapter 5.2.2.
Clear medical history, family history, rapid progression and fair oral hygiene all 
contributed to a diagnosis of Aggressive Periodontitis. The pattern of destruction was 
consistent with a diagnosis of LAgP.
5.2.3. Statistical analysis
Clinical data from all patients were entered in an SPSS 12.0 file and proofed for entry 
errors. Continuous, normally distributed variables are reported as means ± standard
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deviations (SD). The normality of distribution of the clinical parameters (av. PPD, av. 
LCAL, number of PPD > 5 mm, number of PPD > 10 mm and FMBS) was plotted and 
tested by Kolgomorov- Smirnov and Shapiro-Wilk tests. Since average PPD and average 
LCAL did not show normal distribution, they were log-transformed for the analysis. 
Comparisons of continuous and categorical data between groups were analyzed with 
ANOVA and Chi-square test, respectively. Multivariate analysis was used to detect the 
possible influence of smoking, ethnicity, age and gender on clinical parameters, 
separately in GAgP (whole group and Caucasians) and LAgP cases. The a value was set 
at 0.05. The normality of distribution of each of the residuals was then confirmed by Q- 
Q plots and by Kolgomorov- Smirnov and Shapiro-Wilk tests.
5.3. RESULTS
Demographic and clinical data on all patients are reported in table 5.1, while table 5.2 
shows the subdivisions in GAgP and LAgP. Average FMBS, PPD, LCAL and PPD > 5 
mm and > 10 mm are presented. Patients had an average age just short of 30 years old, 
half of them were Caucasians, and about half of them had never smoked in their life. 
The female: male ratio was almost 2: 1. Average clinical measurements reveal that 
FMPS was 42% on average, and about half of the sites bled on probing. The patients had 
an average of 28 teeth each including third molars, so they had lost just a small 
percentage of their teeth. The mean probing pocket depth (excluding third molars) 
approached 4 mm per site, and the mean LCAL was 4.5 mm. Fifty-three sites per patient 
on average had > 5 mm PPD and about 50% of the patients had at least 1 site with 10 
mm PPD, with an average of 2.9 such sites in each patient. As expected, GAgP patients 
were older than GAgP patients and had statistically significant increased averages of 
clinical measurements.
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PATIENTS
(n=224) %
| AGE 29.9 ± 7 .2 -
GENDER
Male 79 35.7
Female 145 64.3
Caucasian 112 50.0
ETHNICITY
Afro-Caribbean 59 26.3
Asian 34 15.2
other 19 8.5
Non smokers 118 52.7
SMOKING
Former smokers 52 23.2
Light smokers (<20/day) 38 17.0
Heavy smokers (>20/day) 16 7.1
FULL MOUTH PLAQUE SCORES - 41.9 ± 2 4 .9
FULL MOUTH BLEEDING SCORES - 49.7 ±24.1
NUMBER OF TEETH 28.0 ± 2 .8 -
Av. PPD 3.9 ±  1.1 -
Av. REC 0.5 ± 0 .8 -
Av. LCAL 4.5 ± 1.6 -
NUMBER OF PERIODONTAL POCKETS > 5 
mm
53.4 ± 3 4 .0 34.5 ± 2 2 3
NUMBER OF PERIODONTAL POCKETS > 10 
mm
2.9 ± 5 .3 1.9 ± 3 .4
Table 5.1: Demographic and clinical characteristics o f  the Aggressive Periodontitis (AgP) patients. PPD 
indicates probing pocket depths, REC indicates recession and LCAL stands for lifetime cumulative
attachment loss
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GAgP LAgP Comparison
between
groups(n=167) % (n=57) %
AGE 3 1 .4  ±  6 .0 - 2 5 .6  ± 8 . 4 - p< 0.000
GENDER
Male 59 35.3 2 0 35.1 p= 1.000
Pearson
Chi-squareFemale 108 64.7 3 7 64.9
Caucasian 88 52.7 2 4 42.1
ETHNICITY
Afro-
Caribbean 45 26.9 14 24.6
p= 0.226
Pearson
Chi-squareAsian 21 12.6 13 22.8
Other 13 7.8 6 10.5
Non smokers 79 47.3 3 9 68.4
SMOKING
Former
smokers 42 25.1 10 17.5 p= 0.015 
Pearson 
Chi-squareLight smokers (< 20/day) 3 0 18.0 8
14.0
Heavy smokers 
(> 20/day) 16
9.6 0 0
FULL MOUTH PLAQUE 
SCORES - 44.5 ±25.1 -
32.0 ±  
21.7 p= 0.007
FULL MOUTH BLEEDING 
SCORES - 49.7 ±24.1 -
33.8 ±  
23.0 p< 0.001
NUMBER OF TEETH 2 8 .0  ±  2 .9 - 2 8 .2  ± 2 .5 - p= 0.647
AVERAGE PPD 4 .2  ±  1.0 - 2 .8  ± 0 . 6 - p< 0.001
AVERAGE REC 0 .7  ± 0 .8 - 0.1 ± 0 . 2 - p< 0.001
AVERAGE LCAL 4 .9  ±  1.5 - 3 .0  ± 0 .8 - p< 0.001
NUMBER OF PERIODONTAL 
POCKETS > 5  mm 6 3 .9  ± 3 1 .8 46.1 ±13.8 2 1 .8  ±  15 .6
13.8± 
9.8 p< 0.001
NUMBER OF PERIODONTAL 
POCKETS > 10 mm
3 .3  ± 5 .8 2.1 ±3.8 2 .0  ± 3 . 7 1.2 ± 2.2 p= 0.117
Table 5.2: demographic and clinical characteristics o f  AgP divided by diagnosis: GAgP and LAgP 
5.3.1. Disease distribution
Teeth exhibiting at least one site with 5 mm PPD were defined as ‘affected’. The choice 
of PPD rather than LCAL was made because LCAL data were not available for all 
patients. Figure 5.6 reports the number of missing teeth and the percentage of affected 
teeth in the mixed AgP group. Excluding third molars, 6.8% of 6272 teeth of all AgP
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patients were missing. More teeth were missing in the maxilla (7.5%) rather than in the 
mandible (6.1%). First premolars were the most commonly missing teeth (12.5%), 
followed by first molars (11.5%) and second premolars (8.7%). Almost six per cent of 
second molars, 4.7% of incisors and just 2.3% of canines were missing. The same 
pattern maxilla-mandible was present for percentage of teeth affected by periodontal 
disease (62.3 versus 57%). In terms of tooth type, 86% of first molars were affected, 
followed by their adjacent teeth: 74% of second molars and 58% of first premolars. 
Fifty-one per cent of incisors, 48% of first premolars and canines were affected. The 
difference between upper and lower jaw was most evident for percentages of affected 
incisors (respectively 55.5% versus 47.4%) and first premolars (respectively 52.8% 
versus 43.6%).
100,0
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50,0
I percentage affected teeth AgP  
I percentage m issing teeth AgP
40,0
30,0
20,0
10,0
17 16 15 14 13 12 11 21 22 23 24 25 26 27 47 46 45 44 43 42 41 31 32 33 34 35 36 37
tooth number
Figure 5.6: percentages of missing and affected (at least one PPD > 5 mm) teeth in AgP patients.
Figures 5.7 and 5.8 show the percentages of affected teeth separately in the GAgP and 
LAgP groups. Clear differences appeared comparing the groups, with dramatic increases 
in all percentages in the GAgP group. These patients showed a more even distribution of 
affected teeth, with peaks around the molars and especially in the maxilla. The maxillary 
first molars were the most frequently affected (90%), whereas the least affected
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maxillary tooth was 13 (UR3), which was still involved in >60% of subjects. In the 
mandible the least affected was 31 (LL1), which was involved in 50% of subjects. A 
more classical incisor-molar pattern was evident in the LAgP group. In LAgP cases, all 
percentages were considerably lower. First molars were the only teeth consistently 
affected (74%), followed by second molars (37%), second premolars (25%), incisors 
(20%), first premolars (12%) and canines (11%). Respectively 29 and 26% of teeth were 
affected in the maxilla and mandible.
GAgP affected and missing teeth
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Figure 5.7: percentages of affected (at least one PPD > 5 mm) teeth in GAgP patients
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Figure 5.8: percentages of affected (at least one PPD > 5 mm) teeth in LAgP patients
Figures 5.9, 5.10, 5.11 and 5.12 show the distribution for all AgP patients of mean PPD 
buccally and palatally in the maxilla, and buccally and lingually in the mandible. The 
figures show the evidently higher probing pocket depth around molars. The site with 
highest PPD was 36 (LL6) disto-lingual, which had an average PPD of 6.02 mm. The 
smallest average PPD was in relation to 34 (LL4) buccal (1.9mm). Distal surfaces of 
second premolars were consistently found to have a higher average PPD than the 
correspondent mesial surface of the same teeth. The same was observed for mesial 
surfaces of second molars in the maxilla, as compared to their distal surfaces. 
Interproximal surfaces had higher mean PPD compared to mid surfaces. Maxillary teeth 
had increased mean PPD compared to mandibular teeth (data reported in appendix II).
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Figure 5.9: average probing pocket depths on buccal surfaces of the maxilla in AgP patients
PPD upper palatal
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Figure 5.10: average probing pocket depths on palatal surfaces of the maxilla in AgP
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Figure 5.11: average probing pocket depths on buccal surfaces of the mandible in AgP patients
PPD lower lingual
tooth site
Figure 5.12. Average probing pocket depths on lingual surfaces of the mandible in AgP patients
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5.3.2. Gender differences
Table 5.3 and 5.4 show the average clinical measurements divided by the demographic 
characteristics of the patients, both for GAgP (table 5.3) and LAgP (table 5.4). Gender 
distributions were constant in the different ethnic and smoking subgroups. Average age 
of diagnosis was 30.2 years old for women and 29.2 years old for men. In the GAgP 
group, men had an increase in the average PPD, LCAL, as well as in the number of PPD 
> 5 mm and > 10 mm compared to women (see table 5.3). Multivariate analysis showed 
these differences to be border line statistically significant only for number of probing 
pocket depths > 10 mm (p=0.050).
G AgP Av.PPD
Av
LCAL
no.
pockets 
> 5mm
no.
pockets
>10
mm
FMBS
GENDER
Female 4.1± 0.9 4.7± 1.3 61.7± 28.8 2.3± 5.1 52.9± 52.9
Male 4.4± 1.1 5.2± 1.8 67.9± 36.6 4.9± 6.6 55.3± 55.3
ETHNICITY
Caucasian 4.3± 1.1 5.1± 1.7 67.2± 34.8 3.2± 6.4 51,4± 24.3
Black 4.3± 0.8 4.9± 1.1 63.4± 25.2 4.5± 5.8 59.0± 22.9
Asian 3.8± 0.9 4.2± 1.2 50.7± 31.2 2.1± 3.9 4 4 .1± 19.0
Other 4.2± 0.9 4.8± 1.7 65.0± 30.8 1.1± 1.6 65.2± 18.7
SMOKING
Never 3.99± 0.9 4.5± 1.3 55.5± 27.7 3.2± 5.6 52 .1± 23.3
Former
or
current
Former 4.26± 1.1 5.2± 1.8 67.4± 35.2 4.14± 7.2 53.5± 23.3
Current
light 4.48± 1.0 5.0± 1.4 71 .3± 34.1 3.00± 5.0 56.9± 24.2
Current
heavy 4.75± 0.9 5.7± 1.6 8 3 .1± 26.6 1,81± 3.3 56.3± 24.3
total 4.43± 1.0 5.2± 1.6 71.6± 33.6 3.3± 6.0 55.2± 23.5
Table 5.3: clinical characteristics o f GAgP patients divided by gender, ethnicity and smoking
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LA gP Av.PPD
Av
LCAL
no. 
pockets 
> 5 mm
no.
pockets
>10
mm
FMBS
G ENDER
Female 2.7± 0.6 2.9± 0.7 19.4± 13.7 1.5± 3.2 30.3± 19.1
Male 3.0± 0.7 3.3± 0.9 26.2± 18.4 2.8± 4.4 40.2± 20.8
ETHNICITY
Caucasian 2.9± 0.8 3.1± 0.9 25.2± 19.9 1.9± 4.0 51.4± 18.0
Black 2.9± 0.6 3.2± 0.8 22.8± 12.3 3.2± 4.6 59.0± 12.3
Asian 2.6± 0.4 2.8± 0.5 16.7± 12.1 1.1± 2.0 4 4 .1± 25.1
Other 2.6± 0.1 2.7± 0.2 16.3± 6.4 1.0± 1.7 65.2± 47.3
SM OKING
Never 2.8± 0.6 3.0± 0.7 20.3± 13.0 1.9±3.4 34 .1± 20.0
Former
or
current
Former 3.2± 0.9 3.5± 1.1 3 2 .1± 24.8 3.3± 5.4 25.0± 21.3
Current
light 2.6± 0.3 2.8± 0.3 16.0± 5.9 0.7± 0.9 41.4± 19.3
Current
heavy - - - - -
total 2.9± 0.7 3.3± 0.9 24.9± 20.2 2.2± 4.2 33.2± 21.0
Table 5.4: clinical characteristics o f  LAgP patients divided by gender, ethnicity and smoking
5.3.3. Ethnic differences
There were higher percentages of Asian subjects affected by LAgP rather than GAgP. 
Asians also had a decrease in all clinical parameters when compared to Blacks and 
Caucasians (table 5.3), although these differences did not reach statistical significance. 
Multivariate analysis revealed that ethnicity was associated with higher FMBS 
(p=0.013).
5.3.4. Effect of smoking
In the GAgP group, smokers were found to have increased averages of PPD, LCAL and 
number of PPD > 5 mm (table 5.3). Multivariate analysis revealed that these differences 
were not statistically significant in the whole group of GAgP patients. However, in the 
Caucasian GAgP subgroup, smoking was associated with average PPD (p=0.002), 
average LCAL (p=0.001) and number of PPD > 5 mm (p=0.009). A similar tendency of 
increased disease severity was noted in the LAgP group (table 5.4), but no statistical 
significance was observed (probably because of the small sample size).
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5.3.5. Age differences
Older subjects had higher average PPD, LCAL and number of PPD > 5 mm (data not 
presented in tables). Multivariate analysis revealed that age was associated with 
increased average PPD (p=0.042), LCAL (p=0.020) and number of PPD > 5 mm 
(p=0.042) in GAgP patients. In the Caucasian GAgP subgroup age was associated with 
average PPD (p=0.029) and average LCAL (p=0.003). No statistically significant 
associations were noted in the LAgP group.
5.4. DISCUSSION
Clinical characteristics o f 224 patients diagnosed with AgP were examined. Age, gender 
and smoking were found to have an effect on disease severity. Older subjects, males and 
smokers had increased clinical parameters. The effect o f age on AgP severity has been 
described previously (Hormand and Frandsen 1979) and is linked to the cumulative 
effect of aetiologic factors throughout the years. The observation that smokers have 
more severe disease is in agreement with the known effect of smoking on periodontitis 
(Haber et al. 1993) and confirms previous reports in relation to AgP (Schenkein et al. 
1995, Mullally et al. 1999). The data from our patients point towards a more important 
effect of smoking in Caucasians (with regards to average PPD, average LCAL and 
number o f > 5 mm PPD). Nonetheless, since this study was not performed on a random 
population, but on patients referred by their general dentists, these results may be a 
reflection o f health awareness and care of subgroups of individuals. For example, males 
and smokers may be less concerned about their oral health and consequently delay their 
attendance at their dental practice until the problem becomes very severe. This 
ascertainment bias in the supposed female preponderance in AgP was postulated by Hart 
et al. (1991) and confirmed by the increased percentage o f women in our sample.
In agreement with previous reports, patients diagnosed with LAgP were significantly 
younger than GAgP subjects (Hormand and Frandsen 1979, Bial and Mellonig 1987), 
and a smaller percentage of them were smokers (Schenkein et al. 1995). This might 
mean that the effect of smoking is more evident on GAgP, and that in some LAgP cases
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the disease may spread with age, especially in smokers, and evolve to become GAgP 
(Brown et al. 1996).
Interesting data were observed with regard to disease distribution. These data have to be 
interpreted carefully, because they are derived from analysis o f probing pocket depths, 
which do not reflect exactly attachment and bone loss, and because they were collected 
by three different examiners. Nonetheless, periodontal pocketing is an earlier sign of 
periodontal disease than radiographic bone loss, which depends on the degree of 
demineralization o f the bone and may occur only at a more advanced stage of 
periodontal destruction. The maxilla was confirmed to be more affected by AgP 
(Hormand and Frandsen 1979), with an increase in the percentage of teeth with at least 
one > 5 mm periodontal pocket. First molars were the most commonly affected teeth, 
and also the ones with higher average probing pocket depths in both GAgP and LAgP. 
Among all other teeth, Hormand and Frandsen (1979) and Bial and Mellonig (1986) 
found incisors to be more frequently affected. We also know from the current 
classification that LAgP cases have an incisor-molar pattern of attachment and bone 
loss, with no more than 3 other teeth involved. In this report, teeth adjacent to first 
molars were found to be more frequently affected than incisors, not only in the whole 
group of patients, but also in the LAgP group. This is likely to be secondary to the 
presence o f periodontal disease in the adjacent first molars and is confirmed by the fact 
that distal sites of second premolars and mesial sites of second molars show more severe 
disease. Currently, the possibility of spread of the periodontal pathogenic process to the 
surfaces adjacent to first molars has been underestimated in the classification. In 
practical terms, we might encounter a case o f AgP where first molars and incisors are 
affected and, as a reflection of the first molar involvement, second premolars may also 
show attachment loss. Based on the current classification, we would have to classify 
this as a GAgP, even if  the pattern is genuinely that of LAgP.
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In conclusion, data from the AgP group presented here can be summarized as follows:
• Age, male gender and smoking are associated with periodontal disease severity. 
LAgP may evolve into GAgP with age, especially in smokers.
• Severe periodontal pockets in AgP are more common in the maxilla and affect 
mainly first molars and their adjacent teeth, followed by incisors.
• More accurate clinical diagnosis is required to distinguish clear cases of LAgP 
from GAgP.
Further studies should be conducted in order to compare the disease distribution in large 
cohorts o f GAgP, LAgP and CP patients. Differences in extent, severity and type of 
affected teeth may contribute to a better differential diagnosis between these different 
disease entities.
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CHAPTER 6
6. GENETIC ASSOCIATION STUDY
6.1. Background
The genetic background of Aggressive Periodontitis was discussed in the introductory 
chapter of this thesis. AgP is commonly thought to be a multifactorial polygenic disease, 
determined by the interaction of environmental and genetic factors. A very small 
percentage o f individuals seem to exhibit a strong predisposition to the periodontal 
damage characteristic o f AgP. Environmental factors such as cigarette smoking and the 
presence o f specific bacteria in the subgingival plaque are thought to trigger the onset of 
AgP in susceptible individuals (Kinane et al. 2005). Early onset periodontitis represents 
a common feature o f a few single gene disorders, such as Papillon- Lefevre syndrome 
and some genes able to determine early onset periodontitis have been identified (Kinane 
et al. 2005). These single gene disorders, however, can explain only a minimal subset of 
early onset periodontitis cases. All the others seem to be consistent with a polygenic 
pathogenesis. However, despite increases in the knowledge o f the human genome and of 
the role of up to 50,000 human genes, we still do not know which genetic risk factors are 
able to determine a subtle variation in the immune response, which manifests itself only 
through a modification o f the AgP risk, with no other consequences elsewhere in the 
body.
While in single gene defects a single mutation is able to cause the onset o f a disease, in 
polygenic diseases, a range o f different genetic variants in several genes are responsible 
for determining the predisposition to the disease. Millions of these genetic variants, 
which are called polymorphisms, exist in the human genome. Two types of genetic 
variants are distinguished: diallelic polymorphisms (SNPs, single nucleotide
polymorphisms) and multiallelic markers (Collins et al. 1999). In diallelic SNPs, the two 
alleles give three possible combinations (genotypes): homozygosity for the common 
allele (wild type), homozygosity for the rare allele or heterozygosity (presence of one 
copy o f each allele).
Approaches to the detection of genetic risk factors for the onset of a disease include 
family studies (including twin studies, linkage and segregation studies) and case-control
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association studies. In these latter studies genetic polymorphisms are studied in two 
cohorts o f subjects, one affected by the disease and one diagnosed as not affected by that 
particular disease. Several polymorphisms have been suspected as potential 
susceptibility factors for AgP and have been tested in case-control association studies. 
Conflicting results have emerged from most studies, and still no genetic polymorphisms 
have been confirmed as risk factors for AgP. In chapter 2, an overview o f the most 
promising polymorphisms was presented.
The aim of this study was to detect genetic polymorphisms as risk factors for the onset 
o f AgP in a large cohort of subjects o f mixed races. Considering the close relation 
between ethnicity and genetic polymorphisms, subgroup analyses were conducted for 
the different ethnic groups. The null hypothesis tested was that there was no difference 
in the distribution o f the studied genotypes between the groups o f patients and healthy 
controls.
6.2. MATERIALS AND METHODS
In chapter 1, several important aspects in relation to the design o f genetic association 
studies were discussed. These aspects concern the definition o f disease and healthy 
status, the selection o f subjects and the selection o f a panel o f genetic polymorphisms. 
The next subparagraphs deal with the ways we attempted to overcome the challenge 
represented by all these factors.
6.2.1. STUDY DESIGN
6.2.1.1. Definition o f  disease
Confusion reigns in the AgP genetic literature in terms of the definition o f disease, 
because of the recent introduction of the new classification (Armitage 1999), and 
because o f the scope it leaves to personal interpretation, especially with regard to the 
differential diagnosis between AgP and the more severe cases o f Chronic Periodontitis. 
The diagnosis o f AgP applied to this study was very strict. Only patients whose degree 
o f periodontal destruction could not be correlated with the cumulative effect of local 
factors were included in the study (see chapter 4 for exact inclusion and exclusion
criteria). By doing so, we aimed to include only subjects with severe periodontal 
destruction, not explicable other than by the presence of a highly predisposing genotype. 
This aimed at reducing the risk of including false positives in the study.
6.2.I.2. Definition o f  controls
6.2.1.2.1 Definition o f  healthy status
According to the new classification, age no longer represents one o f the criteria for 
diagnosis o f AgP. However, it is assumed that the onset o f AgP is usually in adolescence 
or early adulthood. Therefore, it is highly unlikely that young adults who are examined 
and found to have no periodontal destruction would have a genotype showing 
susceptibility to AgP. Therefore, in order to reduce the risk o f including subjects who 
may later develop AgP (false negatives), only patients at least 25 years old were 
enrolled. Volunteers with known genetic diseases, infections or severe medical 
conditions (e.g. AIDS) or history of periodontal disease or tooth loss due to periodontal 
disease were not included. Clinical exclusion criteria were different for individuals 
younger than 35 years o f age compared to those older than 35 years (more stringent 
criteria were applied to younger subjects):
- < 35 years old subjects were excluded if they presented with at least one site with PPD 
and LCAL > 4 mm.
- > 3 5  years old subjects were excluded if they presented with one or more sites with 
PPD and LCAL > 5 mm.
6.2.1.2.2 Stratification bias
One o f the objectives o f the control recruitment was to obtain a group o f subjects as 
similar as possible to our patient group, the only constant difference being their 
periodontal status. In order to achieve this aim, we recruited subjects referred to other 
Departments o f the Eastman Dental Hospital. Therefore, these two groups o f subjects 
(AgP patients and controls) belong to a similar socio-economic group of subjects 
registered with the National Health System in the United Kingdom, and referred to the 
EDH for care. All control subjects had some form of dental problems, but no periodontal
disease. No individual matching was attempted in terms of smoking, ethnicity and 
gender.
The degree o f non-response to participation in the control group was low, with about 
90% of the suitable individuals who were asked to participate in the study agreeing. An 
even higher percentage o f responders (subjects who agreed to have a blood sample taken 
for genetic analysis) was noted in the patient group (only 6 patients out of 230 declined). 
We can therefore suppose that any bias produced by non-responders in the two groups 
was minimal, and was likely to be balanced in the two groups.
6.2.1.3. Power
No large genetic association studies have been published so far in the Early Onset / 
Aggressive periodontal literature. Most published studies include less than 100 subjects 
in each group (cases/controls). These numbers might not be enough to detect subtle 
differences in genotype distributions, such as the ones we expect in a multifactorial 
disease such as AgP. We based our power calculation on a pilot study (Brett et al. 2003) 
performed on a total o f 90 AgP (50 o f whom were Caucasians), 82 CP patients (55 of 
whom were Caucasians), and 100 Caucasian blood donors. Frequencies of IL-1A -889, 
IL-1 B -511 and +3954, IL-6 -174, IL-10 -627 and -1082, TNF-a -308, TLR4 299 and 
399 and VDR Taq-I (1056) polymorphisms were studied in patients and controls. 
Statistical analysis performed by Clump software revealed that IL-1 +3954 was 
associated with AgP, while IL-6 -174, VDR and TLR4 399 were associated with the 
periodontitis trait. The limitations of this pilot study, apart from a small sample size, 
include the failure to take account of environmental factors in the analysis and also the 
lack o f knowledge regarding the periodontal conditions o f the controls, some of whom 
may have had periodontitis. The sample size calculation was based on the results relative 
to the IL-6 genotype, which showed no statistically significant association with the AgP 
trait, although a trend was present for an increase in prevalence o f G allele in patients, 
and an increase of C homozygosity in controls. N-Query advisor® software was used in 
order to calculate the sample size for this study. The preliminary analysis indicated a 
prevalence of 10% in AgP Caucasians and 25% in Caucasian controls for IL-6 C
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homozygosity. A total sample size of 250 cases and 250 controls would give an overall 
study power o f 99% to detect an odds ratio of 3 of belonging to the AgP group. 
Assuming 65% of our patients were Caucasians, within this subgroup the power would 
be 93% to detect a similar odds ratio. Since the preliminary analysis was undertaken 
using a control group o f unknown periodontal status, the actual odds ratios are likely to 
be greater than those indicated in that analysis. Therefore, these power calculations 
represented a conservative estimate of the study power. The number o f subjects recruited 
for this study falls slightly short of 250 in each group. This still represents a >90% 
power to detect significant associations.
6.2.1.4. External validity
Our group o f patients and controls belongs to a very heterogeneous community of 
subjects living in London. This heterogeneity may represent a problem in terms of the 
interpretation of the genetic data; on the other hand, it also makes it easier to generalise 
our results, because they are not obtained in a small secluded population. Even 
restricting the analysis to the subgroup of Caucasians, the same consideration can be 
applied.
6.2.1.5. Choice o f  genetic marker
At least one million SNPs exist in coding regions of the human genome, all 
theoretically able to have a role in disease susceptibility (Collins et al. 1999). Based on 
the existing literature on the pathogenesis and genetics o f AgP, the task o f selecting a 
panel of candidate genetic loci to be tested is not easy. A whole range of genetic 
polymorphisms have been suspected to play an important role in the susceptibility to 
AgP: Interleukin-1 ( Diehl et al. 1999, Parkhill et al. 2000, Hodge et al. 2001, Tai et al. 
2002, Quappe et al. 2004), Interleukin-4 (Michel et al. 2001, Gonzales et al. 2004), 
Interleukin-10 (Kinane et al. 1999a), TNF-a (Kinane et al. 1999a), Vitamin D receptor 
(Hennig et al. 1999, Yoshihara et al. 2001), Fca receptor (Kaneko et al. 2004), Fey 
receptors (Fu et al. 2002, Chung et al. 2003, Loos et al. 2003, Yasuda et al. 2003, 
Yamamoto et al. 2004), FP receptors (Gwinn et al. 1999, Zhang et al. 2003), estrogen 
receptor a  (Zhang et al. 2004), matrix metalloproteinase 1 and 3 (Itagaki et al. 2004),
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matrix metalloproteinase 9, cathepsin G, collagen and many others (Suzuki et al. 2004). 
These markers and others have also been studied in relation to Chronic Periodontitis 
(Kinane & Hart 2003).
Considering the evidence in the literature with regard to neutrophil function in AgP 
(Kantarci et al. 2003), it was decided to focus this association study mainly on the role 
genetic polymorphisms regulating PMN function may have in predisposing to AgP. 
Therefore, the panel o f SNPs chosen for investigation in this study was as follows: Fca 
-324 (Kaneko et al. 2004), FcyRIIa 494 (Carlsson et al. 1998), FcyRIIb 232 (Yasuda et 
al. 2001), FcyRIIIa 559 (Wu et al. 1997), FcyRIIIb NA (Bux et al. 1997), FcyRIIIb SH 
(Bux et al. 1997), FPR 301 (Zhang et al. 2003), FPR 546 (Zhang et al. 2003), FPR 568 
(Zhang et al. 2003) (see paragraph 6.3.3 for selection o f FPR markers), p22phox 242 
NADPH oxidase (Parkos et al. 1988). In addition to these genetic markers of PMN 
function, two genetic polymorphisms of cytokines involved in periodontal disease 
pathogenesis [Interleukin-6 -174 (Fishman et al. 1998), TNF- a  -308 (Wilson et al. 
1997)] and one involved in the immune response and in bone metabolism [VDR Taq-I 
(Ensrud et al. 1999)] were also selected. Therefore, a total o f 13 candidate SNPs were 
selected. All these polymorphisms are SNPs caused by a single nucleotide substitution. 
Each individual presents two alleles for the correspondent nucleotide. Therefore, for 
each polymorphism, three possible genotypes exist: two copies o f the common allele 
(homozygosity for the common allele), two copies o f the rare allele (homozygosity for 
the rare allele) or one copy of each allele (heterozygosity). A summary of the chosen 
SNPs, their gene location, and their supposed function is represented in table 6.1.
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Molecule Chromosome Function Polymorphism Amino acid change
Suspected
effect
IL-6 7p21
Pro-
inflammatory 
cytokine 
Stimulation o f  
osteoclasts
-174 G-C 
promoter region 
(negative 
regulatory 
domain)
NO
(regulatory
gene)
A llele C: 
inhibition o f  
production o f  
IL-6
TNF-a 6p21
Pro-
inflammatory 
cytokine 
Effect on lipid 
metabolism, 
insulin resistance
-308 A-G  
promoter region
NO  
(effect on 
transcription 
al activity)
A llele A: 
higher 
transcription 
levels o f  
TNF-a
VDR 12ql2-14
Ca metabolism  
Immune 
modulation 
Regulation o f  
osteoblasts
Taq-I (1056) synonymous
Linkage 
disequilibriu 
m with 
another SNP 
(?)
Fc-aR 19pl3 .4
Bacterial 
recognition 
(IgA- PMN)
324 A-G  
IgG-like domain 
(ligand-binding 
site)
synonymous
A llele A: 
decreased 
phagocytosis 
o f
P.gingivalis
Fc-yR Ila 1q 2 1-24
Bacterial
recognition
(IgG2-PMN)
494 A-G
131 H -R in  
IgG binding 
site
A llele H: > 
receptor 
affinity and 
specificity, 
and
phagocytosis 
o f  IgG-2 
opsonized 
particles
Fc-yR lib lq21-24
Bacterial
recognition
(IgG-
lymphocytes)
695 C-T
232 I-T in 
exon 5
?? unknown
Fc-yR Ilia
1 q 2 1 -24
Bacterial
recognition
(IgG-PMN)
559 G-T 176 V-F
Amino acid 
V: > affinity 
for IgG 1,3,4
Fc-yR Illb 1 q 21 -24
Bacterial
recognition
(IgG-PMN)
141 C-G 
(NA1/NA2)
4 amino acid 
substitutions 
first 
extracellular 
domain
N A 1:
different
glycosilation,
different
ligand
activity, >
phagocytosis
o f
P.gingivalis
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Molecule Chromosome Function Polymorphism Amino acid change
Suspected
effect
Fc-yR Illb 1 q 2 1 -24
Bacterial
recognition
(IgG-PMN)
266 C-A
78 Ala-Asp  
4 amino acid 
substitutions 
first 
extracellular 
domain (SH 
antigen)
?? unknown
FPR 19 (FPR-1 gene)
Bacterial 
recognition, 
chemotaxis, 
phagocytosis, 
oxidative burst
301 G-C
101 Val-Lys
Similar 
amino acids 
(small 
change)
FPR 19 (FPR-1 gene)
Bacterial 
recognition, 
chemotaxis, 
phagocytosis, 
oxidative burst
546 C-A
synonymous -
FPR 19 (FPR -1 gene)
Bacterial 
recognition, 
chemotaxis, 
phagocytosis, 
oxidative burst
568 A-T
190 Arg- 
T ryps(2nd 
extracell.
loop, 
important 
for ligand 
affinity)
Different
ligand
affinity
P22phox
NADPH
oxidase 16 (CYBA  
gene)
Superoxide 
production in 
PMN and 
osteoclasts
242 C-T
72 Hys- Tim 
(heme- 
binding site)
Modulation 
o f  superoxide 
production
Table 6.1: Schematic representation o f  the panel o f  SNPs selected for the study, giving name o f the 
m olecule, relative gene, chromosome location, function, details o f  the polymorphisms and their
suscepted effects.
6.2.2. SELECTION OF SUBJECTS
Consecutive AgP patients referred to the Department o f Periodontology of the Eastman 
Dental Hospital and Institute were recruited as described in chapter 4. Healthy controls 
were recruited from subjects referred to the Departments of Oral Surgery, Conservation, 
Endodontics and Staff Dental Service. Additional subjects were selected among patients 
referred for assessment to the implant clinic of the Periodontal Department, and from 
subjects screened for participation in the IQE (International Qualifying Examination); 
these consisted mainly o f students and staff at University College London, who needed 
dental examination or treatment. A total o f 100 subjects were selected from Oral
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Surgery, 52 from Endodontics, 50 from the IQE screening, 16 from the Conservation 
Department, 11 from Staff Dental Service and 2 from the Periodontal Department.
Control subjects were approached when they attended one of these clinics at the EDH. 
The purpose of the study was explained to them and they were asked to participate. 
Suitable subjects at least 25 years old who volunteered underwent a specific periodontal 
examination, performed by a single examiner. The examination consisted of assessment 
o f oral hygiene, gingival appearance and recording o f Community Periodontal Index for 
Treatment Needs (CPITN). Panoramic radiographs were also obtained. Their smoking 
history and their parents’ ethnic origins were recorded. Individuals who at the 
examination were found to satisfy the clinical entry criteria indicated in paragraph
6.2.1.2.1 had a blood sample taken for DNA extraction, in the same fashion as for the 
AgP patients.
6.2.3. GENETIC ANALYSIS
6.2,3.1. DNA extraction
DNA was extracted from leukocytes using Nucleon® BACC2 kit (Nucleon Bioscience, 
Coatbridge, UK) according to manufacturer’s instructions. Briefly, blood samples 
collected in EDTA tubes were thawed at room temperature and 30 ml of reagent A (red 
cell lysis buffer; 10 mM Tris-HCL pH 8; 0.32 M sucrose; 5 mM MgCb; 1% Triton X- 
100) were added to 10 ml of blood in a 50 ml polypropylene centrifuge tube. The 
contents were mixed by inverting several times and then centrifuged at 1300g for 5 min 
to sediment the leukocytes. The supernatant was discarded and 2.0 ml of reagent B 
(white cell lysis buffer) and 300 pg of proteinase K (Invitrogen, Paisley, UK) were
o
added to the cell pellet. After vortexing, the tubes were incubated at 37 C for 30 min 
and 0.5 ml sodium perchlorate (0.5 M) was added, the contents mixed by inversion, 
then 2.0 ml chloroform added and mixed again. 300 pi of Nucleon® resin was added 
and tubes centrifuged at 1300g for 3 min to separate the phases; this was followed by 
the removal o f the upper aqueous phase containing the DNA which was transferred to a 
fresh tube. Two volumes of cold ethanol were added to precipitate the DNA and the
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DNA resuspended in 250 pi of sterile water. The DNA concentration was estimated by 
measuring absorbance at a 260 nm wavelength using a spectrophotometer. 10 ng of 
DNA were subsequently used for polymerase chain reaction (PCR) analysis.
6.2.3.2. Genetic polymorphism analysis
Allelic discrimination assays were performed using the Applied Biosystems 7300/7500 
Real Time PCR System. Some of the primers and probes (listed in table 6.2) were 
designed using the Assay-by-Design service offered by Applied Biosystems 
(Warrington, Cheshire, UK). The other primers and probes (listed in table 6.3) were 
obtained from Applied Biosystems from their Assays-on-Demand products. Genotyping 
was performed in 25pl reactions consisting of lOng o f genomic DNA, 12.5pl o f 2X 
Taqman Universal PCR Master Mix, either 0.625pl (40X) or 1.25pl (20X) primer/probe 
sets, with the addition o f purified water. Cycling conditions were 2 m at 50C ; 10 m at 
95 C; 40 cycles o f 95 C for 15 s; 60 C for 1 m. Real-time fluorescence detection was 
performed during 60 C annealing/extension step of each cycle. The allelic 
discrimination assay is a multiplexed, end-point assay which detects variants o f a single 
nucleic acid sequence. The presence of two primer/probe pairs in each reaction allows 
genotyping o f the two possible variants at the SNP site in a target template sequence. 
Two fluorescent dye detectors are used, one being a perfect match to the wild type, the 
other one to the mutation. The allelic discrimination measures the change in 
fluorescence o f the dyes associated with the probes. 7300/7500 SDS software plots the 
results of the allelic discrimination run on a scatter plot of allele X versus allele Y and 
automatically calls genotypes dependent on fluorescence intensities o f VIC and FAM 
reporter dyes. Examples o f the scatter plots showing the distribution of the genotypes 
for each SNP are shown in appendix III to XIV. Hidden duplicates were added to each 
plate to test error rates. However, no detection errors were observed.
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Gene SNP Substitution Oligo Sequence
IL-6-174 G to C
Probe-G VIC-CCTTTAGCATCGCAAGAC-MGB
Probe-A FAM-CTTTAGCATGGCAAGAC-MGB
Primer-F GACGACCTAAGCTGCACTTTTC
Primer-R GGGCTGATTGGAAACCTTATTAAGATTG
FCyRIIB T to C
Probe-T VIC-CTACAGCAATCCCAG-MGB
Probe-C FAM-CTACAGCAGTCCCAG-M GB
Primer-F CCAAGCTCCCAGCTCTTCAC
Primer-R CCACTACAGCAGCAACAATGG
FCyRIIIB NA G to C
Probe-G VIC-CAATGGTACAGGGTGCT-MGB
Probe-C FAM-CAATGGTACAGCGTGCT-MGB
Primer-F CCAAAGGCTGTGGTGTTCCT
Primer-R CTTCAGAGTCACACTGTCCTTCTC
FCyRIIIB SH C to A
Probe-C VIC-CTTCATTGACGCTGCCAC-MGB
Probe-A FAM-TTCATTGACGATGCCAC-MGB
Primer-F AGCCAGGCCTCGAGCTA
Primer-R TGTACTCTCCACTGTCGTTGACT
FPR-301 G to C
Probe-G VIC- CCTGTGCAAATTCGTCTT-MGB
Probe-C FAM-CTGTGCAAATTCCTCTT-MGB
Primer-F TGGCCTTTCGGCTGGTT
Primer-R AGCGGTCCAGAGCAATGAG
FPR-546 C to A
Probe-C VIC-AACTTTTCGCCCTGGAGG-MGB
Probe-A FAM-TTTTCGCCATGGAGG-MGB
Primer-F GGGACAGTAGCCTGCACTTTT
Primer-R TGCCTCTCACCGTCAACATG
FPR-568 A to T
Probe-A VIC-CCCTAAAGAGAGGATAAA-M GB
Probe-T FAM -CCCTAAAGAGTGGATAAA-M GB
Primer-F GGACAGTAGCCTGCACTTTTAACTT
Primer-R TGCCTCTCACCGTCAACATG
FCyRIIIA G to T
Probe-G VIC-CCAACAAGCCCCC-M GB
Probe-T FAM-CCCAAAAGCCCCC-MGB
Primer-F GACAGCGGCTCCTACTTCTG
Primer-R GACAGCGGCTCCTACTTCTG
Table 6.2: Gene polymorphism real-time probe/primer combinations designed using Assay-by Design
service from Applied Biosystems
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Gene SNP Substitution
National Centre for Biotechnology 
Information (NCBI) dbSNP ID 
number
FCyRIIA 494 A to G rs 1801274
FCaR 324 A to G rs 1865096
TNFa (-308) A to G rs 1800629
VDR Taq-I T to C rs731236
Table 6.3: Inventoried SNP genotyping assay products from Applied Biosystems
Because of the nature of the nucleotide sequence in the proximity of the polymorphism, 
it was not technically possible to design a primer for Real Time PCR for the NADPH 
oxidase p22phox 242 polymorphism. Therefore, in order to detect this polymorphism, the 
PCR product was exposed to a restriction enzyme (Rsal), able to digest it. After 
digestion, the DNA fragments amplified by PCR were run on an electrophoretic gel and 
then visualized under UV light. 10 ng of DNA were used for polymerase chain reaction 
(PCR). Each PCR reaction was performed in 25 pi volume containing 1 pi of DNA in 
buffer containing 10 mM Tris-HCl, pH 8.3, 50 mM KC1, 500 pM of each dNTPs 
(dATP, dCTP, dTTP, dGTP), 2mM M gCf and 50 pmol o f each o f the primers and 1U 
of taq polymerase (Abgene, UK). Sequences of the oligonucleotide primers used for 
PCR amplification, the size of the predicted PCR products and the PCR amplification 
programme used were described previously (Inoue et al. 1998) and are given below: 
sense primer 5’ TGCTTGTGGGTAAACCAAGGCCGGTG 3’ and antisense primer 5’ 
AACACTGAGGTAAGTGGGGGTGGTCCTGT 3’; cycling conditions: 95° C for 5 
min, 35 cycles of 95 C for 30 sec., 62 C for 30 sec., 72 C for 1 min. The PCR products 
were digested at 37 C for 17 h using 5 u of Rsal enzyme. This enzyme cut the PCR 
product in the presence o f allele T at position 242. If the allele T was not present, the 
enzyme did not cut the target DNA at that point. The digested products were separated 
on a 3% agarose gel containing 0.5 mg/ml ethidium bromide in 1 TBE buffer at 100 V 
for 2 h. The bands were visualised using UV transilluminator. The products yielded 
were: 188bp + 160 bp (allele T) and 348bp (allele C). An example of one of the results 
for this polymorphism as obtained by gel electrophoresis is reported in appendix XV.
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All the results were confirmed by a blind examiner, unaware of the origin of the 
genomic DNA. Whenever the results were not clear, the analysis was repeated. If, after 
repetition, the result was still uncertain, no result was recorded for that polymorphism. 
The total numbers o f detected alleles for each genotype are reported in table 6.11. Out 
of a total of 5785 genotypes to be detected, only 0.01% was not scored. Therefore, this 
should not affect the reliability of our results.
6.2.3.3. Sequencing analysis
Sequencing of the region of the FPR gene containing candidate SNPs (Zhang et al. 
2003) was performed prior to SNPs analysis in a subset o f subjects in order to detect 
possible informative SNPs in the gene. Polymorphisms at nucleotide 301, 306, 329, 348, 
378, 546, 568 and 576 were analyzed in 31 LAgP patients and 28 healthy controls. DNA 
purification was performed before the sequencing reaction. In brief, 15 pi o f H20  were 
added to 5 pi o f DNA and transferred to a 0.5 ml tube on ice. Then 2 pi 3M sodium 
acetate and 50 pi o f 95% ETOH were added, and the tubes were incubated for 10-15 
minutes, after which they were centrifuged at 14 k for 20 minutes at 4° C. The liquid was 
then removed, and 250 pi o f 75% ETOH were added. The tubes were centrifuged again 
at 14 k for 15 minutes at 4° C and the ETOH removed. The samples were then dried for 
a few seconds at 95° C and resuspended in 15-20 pi o f TSR and vortex mixed. 
Subsequently, the samples were heated at 95° C for 2-3 minutes, vortex mixed and 
placed on ice. The reagents used were 2 pi of 1:4 buffer- diluted ABI stock®, 10-30 
pmoles of primer and 200-400 ng of DNA in a final volume of 5-7 pi. The sequencing 
reaction followed this protocol: rapid thermal ramp to 95° C, 95° C for 10 seconds, rapid 
thermal ramp to 50° C, 50° C for 5 seconds, rapid thermal ramp to 60° C, 60° C for 4 
minutes, followed by rapid thermal ramp to 4° C and hold. ABI 310® genetic analyzer 
was used for sequencing. The resulting peaks, corresponding to the DNA bases, were 
analyzed by Chromas® software, which allowed to read the DNA sequence.
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6.2.3.4. Hardy- Weinberg equilibrium
Nearly one century ago, two scientists (Godfrey Hardy and Wilhelm Weinberg) 
independently developed a formula to calculate the distribution of genotypes in a 
population throughout generations (Crow 1999). Until then, it was believed that rare 
alleles would decrease in frequency with time, and eventually disappear. They 
concluded, based on probability considerations, that genotype frequencies are stable and 
wouldn’t change if there was no evolution of the species. Hardy and Weinberg 
developed an equation that can be used to discover the expected genotype frequencies in 
a population. This formula is now known as the Hardy-Weinberg equilibrium. In this
9 9equation (p + 2pq+ q ) = 1, p is the frequency of the dominant allele and q is the 
frequency o f the recessive allele for a trait (Crow 1999). The Hardy-Weinberg law fails 
to apply in cases o f mutations, considerable introduction in a population of individuals 
from other communities, non random mating and natural selection. In this last event, if a 
particular genotype makes individuals less able to produce offspring or less successful to 
survive until the end of their reproductive period, that genotype is likely to undergo a 
reduction in population frequency. The Hardy-Weinberg equilibrium was tested in all 
the studied polymorphisms in our sample.
6.2.4. STATISTICAL ANALYSIS
The GC utilities package was used for linkage disequilibrium (LD) analysis between 
genetic markers. The LD pairs programme allowed us to investigate if any genetic 
polymorphisms were in linkage disequilibrium with each other. Pair-wise linkage was 
tested for FcyR (Ila, lib, Ilia, Illb NA and Illb SH) and FPR (301, 546 and 568). 
Separate analysis was performed to test for linkage disequilibrium in the whole group of 
subjects, and in both patients and controls separately. R squared and D ’ values are 
reported as measures of LD; the maximum value of 1 indicates that no recombination 
exists between pairs of markers (Stram 2004).
Statistical analysis was performed using the SPSS 12.0 package. Continuous, normally 
distributed variables were reported as means ± standard deviation (SD). Comparisons of 
continuous and categorical data between groups were analyzed with ANOVA and Chi-
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square test, respectively. For these analyses, the alpha value was set at 0.05. However, 
because of the inherent problem of multiple testing, which can lead to spurious results 
(Altman 1991), the alpha value for association between genetic SNPs and AgP was set at 
0.01. Chi- square was used as a screening tool to select possible associations. Whenever 
a p value of 0.2 or lower was detected, multiple logistic regression analysis adjusting for 
confounders (gender, ethnicity, and smoking) was performed to investigate the 
association between genotypes as well as presence or absence o f alleles (for example, 
supposing the two alleles were C and G, GG versus CG and CC, and CC versus CG and 
GG) in the AgP and control groups. These analyses allowed investigation of different 
types of genetic models. Only the results which resulted in the highest associations 
(lowest p values) for each SNP are reported. Further analyses were performed in the 
subgroups o f LAgP and GAgP. Because of the known strong association between 
ethnicity and genetic background and the risk of finding spurious associations (Pritchard 
& Rosenberg 1999), separate analyses were performed in Caucasians and Blacks. 
Considering the recognized powerful effects of smoking as a risk factor for AgP 
(Schenkein et al. 1995, Tonetti & Mombelli 1999), and the potential for residual 
confounding, separate analyses were also performed on non smokers, smokers (past and 
current), Caucasian smokers and Caucasians who never smoked.
Logistic regression analysis considers each SNP as an independent variable, without 
taking into account interactions between polymorphisms, even if these are located in the 
same gene (Sham et al. 2004). Haplotype associations were analyzed in this study by use 
of the WHAP package. This program provides a method to test haplotype associations 
with qualitative and quantitative traits (ref. www.genome.wi.mit.edu/-shaun/whap/). 
Haplotypes with a frequency of less than 1% are automatically excluded from analysis. 
Different thresholds can be chosen in order to exclude rare haplotypes (< 2% or <5% for 
example). WHAP analysis was performed respectively for FcyR (Ha, lib, Ilia, Illb NA, 
Illb SH) and FPR (301, 546, 568) polymorphisms. Interactions between all the 
polymorphisms studied, as pairs, triplets, quads and quintets and as single markers were 
tested. For example, FPR 301 polymorphism association with the disease trait was tested 
alone, in combination with 546, in combination with 568, and with both 546 and 568
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together. The RunGC programme was used for separate analysis of haplotype 
frequencies in both cases and controls, and to test for significant differences between 
these two groups using a likelihood-ratio test (LRT).
6.3. RESULTS
A total of 224 AgP patients and 231 healthy controls took part in the study. Their 
demographic characteristics are presented in table 6.4. Due to our age criteria for 
recruitment, controls were on average older than the patients (controls average age: 38.4 
range 25-77; patients average age: 29.9 range 10-45). No statistically significant 
differences were detected in the two groups for gender, smoking, and ethnicity. 
However, a higher percentage of males, Caucasians and non smokers were detected in 
the control compared to the patient group.
PATIENTS CONTROLS Compariso 
ns between 
groups(n=224) % (n=231) %
AGE 29.9 ± 7 .2 - 38.4 ±  12.2 - -
GENDER
M ale 79 35.3 99 42.9 P=0.103 
Fisher’s 
exact testFemale 145 64.7 132 57.1
ETHNICITY
Caucasian 112 50.0 144 62.3
P=0.06 3 
Pearson ’s 
Chi-square
Black 59 26.3 45 19.5
Asian 34 15.2 29 12.6
other 19 8.5 13 5.6
SMOKING
No smokers 118 52.7 135 58.4
P=0.168 
Pearson’s 
Chi-square
Former smokers 52 23.2 41 17.7
Light smokers 
(< 20/day)
38 17.0 46 19.9
Heavy smokers 
(> 20/day)
16 7.1 9 3.9
Table 6.4: Comparison o f demographic characteristics o f  patients and controls
Table 6.5 and 6.6 report the demographic characteristics o f subjects belonging to the two 
biggest ethnic subpopulations of the study, respectively Caucasians and Blacks. Among
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Caucasians, a statistically significant imbalance was noted for gender and smoking, with 
higher proportions o f women and smokers present in the Caucasian patient group when 
compared to controls. In the Black subgroup the opposite tendency was observed: fewer 
women and fewer smokers were present in the patient group compared to the control 
group.
CAUCASIANS
PATIENTS CONTROLS Comparisons 
between groups(n=106) % (n=144) %
AGE 29.0 ± 7 .2 - 39.0 ± 13.5 - -
GENDER
Male 36 32.1 70 48.6 P=0.010 
Fisher’s exact 
testFemale 76 67.9 74 51.4
SMOKING
Non smokers 38 33.9 81 56.3
P=0.002 
Pearson’s Chi- 
square
Former smokers 37 33.0 30 20.8
Light smokers 
(< 20/day)
23 20.5 26 18.1
Heavy smokers 
(> 20/day)
14 12.5 7 4.9
Table 6.5: Comparison o f demographic characteristics o f  Caucasian patients and controls
BLACKS
PATIENTS CONTROLS Comparisons 
between groups(n=59) % (n=45) %
AGE 29.2 ±  8.6 - 38.6 ± 9 .5 - -
GENDER
Male 25 42.4 12 26.7 P=0.105 
Fisher’s exact 
testFemale 34 57.6 33 73.7
SMOKING
Non smokers 43 72.9 26 57.8
P=0.277 
Pearson ’sChi- 
square
Former smokers 5 8.5 6 13.3
Light smokers 
(< 20/day)
10 16.9 13 28.9
Heavy smokers 
(> 20/day)
1 1.7 0 0
Table 6.6: Comparison o f demographic characteristics o f Black patients and controls
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Table 6.7 represents the demographic characteristics in the group of GAgP and LAgP 
patients. The subjects diagnosed with Localised AgP were on average younger. No 
gender differences were detected between the groups, with both LAgP and GAgP 
showing more females than males affected, with a ratio o f approximately 2:1. Among 
LAgP patients the proportions o f smokers was lower (p= 0.015).
GAgP LAgP Comparison
between
groups(n=l 67) % (n=57) %
AGE 31.4 ± 6 .0 25.6 ± 8 .4 p< 0.001
GENDER
Male 59 35.3 20 35.1 p= 1.000
Pearson
Chi-squareFemale 108 64.7 37 64.9
ETHNICITY
Caucasian 88 52.7 24 42.1
p= 0.226 
Pearson 
Chi-square
Afro-
Caribbean
45 26.9 14 24.6
Asian 21 12.6 13 22.8
other 13 7.8 6 10.5
SMOKING
Non smokers 79 47.3 39 68.4
p= 0.015 
Pearson 
Chi-square
Former
smokers
42 25.1 10 17.5
Light smokers 
(< 20/day)
30 18.0 8 14.0
Heavy 
smokers 
(> 20/day)
16 9.6 0 0
Table 6.7: Comparison o f  demographic characteristics o f GAgP and LAgP patients
6.3.1. FPR gene sequencing
During the sequencing analysis performed on 31 LAgP patients and 28 controls, two of 
the reactions did not give clear results for the first SNPs in the selected coding region of 
the FPR gene. Therefore, the markers from 301 to 378 were assessed only in 12 of the 
28 controls and in 31 of the patients. None of the mutations described by Gwinn et al. 
(1999) in a LAgP Black population were detected in any o f the samples included in this 
study: T homozygosity and C homozygosity were always found respectively at position 
329 and 378. At position 306, the T mutation was detected only in 1 AgP patient,
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confirming the rarity of this allele as observed by Zhang et al. (2003), which did not 
make it a realistic candidate risk indicator for AgP. Chi-square analysis revealed that the 
301 polymorphism had a tendency for association with the AgP trait (p<0.001, but this 
result was not reliable because of the small sample size), while no associations were 
found for the 306 (p=1.000), 348 (p=0.804), 546 (p=0.247) and 568 (p=0.799) 
polymorphisms. The polymorphism at position 576 is three-allelic, therefore either a 
thymine, a cytosine or a guanine can be present. Being three-allelic, it is not suitable for 
real time PCR analysis. In our sample, the percentages of C, G or T allele frequencies 
were respectively 17, 35 and 48% in patients and 14, 48 and 38% in controls, and the 
genotype distribution was not statistically different (p=0.470). All these results have to 
be taken with caution, because of the small sample size and o f the imbalance in 
ethnicities between patients and controls, and were used only as a screening tool to 
detect the most promising association and exclude the unlikely ones (as for the 329 and 
378 polymorphisms). Based on these results, the 301 (which showed a statistically 
significant association with the disease) and 546 polymorphisms (which showed a trend 
for association) were included in the panel of SNPs to study in the whole group of 
patients and controls. Based on the observations about the possible functionality of the 
different SNPs (Zhang et al. 2003, see chapter 2), the 568 SNP was also included in the 
chosen panel o f polymorphisms.
6.3.2. Hardy-Weinberg equilibrium
The Hardy-Weinberg formula was applied to the genotype frequencies in our subject 
sample to test for any deviations from the expected genotype equilibrium (a web site 
was used to run the analysis: http: //www .kursus.kvl.dk/shares/vetgen/
P op gen/ genetik/applets/kitest.htm). No significant differences were noted when 
frequencies o f genotypes of all individuals (cases and controls pooled together) and 
controls alone were computed. When genotypes from AgP patients alone were analyzed, 
significant variations from the expected equilibrium were detected for Fcylllb SH and 
IL-6 -174 polymorphisms.
105
6.3.3. Linkage disequilibrium between polymorphisms
Tables 6.8 and 6.9 show the p values relative to the pair-wise linkage disequilibrium 
(LD) between markers respectively for FcyR and FPR. The top right elements of the first 
table show R-squared measures of linkage disequilibrium. In parenthesis D ’ measures 
are shown, taking into account differences in allele frequencies. R-squared and D’ 
values approaching 1 indicate higher LD. The bottom left elements of the table shows 
the respective p values for the LD. Among FcyR, significant linkage disequilibrium was 
detected between FcyRIIa and FcyRIIIa (p<0.001); this LD was not significant in the 
patient group (p=0.09). Significant LD was also detected between FcyRIIb and FcyRIIIb 
NA (p=0.009 controls; p= 0.025 patients), FcyRIIIa and FcyRIIIb NA (p=0.02 controls; 
p= 0.003 patients), and FcyRIIIb NA and FcyRIIIb SH (p=0.010 controls; p<0.001 
patients). Among FPR, the 301, 546 and 568 polymorphisms were all in LD with each 
other (only 301 and 546 were not in LD in the control group, p=0.09).
Fey receptor 
polym orphism s
Ila lib I lia I llb  NA Illb  SH
Ila
All subjects
-
0 .016(0 .037) 0.198 (0.273) 0.081 (0.096) 0.046 (0.182)
Controls 0.038 (0.088) 0.265 (0.368) 0.022 (0.028) 0.082 (0.363)
Patients 0.067 (0.149) 0.115 (0.157) 0.129 (0.146) 0 .030(0 .107)
lib
All subjects 0.70827
-
0.074 (0.228) 0.156 (0.414) 0.076 (0.134)
Controls 0.54851 0.104 (0.326) 0.166 (0.463) 0.096 (0.188)
Patients 0.28992 0.037(0 .112) 0.145 (0.366) 0.057 (0.092)
I lia
All subjects 0.00003 0.10960
-
0.176 (0.284) 0.001 (0.002)
Controls 0.00003 0.09545 0.164 (0.274) 0.058 (0.355)
Patients 0.09310 0.57160 0.186 (0.289) 0.037 (0.099)
I llb  NA
All subjects 0.08123 0.00067 0.00016
-
0.190 (0.889)
Controls 0.68918 0.00912 0.02207 0.182 (0.988)
Patients 0.04496 0.02506 0.00256 0.211 (0.862)
I llb  SH
All subjects 0.33750 0.10035 1.00000 0.00001
-Controls 0.30783 0.13801 0.38333 0.00975
Patients 0.61011 0.38966 0.52708 0.00024
Table 6.8: R-squared and D ’ values (in parenthesis) for Linkage Disequilibrium with relative p values 
for FcyR. The top right elements show R-squared values o f linkage disequilibrium. In parenthesis D ’ 
values are shown. The bottom left elements show the respective p values.
106
FP receptor polymorphisms 301 546 568
301
All subjects
-
0.152 (0.155) 0 .217(0 .843)
Controls 0.108 (0.115) 0.195 (0.764)
Patients 0.204 (0.226) 0.256 (0.995)
546
All subjects 0.00085
-
0 .214(0 .820)
Controls 0.09194 0.190 (0.792)
Patients 0.00163 0.247 (0.865)
568
All subjects 0.00000 0.00000
-Controls 0.00059 0.00021
Patients 0.00030 0.00016
Table 6.9 R-squared and D ’ values (in parenthesis) for Linkage Disequilibrium with relative p values for 
FPR. The top right elements show R-squared values o f linkage disequilibrium. In parenthesis D ’ 
values are shown. The bottom left elements show the respective p values.
6.3.4. Comparison between AgP and controls
The distributions o f all studied polymorphisms in relation to the diagnosis (AgP/healthy 
controls) in all subjects are reported in table 6.10. This table is further sub divided for 
the two main ethnic groups of the study, Caucasians and Blacks. The results of the Chi- 
square test to identify differences in the distributions are also reported. Chi-squared 
analysis for all subjects showed statistically significant differences for IL-6 -174 and 
NADPH oxidase p22phox C242 T polymorphisms (p=0.005 and p=0.003 respectively). 
Increases in the frequency of IL-6 -174 G homozygosity and in the carriage of the 
NADPH oxidase p22phox T allele were noted in the patient group. Trends for association 
with the disease trait were noted for FcyRIIIb NA (p=0.068) and SH (p=0.107) rare 
alleles, although they did not reach statistical significance.
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Poly­
m orphism
G eno
-type
All subjects Chi
sq u a re
P=
C aucasians Chi
sq u a re
P=
Blacks Chi
square
P=P atien ts
(n=224)
C ontro ls
(n= 23t)
Patients 
(n= l 12)
C ontro ls
(n=144)
Patien ts
(n=59)
C ontro ls
(n=45)
FcaR
AA 18
(8.2%)
15
(6.5%)
0.564
10
(9.0%)
7
(4.9%)
0.288
2
(3.5%)
0
(0%)
0.363AG 86(39.3%)
84
(36.4%)
50
(45.0%)
60
(41.7%)
14
(24.6%)
9
(20.0%)
GG 115(52.5%)
132
(57.1%)
51
(45.9%)
77
(53.5%)
41
(71.9%)
36
(88.0%)
FcyR IIa
HH 55
(25.2%)
61
(26.4%)
0.957
26
(23.4%)
37
(25.7%)
0.695
14
(25.0%)
9
(20.0%)
0.407HR 109
(50.0%)
113
(48.9%)
52
(46.8%)
71
(43.9%)
31
(55.4%)
22
(48.9%)
RR 54
(24.8%)
57
(24.7%)
33
(29.7%)
36
(25.0%)
11
(19.6%)
14
(31.1%)
FcyR IIb
CC 6(2.7%)
9
(3.9%)
0.584
1
(0.9%)
4
(2.8%)
0.555
3
(5.3%)
2
(4.4%)
0.947CT
61
(27.7%)
56
(24.2%)
24
(21.4%)
31
(21.5%)
19
(33.3%)
14
(31.1%)
TT 153
(69.5%)
166
(71.9%)
87
(77.7%)
109
(75.7%)
35
(61.4%)
29
(64.4%)
FcyR IIIa
VV 28
(12.8%)
27 
(11.8%)
0.874
15
(13.5%)
19
(13.4%)
0.981
9
(15.8%)
2
(4.4%)
0.120VF 95
(43.6%)
105
(45.9%)
52
(46.8%)
65
(45.8%)
21
(36.8%)
23
(51.1%)
FF 95
(43.6%)
97
(42.4%)
44
(39.6%)
58
(40.8%)
27
(47.4%)
20
(44.4%)
FcyR IIIb
NA
NA2/
NA2
71
(32.1%)
75
(32.5%)
0.068
42
(37.5%)
47
(32.6%)
0.060
17
(29.3%)
1 1
(24.4%)
0.840
NA1/
NA2
104
(47.1%)
126
(54.5%)
50
(44.6%)
83
(57.6%)
28
(48.3%)
24
(53.3%)
NA1/
NA1
46
(20.8%)
30
(13.0%)
20
(17.9%)
14
(9.7%)
13
(22.4%) 10(22.2%)
F cyR IIIb
SH
SH+/
SH+
4
(1.8%)
0
(0%)
0.107
0
(0%)
0
(0%)
0.185
4
(6.9%)
0
(0%)
0.188
SH-
/SH+
24
(10.8%)
22
(9.5%)
6
(5.4%)
3
(2.1%)
14
(24.1%)
13
(28.9%)
SH-
/SH-
194
(87.4%)
209
(90.5%)
106
(94.6%)
141
(97.9%)
40
(69.0%)
32
(71.1%)
F P R  301
cc 21(9.7%)
28
(12.2%)
0.555
9
(8.2%)
18
(12.7%)
0.507
4
(7.1%)
4
(8.9%)
0.684CG
92
(42.4%)
101
(44.1%)
52
(47.3%)
62
(43.7%)
21
(37.5%)
20
(44.4%)
GG
104
(47.9%)
100
(43.7%)
49
(44.5%)
62
(43.7%)
31
(55.4%)
21
(46.7%)
Table 6.10: Distributions o f all studied polymorphisms in all subjects. Genotype distributions for all 
studied polymorphisms are presented in patients and controls o f mixed ethnicity, and in the two main 
ethnic groups o f the study, Caucasians and Blacks, with relative Chi-squared, (continues in the next
page)
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Poly­
m orphism
G eno
-type
All sub jects Chi
square
P=
C aucasians Chi
sq u a re
P=
Blacks Chi
square
P=P atien ts
(n=224)
C ontro ls
(n=231)
Patients 
( n = l12)
C ontro ls
(n=144)
P atien ts
(n=59)
C ontro ls
(n=45)
F PR  546
AA 28(12.7%)
25
(10.8%)
0.405
12
(10.7%)
15
(10.4%)
0.500
6
(10.5%)
5
(11.1%)
0.830AC
100
(45.5%)
95
(41.1%)
52
(46.4%)
57
(39.6%)
21
(36.8%)
19
(42.2%)
CC 92(41.8%)
111
(48.1%)
48
(42.9%)
72
(50.0%)
30
(52.6%)
21
(46.7%)
FP R  568
AA 165(75.0%)
181
(78.4%)
0.376
82
(73.9%)
113
(79.0%)
0.427
45
(77.6%)
41
(91.1%)
0.165AT 54
(24.5%)
47
(20.3%)
29
(26.1%)
29
(20.3%)
12
(20.7%)
4
(8.9%)
TT 1 (0.5%) 3(1.3%)
0
(0%)
1
(0.7%) 1 (1.7%)
0
(0%)
VDR
tt
32
(14.3%)
45
(19.5%)
0.328
14
(12.5%)
28
(19.4%)
0.328
10
(16.9%)
7
(15.6%)
0.974Tt 97(43.3%)
96 
(41.6%)
54
(48.2%)
63
(43.8%)
20
(33.9%)
15
(33.3%)
TT 95(42.4%)
90
(39.0%)
44
(39.3%)
53
(36.8%)
29
(49.2%)
23
(51.1%)
T N F-a
AA 157(70.7%)
157
(68.3%)
0.839
68
(60.7%)
90
(62.9%)
0.519
41
(70.7%)
31
(68.9%)
0.265AG
61
(27.5%)
69
(30.0%)
40
(35.7%)
51
(35.7%)
17
(29.3%)
12
(26.7%)
GG
4
(1.8%)
4
(1.7%)
4
(3.6%)
2
(1.4%)
0
(0%)
2
(4.4%)
IL-6
CC
17
(7.7%)
30
(13.0%)
0.005
14
(12.5%)
28
(19.4%)
0.041
0
(0%)
0
(0%)
0.554CG
66
(29.7%)
91
(39.4%)
49
(43.8%)
74
(51.4%)
6
(10.5%)
7
(15.6%)
GG 139(62.6%)
110
(47.6%)
49
(43.8%)
42
(29.2%)
51
(89.5%)
38
(84.4%)
NADPH
CC 67(33.7%)
112
(50.0%)
0.003
34
(34.0%)
73
(52.1%)
0.017
14
(25.9%)
15
(35.7%)
0.050CT 96(48.2%)
84
(37.5%)
55
(55.0%)
53
(37.9%)
22
(40.7%)
22
(52.4%)
TT 36(18.1%)
28
(12.5%)
11
(11.0%)
14
(10.0%)
18
(33.3%)
5
(11.9%)
Table 6.10 continued.
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Logistic regression revealed that the presence of the NADPH oxidase p22phox T allele 
was associated with a diagnosis of AgP, adjusting for gender, smoking and ethnicity 
(p=0.002, O.R. =1.87, 95% C.I. =1.27-2.83) (see table 6.11). The association o f IL-6 G 
homozygosity with diagnosis of AgP did not reach statistical significance, having 
adjusted for gender, smoking and ethnicity (p=0.016, O.R. =1.68, 95% C.I. =1.10-2.57).
Logistic regression analysis for presence of T allele (tot.AgP vs. controls)
P= O.R. 95% C.I.
Unadjusted 0.001 1.97 1.33-2.92
Bivariate (adjusted for gender) 0.001 1.96 1.32-2.90
Bivariate (adjusted for smoking) 0.001 1.95 1.32-2.90
Bivariate (adjusted for ethnicity) 0.001 1.93 1.29-2.88
Multivariate (adjusted for gender, smoking 0.002 1.87 1.27-2.83
and ethnicity)
Table 6.11 Results o f  logistic regression analysis on all subjects for presence o f  T allele o f NADPH 
p22phox 242 SNP. Unadjusted values, bivariate and multivariate values adjusted for confounders are
presented.
Chi-squared analysis in the subgroup of Caucasians showed some evidence of 
association with the AgP trait for IL-6 (p=0.041) and NADPH oxidase (p=0.017), with 
GG and TT respectively being increased in patients compared to controls. Logistic 
regression analysis revealed that carriage of NADPH oxidase T allele was associated 
with diagnosis of AgP, adjusting for gender and smoking (p=0.009, O.R. =2.07, 95% 
C.I. =1.20-3.59 respectively) (see table 6.12).
Logistic regression analysis for presence of T allele (tot. AgP vs. controls)
p= O.R. 95% C.I.
Unadjusted 0.006 2.11 1.24-3.59
Bivariate (adjusted for gender) 0.009 2.05 1.12-3.51
Bivariate (adjusted for smoking) 0.007 2.12 1.23-3.64
Multivariate (adjusted for gender and smoking) 0.009 2.07 1.20-3.59
Table 6.12 Results o f  logistic regression analysis on Caucasian subjects for presence o f  T allele o f  
NADPH p22phox 242 SNP. Unadjusted values, bivariate and multivariate values adjusted for
confounders are presented.
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IL-6 G homozygosity showed a trend for association with diagnosis of AgP, adjusting 
for gender and smoking (p=0.032, O.R. =1.80, 95% C.I. =1.05-3.10). Similarly, in 
Caucasians who never smoked (consisting of 38 patients and 81 controls), NADPH 
oxidase T allele showed some evidence of association with a diagnosis of AgP, adjusting 
for gender (p=0.012, O.R. =3.16, 95% C.I. =1.28-7.76).
Among smokers (current and past: 106 AgP patients and 94 controls) of mixed ethnicity, 
both homozygosity for FcyRIIIb NA1 homozygosity and presence of VDR T allele 
showed tendencies for association with AgP (p= 0.027, O.R.= 2.46, 95% C.I.= 1.10- 
5.50 and p= 0.032, O.R.= 2.35, 95% C.I.= 1.07- 5.15 respectively). Both FcyRIIIb NA 
and VDR Taq-I polymorphisms and smoking were shown to be independent variables 
(p=0.910 and p=0.998 respectively). Figure 6.1 shows the genotype distribution for the 
Taq-I VDR polymorphism in controls and patients who never smoked, and figure 6.2 
shows the same data in the smokers.
non sm okers
n controls 
■ AgP patients
tt tT TT
VDR genotype
Figure 6.1 VDR Taq-I genotype distribution in subjects who never smoked
sm okers
50
n controls 
B AgP patients
tt tT
VDR genotype
TT
Figure 6.2 VDR Taq-I genotype distribution in smokers (current and past)
While in non smokers the distribution between controls and patients is very similar, 
among smokers there is an evident enrichment of T allele presence. Logistic regression 
analysis on the whole group of subjects in order to investigate a possible interaction 
between smoking (current and past) and VDR polymorphism revealed that neither of 
these two factors was independently associated with AgP (p=0.348 and p=0.898 
respectively). However, the interaction VDR/smoking showed a trend for association
Among Black subjects, only NADPH oxidase p22phox C242 T polymorphisms did not 
exhibit a homogeneous distribution between patients and controls (p=0.050). Tendencies 
for not equivalent distributions, which did not reach statistical significance, were noted 
for FcyRIIIa (p=0.120), FcyRIIIb SH (p=0.188) and FPR 568 (p=0.165) polymorphisms. 
Logistic regression revealed limited evidence of association between NADPH oxidase 
p22phox polymorphism and diagnosis of AgP having adjusted for gender, smoking and 
ethnicity (p=0.032, O.R. =1.93, 95% C.I. =1.06-3.52). No statistical analysis was 
performed on allele distributions. However, appendix XVI shows allele frequencies in 
patients and controls for all studied polymorphisms.
(p= 0.066).
6.3.5. Comparison between GAgP and LAgP.
The distributions of all polymorphisms in the GAgP and LAgP groups are reported in 
table 6.13. No statistically significant differences were detected, although there was an 
increased prevalence of G homozygosity for IL-6 -174 in the LAgP group (73% versus 
59%, p=0.165).
Polymorphism Genotype
All subjects
Chi square p=
LAgP (n=57) GAgP (n=167)
FcaR
AA 4 (7.3%) 14 (8.5%)
0.956AG 22 (40.0%) 64 (39.0%)
GG 29 (52.7%) 86  (52.4%)
FcyRIIa
HH 14 (25.5%) 41 (25.2%)
0.389HR 31 (56.4%) 78 (47.9%)
RR 10 (18.2%) 44 (27.0%)
FcyRIIb
CC 2 (3.6%) 4 (2.4%)
0.850CT 16 (29.1%) 45 (27.3%)
TT 37 (67.3%) 116(70.3% )
F cyRIIIa
GG 7 (12.7%) 21 (12.9%)
0.800GT 26 (47.3%) 69 (42.3%)
TT 22 (40.0%) 73 (44.8%)
FcyRIIIbNA
NA2/NA2 20 (35.7%) 51 (30.9%)
0.207NA1/NA2 29 (51.8%) 75 (45.5%)
NA1/NA1 7 (12.5%) 39 (23.6%)
FcyRIIIbSH
SH +/SH + 1 ( 1.8%) 3 (1.8%)
1.000SH-/SH+ 6 (10.9%) 18 ( 10.8 %)
SH-/SH- 48 (87.3%) 146 (87.4%)
FPR 301
CC 5 (9.3%) 16 (9.8%)
0.797CG 25 (46.3%) 67 (41.1%)
GG 24 (44.4%) 80 (49.1 %)
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Polymorphism Genotype
All subjects
Chi square p=
_ LAgP GAgP
FPR 546
AA 9(16.4% ) 19(11.5% )
0.165AC 19(34.5% ) 81 (49.1%)
CC 27 (49.1%) 65 (39.4%)
FPR 568
AA 40 (72.7%) 125 (75.8%)
0.739AT 15 (27.3%) 39 (23.6%)
TT 0 (0%) 1 (0 .6 %)
VDR
tt 9(15.8% ) 23 (13.8%)
0.855Tt 23 (40.4%) 74  (44.3%)
TT 25 (43.9%) 70 (41.9%)
TNF-a
AA 42 (73.7%) 115 (69.7%)
0.469AG 15 (26.3%) 46 (27.9%)
GG 0 (0 .0 %) 4 (2.4%)
IL-6
CC 3 (5.4%) 14(8.4% )
0.165CG 12 (21.4%) 54 (32.5%)
GG 41 (73.2%) 98 (59.0%)
NADPH
CC 17 (38.6%) 50 (32.3%)
0.394CT 22 (50.0%) 74  (47.7%)
TT 5(11.4% ) 31 (20 .0%)
Table 6.13 Distributions o f  all studied polymorphisms in LAgP and GAgP subjects with relative Chi- 
squared referring to differences in genotype distributions between patients with LAgP and patients
with GAgP.
6.3.6. Comparison between GAgP and controls.
Table 6.14 shows the distributions of all polymorphisms in the patients diagnosed with 
GAgP and in the healthy controls both in the whole group of subjects and in Caucasians. 
Chi- squared analysis revealed border-line significance for the distribution of FcyRIIIb 
NA polymorphism (p=0.019 and p=0.021 respectively in mixed populations and 
Caucasians) and association with the disease trait for NADPH oxidase p22phox C242 T
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polymorphism (p=0.002 and p=0.034 respectively in mixed populations and 
Caucasians).
Poly­
morphism
Geno­
type
All subjects Chi
square
P=
Caucasians Chi
square
P=
GAgP
(n=167)
Controls
(n=231)
G A gP
(n=88)
Controls
(n=144)
FcaR
AA
14
(8.5%)
15
(6.5%)
0.574
8
(9.2%)
7
(4.9%)
0.359AG
64
(39.0%)
84
(36.4%)
38
(43.7%)
60
(41.7%)
GG 86(52.4%)
132
(57.1%)
41
(47.1%)
77
(53.5%)
FcyRIla
HH 41
(25.2%)
61
(26.4%)
0.869
21
(24.1%)
37
(25.7%)
0.382HR 78
(47.9%)
113
(48.9%)
37
(42.5% )
71
(43.9%)
RR
44
(27.0%)
57
(24.7%)
29
(33.3%)
36
(25.0%)
FcyRIIb
CC
4
(2.4%)
9
(3.9%)
0.602
0
(0%)
4
(2 .8%)
0.287CT 45
(27.3%)
56
(24.2%)
19
(2 1 .6%)
31
(21.5%)
TT 116
(70.3%)
166
(71.9%)
69
(78.4%)
109
(75.7%)
FcyRIIIa
GG
21
(12.9%)
27
( 11 .8 %)
0.783
12
(13.8% )
19
(13.4%)
0.966GT
69
(42.3%)
105
(45.9%)
41
(47.1% )
65
(45.8%)
TT 73
(44.8%)
97
(42.4%)
34
(39.1%)
58
(40.8%)
FcyRIIIbNA
NA2/N
A2
51
(30.9%)
75
(32.5%)
0.019
31
(35.2%)
47
(32.6%)
0.021NA1/N
A2
75
(45.5%)
126
(54.5%)
38
(43.2%)
83
(57.6%)
NA1/N
A l
39
(23.6%)
30
(13.0%)
19
(2 1 .6 %)
14
(9.7%)
FcyRIIIbSH
SH+/SH
+
3
( 1.8%)
0
(0 %)
0.111
0
(0 %)
0
(0%)
0.431SH-
/SH+
18
( 10 .8%)
22
(9.5%)
4
(4.5%)
3
(2 . 1%)
SH-/SH- 146(87.4%)
209
(90.5%)
84
(95.5%)
141
(97.9%)
FPR 301
CC 16
(9.8%)
28
( 12.2%)
0.522
7
(8 .0%)
18
(12.7%)
0.543CG
67
(41.1%)
101
(44.1%)
39
(44.8%)
62
(43.7%)
GG
80
(49.1%)
100
(43.7%)
41
(47.1%)
62
(43.7%)
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Poly­
morphism
Geno­
type
All subjects Chi
square
P=
Caucasians Chi
square
P=
GAgP
(n=167)
Controls
(n=231)
GAgP
(n=88)
Controls
(n=144)
FPR 546
AA 19
(11.5%)
25
( 10 .8%)
0.219
8
(9.1%)
15
(10.4%)
0.164AC 81
(49.1%)
95
(41.1%)
46
(52.3%)
57
(39.6%)
CC 65(39.4%)
111
(48.1%)
34
(38.6%)
72
(50.0%)
FPR 568
AA
125
(75.8%)
181
(78.4%)
0.600
63
(72.4%)
113
(79.0%)
0.382AT 39
(23.6%)
47
(20.3%)
24
(27.6%)
29
(20.3%)
TT 1
(0 .6 %)
3
(1.3%)
0
(0 %)
1
(0.7%)
VDR
tt 23
(13.8%)
45
(19.5%)
0.328
12
(13.6% )
28
(19.4%)
0.499Tt 74
(44.3%)
96
(41.6%)
43
(48.9%)
63
(43.8%)
TT 70(41.9%)
90
(39.0%)
33
(37.5%)
53
(36.8%)
TNF-a
AA
115
(69.7%)
157
(68.3%)
0.819
53
(60.2%)
90
(62.9%)
0.342AG
46
(27.9%)
69
(30.0%)
31
(35.2%)
51
(35.7%)
GG
4
(2.4%)
4
(1.7%)
4
(4.5%)
2
(1.4%)
IL-6
CC
14
(8.4%)
30
(13.0%)
0.065
11
(12.5%)
28
(19.4%)
0.168CG
54
(32.6%)
91
(39.4%)
42
(47.7%)
74
(51.4%)
GG 98
(59.0%)
110
(47.6%)
35
(39.8%)
42
(29.2%)
NADPH
CC 50
(32.3%)
112
(50.0%)
0.002
28
(34.1%)
73
(52.1%)
0.034CT
74
(47.7%)
84
(37.5%)
43
(52.4%)
53
(37.9%)
TT 31
(2 0 .0 %)
28
(12.5%)
11
(13.4%)
14
( 10 .0 %)
Table 6.14: Distributions o f  all studied polymorphisms in GAgP and controls with relative Chi-squared 
results. Genotype distributions for all studied polymorphisms are presented in GAgP patients and 
controls o f  mixed ethnicity (all subjects) and in the Caucasians only.
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Logistic regression analysis revealed that carriage o f at least one copy of p22phox 242 T 
allele was associated with the disease phenotype adjusting for gender, smoking and 
ethnicity (p=0.003, O.R. =1.95, 95% C.I. =1.26-3.01) (see table 6.15). A trend for 
association with the GAgP trait, having adjusted for gender, smoking and ethnicity, was 
noted for the FcyRIIIb NA polymorphism (p=0.013, O.R. =1.97, 95% C.I. =1.15-3.37), 
FcyRIIIb SH polymorphisms (p=0.111) and IL-6 GG (p=0.065).
Logistic regression analysis for presence of T allele (GAgP vs. controls)
P= O.R. 95% C.I.
Unadjusted 0.001 2.10 1.37-3.22
Bivariate (adjusted for gender) 0.001 2.08 1.35-3.18
Bivariate (adjusted for smoking) 0.001 2.06 1.34-3.17
Bivariate (adjusted for ethnicity) 0.001 2.02 1.31-3.11
Multivariate (adjusted for gender, smoking 0.003 1.95 1.26-3.01
and ethnicity)
Table 6.15 Results o f  logistic regression analysis on GAgP patients compared with controls for presence 
o f  T allele o f  NADPH p22phox 242 SNP. Unadjusted values, bivariate and multivariate values
adjusted for confounders are presented.
Sub analysis on the Caucasian GAgP group also showed border-line association for 
FcyRIIIb NA1 homozygosity and NADPH oxidase p22phox 242 T allele with the 
presence of GAgP adjusting for gender and smoking (p=0.013, O.R. =2.73, 95% C.I. 
=1.24-6.04 and p=0.029, O.R. =2.94, 95% C.I. =1.63-5.30 respectively). Logistic 
regression analysis was performed to investigate a possible interaction between these 
two polymorphisms (NADPH oxidase p22phox C242T and FcyRIIIb NA). In the 
Caucasian GAgP group, 19 patients and 14 controls were NA1 homozygous and, out of 
these subjects, 14 patients (74% of this subgroup of patients) and just 1 control (7% of 
this subgroup of controls) had at least one copy of the NADPH oxidase T allele. Logistic 
regression analysis of the interaction between these two genotypes adjusting for gender 
and smoking gave a relative risk of 34 for individuals with both the risk genotypes of 
having GAgP (p=0.005, O.R. = 33.9, 95% C.I.: 2.9-390.5).
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6.3.7. Comparison between LAgP and controls.
The distributions o f all polymorphisms in the patients diagnosed with LAgP and in the 
healthy controls are reported in table 6.16. Only the IL-6 -174 polymorphism showed a 
statistically significant different distribution between the LAgP group and the healthy 
controls (p=0.003).
Poly­
morphism
Geno­
type
AH subjects
Chi
square
P=
Caucasians
Chi
square
P=
LAgP
(n=57)
Controls
(n=231)
LAgP
(n=24)
Controls
(n=144)
FcaR
AA
4
(7.3%) 15 (6.5%)
0.838
2
(8.3%)
7
(4.9%)
0.509AG
22
(40.0%)
84
(36.4%)
12
(50.0%)
60
(41.7%)
GG
29
(52.7%)
132
(57.1%)
10
(41.7%)
77
(53.5%)
FcyR! la
HH 14(25.5%)
61
(26.4%)
0.521
5
(2 0 .8%)
37
(25.7%)
0.474HR 31
(56.4%)
113
(48.9%)
15
(62.5%)
71
(43.9%)
RR 10
(18.2%)
57
(24.7%)
4
(16.7%)
36
(25.0%)
FcyRIIb
CC
2
(3.6%)
9
(3.9%)
0.758
1
(4.2%)
4
(2 .8%)
0.933CT 16
(29.1%)
56
(24.2%)
5
(2 0 .8%)
31
(21.5%)
TT
37
(67.3%)
166
(71.9%)
18
(75.0%)
109
(75.7%)
FcyRIIIa
GG
7
(12.7%)
27
( 11 .8%)
0.946
3
(12.5%)
19
(13.4%)
0.992GT 26(47.3%)
105
(45.9%)
11
(45.8%)
65
(45.8%)
TT 22
(40.0%)
97
(42.4%)
11
(41.7%)
58
(40.8%)
FcyRIIIbNA
N A 2/
NA2
20
(35.7%)
75
(32.5%)
0.898
11
(45.8%)
47
(32.6%)
0.375N A 1/
NA2
29
(51.8%)
126
(54.5%)
12
(50.0%)
83
(57.6%)
NA1/
NA1
7
(12.5%)
30
(13.0%)
1
(4.2%)
14
(9.7%)
FcyRIIIbSH
SH+/
SH+
1
( 1.8%)
0
(0%)
0.114
0
(0 %)
0
(0 %)
0.149SH-/
SH+
6
(10.9%)
22 (9.5%)
2
(8.3%)
3
(2 . 1%)
SH-/
SH­
48
(87.3%)
209
(90.5%)
22
(91.7%)
141
(97.9%)
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Poly­
morphism
Geno­
type
All subjects
Chi
square
P=
Caucasians
Chi
square
P=
LAgP
(n=57)
Controls
(n=231)
LAgP
(n=24)
Controls
(n=144)
FPR 301
CC
5
(9.3%)
28
( 12.2 %)
0.826
2
(8.7%)
18
(12.7%)
0.510CG
25
(46.3%)
101
(44.1%)
13
(56.5%)
62
(43.7%)
GG
24
(44.4%)
100
(43.7%)
8
(34.8%)
62
(43.7%)
FPR 546
AA 9(16.4%)
25
( 10 .8%)
0.440
4
(16.7%)
15
(10.4%)
0.340AC
19
(34.5%)
95
(41.1%)
6
(25.0%)
57
(39.6%)
CC
27
(49.1%)
111
(48.1%)
14
(58.3%)
72
(50.0%)
FPR 568
AA 40
(72.7%)
181
(78.4%)
0.391
19
(79.2%)
113
(78.5%)
0.919AT 15
(27.3%)
47
(20.3%)
5
(2 0 .8%)
29
(25.9%)
TT
0
(0 %)
3
(1.3%)
0
(0%)
1
(0.7%)
VDR
tt
9
(15.8%)
45
(19.5%)
0.732
2
(8.3%)
28
(19.4%)
0.390Tt
23
(40.4%)
96
(41.6%)
11
(45.8%)
63
(43.8%)
TT 25
(43.9%)
90
(39.0%)
11
(45.8%)
53
(36.8%)
TNF-a
AA 42
(73.7%)
157
(68.3%)
0.497
15
(62.5%)
90
(62.9%)
0.837AG
15
(26.3%)
69
(30.0%)
9
(37.5%)
51
(35.7%)
GG
0
(0 %)
4
(1.7%)
0
(0%)
2
(1.4%)
IL-6
CC
3
(5.4%)
30
(13.0%)
0.003
3
(12.5%)
28
(19.4%)
0.019CG
12
(21.4%)
91
(39.4%)
7
(29.2%)
74 
(51.4%)
GG
41
(73.2%)
110
(47.6%)
14
(58.3%)
42
(29.2%)
NADPH
CC
17
(38.6%)
1 12 
(50.0%)
0.290
5
(27.8%)
73
(52.1%)
0.065CT
22
(50.0%)
84
(37.5%)
12
(66.7%)
53
(37.9%)
TT 5(11.4%)
28
(12.5%)
1
(5.6%)
14
( 10 .0%)
Table 6.16: Distributions o f  all studied polymorphisms in LAgP and controls. Genotype distributions 
for all studied polymorphisms are presented in LAgP patients and controls o f  mixed ethnicity (all 
subjects) and in Caucasians only. Relative Chi-squared results are presented.
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Logistic regression analysis revealed that G homozygosity was significantly associated 
with LAgP, having adjusted for gender, smoking and ethnicity (p=0.006, O.R. =2.71, 
95% C.I. =1.33-5.54) (see table 6.17).
Logistic regression analysis for IL-6 homozygosity (tot. LAgP vs. controls)
P= O.R. 95% C.I.
Unadjusted 0.001 3.01 1.58-5.73
Bivariate (adjusted for gender) 0.001 2.98 1.56-5.68
Bivariate (adjusted for smoking) 0.001 2.98 1.56-5.68
Bivariate (adjusted for ethnicity) 0.007 2.65 1.30-5.39
Multivariate (adjusted for gender, smoking 0.006 2.71 1.33-5.54
and ethnicity)
Table 6.17 Results o f  logistic regression analysis on LAgP patients compared with controls for G 
hom ozygosity for IL-6 -174 SNP. Unadjusted values, bivariate and multivariate values adjusted for
confounders are presented.
Even among the small group of Caucasians with LAgP (n=24), G homozygosity showed 
an association with LAgP, having adjusted for gender and smoking (p=0.008, O.R. 
=3.37, 95% C.I. =1.38-8.25) (see table 6.18). FcyRIIIb SH (p=0.114 in all subjects and 
p=0.149 in Caucasians) and NADPH oxidase (p=0.065 in Caucasians) showed 
tendencies for association with LAgP.
Logistic regression analysis for presence of T
controls)
Unadjusted
Bivariate (adjusted for gender)
Bivariate (adjusted for smoking)
Multivariate (adjusted for gender and 
smoking)
Table 6.18 Results o f  logistic regression analysis on LAgP Caucasian patients compared with Caucasian 
controls for G homozygosity for IL-6 -174 SNP. Unadjusted values, bivariate and multivariate values
adjusted for confounders are presented.
allele (tot. Caucasian LAgP vs.
p= O.R. 95% C.I.
0.007 3.40 1.40-8.26
0.007 3.39 1.39-8.29
0.007 3.39 1.39-8.23
0.008 3.37 1.38-
8.25
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6.3.8. Haplotype analyses
No FPR and FcyR haplotypes displayed statistically significant associations with the 
AgP phenotype in Caucasians as analyzed by WHAP (pair- wise results are presented in 
tables 6.19 and 6.20).
FcyR Ila lib Ilia Illb  NA Illb  SH
Ila - 0.644 0.607 0.445 0.117
lib - - 0.876 0.892 0.121
Ilia - - - 0.975 0.290
Illb  NA - - - - 0.132
Illb  SH - - - - -
Table 6.19: p values (adjusted for smoking) obtained by WHAP analysis for pair-wise haplotype effects
on AgP in Caucasian subjects
FPR 301 546 568
301 ~ 1 - 0.563 0.584
546 - - 0.331
568 - - -
Table 6.20: p values (adjusted for smoking) obtained by WHAP analysis for pair-wise haplotype effects
on AgP in Caucasian subjects
Table 6.21 shows the pair-wise results o f haplotype associations for FcyR in relation to 
AgP in the group o f Black patients. No statistically significant results were observed.
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FcyR Ila lib Ilia Illb  NA Illb  SH
Ila - 0.444 0.651 0.195 0.578
lib - - 0.94 0.177 0.669
Ilia - - - 0.147 0.428
Illb  NA - - - - 0.932
Illb  SH - - - - -
Table 6.21: p values (adjusted for smoking) obtained by WHAP analysis for haplotype effect on AgP in
Black subjects
However, haplotype association between all five studied FcyR polymorphisms showed 
some evidence of association with AgP in Black individuals (p=0.047 adjusting for 
smoking). The best haplotypic model was obtained in a constrained model with the 
exclusion of FcyRIIIb SH polymorphism (p=0.034 adjusting for smoking). The 
estimated frequencies o f the possible haplotypes with the four remaining FcyR as 
analyzed by RunGC are presented in table 6.22. The highest likelihood- ratio test (LRT) 
statistics for this haplotype association was obtained for the haplotype including Fey I la 
H allele, FcyRIIb T allele, FcyRIIIa V allele and FcyRIIIb NA2 allele, which had an 
estimated frequency o f 0.109 (11%) in patients and 0.0 in controls. FcyRIIa, FcyRIIIa 
and FcyRIIIb NA haplotypic combination also showed some evidence of association 
with AgP (p=0.049 adjusting for smoking). The highest LRT statistics for these 
genotypes was obtained for the haplotype including FcyRIIa H allele, FcyRIIIa V allele 
and FcyRIIIb NA2 allele, which had an estimated frequency of 0.12 (12%) and 0.0 
respectively in patients and controls.
Allele combinations Estimated frequencies LRT
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Fcylla Fcyllb F cyllla Fcylllb Controls Patients Combined mean
H C V NA2 0.000 0.012 0.010 1.34
H c V NA1 0.000 0.035 0.007 3.68
H c F NA2 0.061 0.016 0.045 2.33
H c F NA1 0.000 0.000 0.003 0.01
H T V NA2 0.000 0.109 0.064 11.55
H T V NA1 0.232 0.102 0.165 4.20
H T F NA2 0.063 0.175 0.100 4.31
H T F NA1 0.087 0.076 0.094 0.06
R C V NA2 0.038 0.042 0.041 0.02
R C V NA1 0.000 0.000 0.001 0.01
R C F NA2 0.100 0.088 0.080 0.06
R C F NA1 0.000 0.028 0.024 3.03
R T V NA2 0.024 0.024 0.027 0.00
R T V NA1 0.005 0.022 0.010 0.83
R T F NA2 0.224 0.068 0.157 7.20
R T F NA1 0.163 0.199 0.169 0.28
Table 6.22: FcyR haplotype frequencies in Black subjects as estimated by RunGC software. All the 
possible allele combinations between FcyRlIa, lib, Ilia and Illb NA polymorphisms are presented. 
Estimated frequencies for each haplotype combination between FcyRIIa, lib, Ilia and Illb NA in 
controls and patients and all subjects are presented. In the last column, Likelihhod- Ratio Test (LRT)
values are reported.
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Single marker analysis on FPR haplotypes in Black subjects revealed a tendency for 
association for FPR 568 (p=0.029). The extent of this association decreased in the 
haplotype analysis (see table 6.23 for pair- wise results).
FPR 301 546 568
301 - 0.449 0.064
546 - - 0.091
568 - - -
Table 6.23: p values (adjusted by smoking) obtained by Whap analysis for haplotype effect on AgP in
Black subjects
6.4. DISCUSSION
6.4.1. Polymorphisms distribution
The distribution of the genotypes for the studied genetic polymorphisms satisfied the 
Hardy-Weinberg equilibrium and was consistent with the literature data. In more detail, 
the distributions o f FcaR 324 genotype and FcyRIIb 695 in controls were consistent with 
those reported respectively by Kaneko et al. (2004) and Yasuda et al. (2003), although 
these were observations made in Japanese subjects. Similarly, VDR Taq-I genotype 
distribution was comparable with previous studies (Carling et al. 1997), as were TNF-a 
(Parks et al. 2004, Donati et al. 2005) and the FPR polymorphisms (Zhang et al. 2003). 
Genotype distributions for FcyRIIa, Ilia and Illb were compared with those reported in a 
recent review of association studies conducted on different populations (Lehmbecher et 
al. 1999). The two alleles (H and R) for FcyRIIa 494 polymorphism have been reported 
as having an almost equal distribution in Caucasian populations, while HH 
homozygosity is more frequent in Asians. Similarly, among our Caucasian controls (see 
table 6.10) H and R were almost equally prevalent. FcyRIIIa 559 genotypes also had a 
distribution in our healthy controls consistent with literature data (Koene et al. 1997, 
Lehmbecher et al. 1999) (see table 6.10). Similarly, for the FcyRIIIb NA polymorphism
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we found a percentage o f 13, 54 and 32 % respectively for NA1/NA1, NA1/NA2 and 
NA2/NA2 genotypes, which is as described in previous studies (Lehmbecher et al. 
1999), with a slight increase of frequency o f NA2 homozygosity in Blacks. Lehmbecher 
et al. (1999) also observed a prevalence o f around 4% and 28% for the FcyRIIIb SH 
positive variant respectively in Caucasians and Blacks. These frequencies are mirrored 
by our data, where 2% of Caucasian and 29% of Black controls were found to be SH 
positive. With regard to IL-6 -174 polymorphism, Fishman et al. (1998) in a North- 
London population, found a genotype distribution of 38% GG, 44% GC and 18% CC in 
Caucasians and 91% GG, 9% GC and 0% CC in Afro-Caribbeans. The corresponding 
figures for our controls were 29% GG, 51% GC and 19% CC in Caucasians, and 84% 
GG, 16% GC and 0% CC in Blacks, showing a slightly higher prevalence of the C allele 
in our sample. However, in a study on 2751 middle-aged healthy U.K. men, the -174C 
allele frequency was found to be 43% (Humphries et al. 2001), higher than the 33% in 
our controls (see appendix XVI). Therefore these results, although showing some small 
differences with our frequencies, are still comparable. Gardemann et al. (1999), 
examining a population of 2205 German Caucasians found a prevalence o f 66% for 
frequency of the C allele at position 242 of the CYBA gene coding for NADPH oxidase 
p22phox , while Cai et al. (1999) also found a prevalence of 66% in 689 Australian 
Caucasians. The same allele had a similar but slightly higher prevalence in our 
Caucasian controls (69%) (see appendix XVI), and a smaller one in our Caucasian 
patients (58%). Obviously, having included only subjects with healthy periodontium as 
controls, this may account for small differences in genotype distribution with these 
various literature data, which did not take into account periodontal conditions, and may 
have included a small percentage of subjects suffering from severe periodontitis.
The main finding o f this study is that IL-6 -174 and NADPH oxidase p22phox C242 T 
polymorphisms were risk indicators for the presence of Aggressive Periodontitis in our 
sample. FcyRIIIb NA polymorphism, FcyR haplotypes and VDR polymorphism in 
smokers also showed some evidence of association with the AgP trait. This finding is in 
agreement with the supposed importance o f genetic factors in the pathogenesis of AgP.
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The polymorphisms which showed association with the disease trait will now be 
discussed in separate paragraphs.
6.4.2. IL-6 polymorphism
Homozygosity for allele G of IL-6 was a significant risk indicator for Localised AgP, 
with a relative risk of around 3. In the Caucasian subgroup for example, 29% of controls 
and 58% of LAgP subjects were GG homozygous (see table 6.16). The presence of the 
G allele at position -174 has been linked to increased promoter activity of the IL-6 gene, 
with consequent increased production of IL-6. Fishman et al. (1998) demonstrated 
increased activity linked with the G allele after stimulation with lipopolysaccharide or 
Interleukin-1 and suspected a protective role for the presence of allele C towards 
juvenile rheumatoid arthritis. However, conflicting reports also exist which describe no 
relationship between this polymorphism and IL-6 concentrations or IL-6 increase related 
to C homozygosity (Endler et al. 2004), probably because o f tissue- specific regulation 
of IL-6 expression (Fife et al. 2005). Since Fishman’s paper, the IL-6 -174 
polymorphism has been associated with several different diseases and conditions, such 
as systemic arthritis, coronary heart disease, Alzheimer disease and Kaposi sarcoma 
(Humphries et al. 2001, Faltraco et al. 2003, Ogilvie et al. 2003). Trevilatto and co­
workers recently found an association between G homozygosis and chronic periodontitis 
in a Caucasian Brazilian population (Trevilatto et al. 2003). The suspected mechanism 
of periodontal disease susceptibility due to this polymorphism may be mediated by an 
increased release and activity of IL-6, which is crucial in mounting an effective 
inflammatory response. IL-6 takes part in the complex cytokine network responsible for 
the effectiveness and amplification of the inflammatory process. In particular, IL-6 has a 
potent role in inducing osteoclasts and determining bone resorption. Increased levels of 
IL-6 are characteristic features of diseases such as rheumatoid arthritis, otseoporosis and 
psoriasis (Terry et al. 2000). The presence of IL-6 in inflamed periodontal tissues has 
been widely demonstrated, in particular in gingival crevicular fluid (Kamma et al. 2004); 
moreover, serum concentrations of IL-6 seem to be associated with the presence of 
periodontal disease (D’Aiuto et al. 2005). Therefore, a plausible explanation of our 
results is that homozygosity for IL-6 -174 G allele predisposes to an increased risk of
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developing AgP, especially the localised form, by means o f an excessive stimulation of 
the IL-6 pro-inflammatory function and, as a consequence, o f the inflammatory and 
destructive processes. This hyperstimulation, especially if  combined with the presence 
of specific bacteria, leads to the considerable tissue damage observed in LAgP patients. 
However, it remains to be explained why, in the complex and to some extent redundant 
network of cytokines, there is no feedback mechanism in place to counterbalance the 
hyperactivity of IL-6 in these subjects and also why the effect of this genotype seems 
more important towards LAgP rather than GAgP. A possible explanation is that in LAgP 
especially and in AgP in general, this possible feedback regulatory system is somewhat 
deficient, or that it is inhibited by the initiation of periodontal inflammation due to 
specific pathogenic bacteria. Thus, in a GG subject under normal circumstances the 
supposed hyperactivity of IL-6 should be balanced by a negative loop. Whenever 
specific bacterial stimuli initiate periodontal inflammation, the negative feedback is 
overwhelmed by the pro-inflammatory messages triggered by the bacteria and IL-6 is 
therefore excessively stimulated, with the establishment of a chronic inflammatory 
process and a persistent pro-inflammatory stimulation. This is a very simplistic scenario, 
reflecting a much more complex reality, but might partially explain the significance of 
this polymorphism. O f course, functional data are needed in relation to the effect of this 
polymorphism on IL-6 release both systemically and locally and both in healthy and 
diseased subjects. Additional information may also be gained by the study o f IL-6 
haplotype, given by the combination of the -174 with other polymorphisms in the same 
gene which seem to act together in enhancing IL-6 promoter activity (Terry et al. 2000, 
Fife et al. 2005, Komatsu et al. 2005). It is also interesting to notice that the increased 
risk due to G homozygosity was not found in the group o f solely Black subjects. The 
reason might be the extreme rarity of allele C in these subjects (see table 6.10) and to the 
fact that because o f the small sample size in Blacks, the study might be underpowered to 
detect such an association.
6.4.3. NADPH oxidase polymorphism
This is the first study to report a role for NADPH oxidase p22phox C242 T polymorphism 
in the susceptibility to Aggressive Periodontitis. The predisposition linked with this
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polymorphism in our sample was seen in the whole AgP group, but it is most striking in 
Generalised AgP, and was consistently found in the Caucasian and Black 
subpopulations, with the limitation of smaller sample sizes (see table 6.13). Analysis of 
the subgroup of Caucasians who never smoked confirmed this tendency for association, 
which was not found in smokers. The T allele was over represented in the AgP group, 
and in particular the TT genotype was strongly associated with GAgP. The risk 
attributable to this polymorphism was independent from other risk factors such as 
smoking and ethnic origin.
The NADPH of neutrophils consists of two membrane components, the gp91phox and the 
p22phox subunit, and four cytosolic components. Upon activation of PMN, all the 
components get assembled, forming a system which catalyzes the reduction of molecular 
oxygen at the expense o f NADPH. The resulting electrons are moved and delivered to 
produce O2 both in the phagosome and in the extracellular environment (Dahlgren 
1999). UshioFukai et al. (1996) provided evidence of the functional importance of 
p22phox in superoxide production in animal models.
The role of the oxidative burst in inducing bacterial killing, but also tissue damage, has 
been widely recognized for many years (Henson 1986, Weiss 1989), and implicated in 
the pathogenesis of rheumatoid arthritis, diabetes, reperfusion injury, ulcerative colitis, 
pre-eclampsia, hemorrhagic shock (Kantarci et al. 2003, Lee et al. 2003, Abdelrahman et 
al. 2005). The potential tissue damaging effect to human periodontal ligament cells by 
PMN activity has been shown in vitro some years ago (Deguchi 1990) and the specific 
effect of release of ROS on gingival epithelial cells has also been demonstrated (Altman 
et al.1992). ROS have been shown to be biologically active and involved in bacterial 
killing by means o f two different mechanisms: i) activation o f proteases through a 
depolarization compensatory mechanism mediated by K+ flux subsequent to the 
reduction of O2 (Reeves et al. 2002, Rada et al. 2004); ii) production of a cascade of 
anti-microbial reactive oxygen metabolites, such as hydrogen peroxide, hypoclorous 
acid and chloramines (Dahlgren et al. 1999, Van Dyke et al. 2003, Rada et al. 2004), 
both in the intracellular and extracellular milieu.
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This is the first study, to the best of our knowledge, which investigated the relation of 
this C —>T substitution in the gene encoding for the p22phox subunit of neutrophil 
NADPH to periodontitis. Conflicting results have been reported about possible 
associations between this polymorphism and the risk of developing cardiovascular 
disease, intracranial aneurysm, and diabetes. Inoue et al. (1998) showed a protective role 
on coronary risk linked with the T allele. However, some other studies found no 
associations (Li et al. 1999, Gardemann et al. 1999, Renner et al. 2000) or association 
between the T allele and a tendency to increased cardiovascular risk in young 
Caucasians (Cai et al. 1999) and progression of coronary atherosclerosis (Cahilly et al. 
2000).
The C — >T mutation causes an amino acid substitution at position 72 (histidine to
tyrosine). This substitution involves a potential haeme-binding site, which can have as a 
consequence an increase or decrease of superoxide production. Functional analyses of 
the effect of this polymorphism are very limited. Shimo-Nakanishi et al. (2004), in order 
to assess the functional relevance of the T substitution, measured the PMN oxidative 
burst on a subset of Japanese patients with thrombotic cerebral infarction and Japanese 
healthy subjects, in relation to the C242T p22phox polymorphism. They showed that, 
under stimulation by PMA (4B-phorbol 12-mystrate 13-acetate), subjects with the T 
allele had significantly higher oxidative burst than CC subjects. On the other hand, 
Wyche et al. (2004), in a study on 90 healthy Caucasians, observed an increased 
superoxide production linked with the presence of the C allele. In this context it is 
important to underline that, despite the fact that the vascular and phagocytic p22phox are 
very similar, the latter has much higher activity (De Keulanauer et al.1998). The 
possible functional changes due to the mutation are still to be elucidated. However, we 
can speculate on a possible effect on the susceptibility to periodontal disease through its 
modulation of the oxidative burst.
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The presence of PMN defects in LAgP patients has been suggested for many years 
(Suzuki et al. 1984, Van Dyke et al. 1985). Several studies have reported a decreased 
chemotaxis (Cianciola et al. 1977), increased superoxide production (Leino et al. 1994, 
Gronert et al. 2004) and phagocytic defects in PMN isolated from LAgP patients 
(Suzuki et al. 1984, Van Dyke et al. 1985, Shapira et al. 1991). The current concept, 
therefore, is that PMN from LAgP patients are constitutionally hyperreactive, and this 
may account for the amount and rapidity of tissue destruction seen in this particular form 
of periodontitis (Kantarci et al. 2003). This finding has also been extended to other 
forms o f periodontitis: Fredriksson et al. (2003), investigating the superoxide production 
in 15 Chronic Periodontitis patients and 15 controls, found that not only the intracellular, 
but also the extracellular radical generation was significantly increased in patients 
compared to controls, justifying the possible ROS-related tissue damage. The fact that 
no differences have been found in receptor numbers, testifies for a possible alteration in 
post receptor signaling pathway (Leino et al. 1994, Fredriksson et al. 2003).
In this context, we have to view the finding of this study as part of a possible 
explanation for the altered PMN response characteristic of aggressive periodontitis. The 
T mutation o f the gene encoding for the p22phox subunit of NADPH of PMNs is one of 
the possible mechanisms which lead to the altered PMN function in AgP. It is interesting 
to note that, despite the fact that our patient group was heterogeneous in terms of ethnic 
background and smoking, even restricting the analysis to Caucasians, and even 
excluding all the current and former smokers, the T allele was still a significant risk 
factor for AgP.
We can only speculate, given the lack of robust evidence of functional effect of this 
polymorphism, that the T mutation may lead to an increased extracellular release of 
reactive oxygen intermediates which, through direct and indirect mechanisms, can 
increase the potential damage on the periodontal tissues. Therefore, this genetic 
polymorphism may represent a mechanism for PMN hyperactivity, independent from 
receptor numbers and DNA expression. Further studies are needed in order to ascertain 
the functional significance of the C242T mutation in healthy and periodontitis patients,
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and to relate it also to superoxide production and phagocytic activity o f known 
periodontal pathogens. This finding opens also interesting prospectives for the future, in 
terms of possible genetic therapy in order to modulate superoxide production in AgP 
patients, without compromising the protective function of PMNs (Fossati et al. 2002).
6.4.4. FcyRIIIb polymorphism
The other polymorphism which showed a trend for association with the AgP phenotype 
is the FcyRIIIb neutrophil antigen (NA). In our sample, the NA1/NA1 allotype was 
found to be increased in prevalence in the GAgP group (23.6% in patients compared to 
13% in controls, see table 6.14). The result approached statistical significance only when 
GAgP patients were compared to controls, and this was also true in the subgroup of 
GAgP Caucasian patients and in the subgroup of smokers o f mixed ethnicity. In the 
Black subgroup, we actually observed an increased prevalence o f NA2 homozygosity in 
patients compared with controls (see table 6.10).
The neutrophil antigen (NA) is present in the membrane-distal IgG-like domain of the 
Fcylllb receptors. A substitution of 4 amino acids in the gene coding for this receptor 
causes differences in receptor glycosylation, which result in different IgG-binding 
properties (van Sorge et al. 2003). The NA polymorphism has been associated with 
periodontitis in a few studies mainly in Japanese populations (Kobayashi et al. 2000a, 
Yoshihara et al. 2001). These studies show an increased prevalence of the NA2 allotype 
in patients with periodontitis. The same allele represented a risk indicator for AgP in a 
Black population (Fu et al. 2002). Functional results supported these finding, showing 
FcyRIIIb-NA2-carrying PMN from both patients with chronic periodontitis and healthy 
controls to be less efficient in phagocytosis upon interaction with IgGl- and IgG3- 
opsonized P. gingivalis (Kobayashi et al. 2000). These literature results are in conflict 
with the results observed in our study of an increase of NA1 homozygosity in patients. 
The difference between our results and those previously reported by other investigators 
may be due to the different ethnicities of the population studied or indeed in some cases 
to the different diseases (AgP vs. CP). We also investigated another polymorphism of 
the FcyRIIIb gene, which is in linkage disequilibrium with the FcyRIIIb NA (see table
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6.8). This polymorphism is characterized by a nucleotide substitution at position 266 and 
gives origin to the SH allotype, associated with neonatal neutropenia (van der Pol et al. 
1998). All SH positive subjects are also NA2 positive. Only 4 subjects in total were SH 
homozygous, they were all Black and they all had AgP (see table 6.10); in the Caucasian 
group, 5.4% of patients versus 2.1% of controls exhibited one copy of the SH allele. 
These results were not statistically significant, but they show that SH+ individuals might 
have an increased risk of having AgP. Therefore, the observed increased risk of having 
AgP observed in relation to NA2 in previous studies may be masked or diluted by a 
subset of NA2 subjects who present the SH allotype (Bux et al. 1997). However, the 
results observed in this study in relation to the NA1 allotype remain difficult to explain 
with the functional evidence which now exists. A possible explanation for the 
pathogenic role o f FcyRIIIb polymorphisms in AgP lies in one of the functions 
transduced by these receptors on PMN: the superoxide production. The supposed higher 
receptor affinity of the NA1 allotype could translate to an increase in superoxide 
production in these patients. NA1 positive individuals have been found in increased 
percentages compared to NA2 subjects in studies on several autoimmune diseases, such 
as Wegener’s granulomatosis, myasthenia gravis and thrombocytopenic purpura (van 
Sorge et al. 2003). Kobayashi et al. (2000b) also found increased superoxide production 
upon interaction with IgGl and IgG3- opsonized P.gingivalis in NA1 compared to NA2- 
carrying individuals. Considering the importance of superoxide production in 
exacerbating extracellular damage and given the interesting results observed in relation 
to the NADPH polymorphism in this study, the release of superoxide has to be 
considered as a possible mechanism of AgP susceptibility mediated by the FcyRIIIb 
polymorphisms. Indeed, the association NA1 homozygosis/ NADPH oxidase p22phox 
242 T allele seems to have an additive effect in determining disease susceptibility to 
GAgP, with a relative risk equal to 34 for Caucasian subjects with both risk genotypes. 
This additive effect may be mediated by a stimulation of superoxide production.
6.4.5. Vitamin D receptor Taq-I polymorphism
The t allele of VDR Taq-I polymorphism was suspected as a susceptibility factor for 
LAgP in a small group of Caucasians (Hennig et al. 1999). On the other hand, the T
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allele has been associated with a risk of CP (Tachi et al. 2003). In our sample, no 
associations were detected between VDR polymorphism and the whole group of AgP. 
However, in the group of smokers the presence of the T allele showed a trend for 
association with the AgP phenotype. This observation confirms our previous report 
(Nibali et al. 2005) o f an interaction between VDR polymorphisms and smoking. 
Following 61 CP patients for 1 year, we found that smokers who were carriers o f the T 
allele for this polymorphism had an increased chance of severe progression of 
attachment loss. Therefore, it seems that while in subjects who do not smoke the T allele 
does not contribute to the periodontitis risk, in smokers the interaction smoking/VDR 
Taq-I T allele may have a role in the pathogenesis of AgP and probably periodontitis in 
general. Speculations about the VDR- smoking interaction may involve a combination 
effect on the immune response or on bone metabolism. Larger sample sizes are needed 
to detect an association between this polymorphism and AgP in smokers.
6.4.6. FcyR haplotype
The association between FcyRIIIb and AgP was discussed in paragraph 6.4.4. Possible 
trends for association were also observed for FcyRIIa 494 and FcyRIIIa 559 
polymorphisms. FcyRIIa are the main receptors involved in interaction with IgG2, and 
the presence of an arginine (R) instead of a histidine (H) at position 131, determined by 
a single nucleotide polymorphism at position 494, has been shown to reduce the binding 
efficiency of the receptor and therefore its effector functions. The R allele therefore is 
supposed to predispose to infections by IgG2-opsonized bacteria (van Sorge et al. 2003, 
Bredius et al. 1994). Yamamoto et al. (2004) found an enrichment of H homozygosis in 
moderate to severe Caucasians with periodontitis. In this study, we observed increased 
prevalence o f R allele and especially R homozygosity in Caucasian subjects (30% vs. 
25% RR homozygous in patients vs. controls), although this did not reach statistical 
significance. This imbalance was more evident in the Caucasian GAgP group (33% vs. 
25%)* Surprisingly, however, in Black subjects an opposite tendency was observed 
(20% vs. 31% RR subjects in patients vs. controls).
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A G-T substitution at nucleotide 559 in the FcyRIIIa gene results in the presence of a 
valine (V) instead of a phenylalanine (F) at position 176, supposedly reducing the 
affinity for IgGl, 3 and 4 (Koene et al. 1997). This polymorphism has been reported as a 
possible risk factor for AgP and CP in different populations and with conflicting results 
(Kobayashi et al. 2000a, Kobayashi et al. 2001, Loos et al. 2003). Almost identical 
percentages o f genotype distributions were detected in our sample between patients and 
controls. However, in the group of Black GAgP subjects, it was noted that 18% of 
patients vs. 4% of controls were V homozygous.
FcyRIIa H/R, FcyRIIb C/T, FcyRIIIa V/F, FcyRIIIb NA and FcyRIIIb SH 
polymorphisms are located in different genes all in the long arm of chromosome 1. The 
detection of linkage disequilibrium between some of these markers confirms the close 
relationship between them, and stimulated the formulation of hypotheses about a 
possible common role in determining disease susceptibility. A haplotype determined by 
a combination of these polymorphisms showed some evidence o f association with AgP 
in the subset of patients of Black ethnicity. The strength o f the association increased 
when the FcyRIIIb SH polymorphism was not included in the analysis. No significant 
association was found in the Caucasian subgroup for the same haplotype. Therefore it 
seems that, in this racial subgroup, the FcyR haplotypes have an important disease- 
predisposing effect, resulting from the additive effect of each single polymorphism. This 
effect might be mediated by the effect on IgG binding, PMN phagocytosis or superoxide 
production. In fact, the signal transduction from FcyRIIIb is supposed to involve 
interaction with FcyRIIa (van Sorge et al. 2002), and stimulation of PMN through 
FcyRIIIb was shown to enhance FcyRIIa- mediated phagocytosis (Pricop et al. 1999). 
On the other hand, it might also be a reflection of the presence of another functional 
polymorphism somewhere else in the gene, in LD with the polymorphisms presented 
here. This result reinforces the importance of the combined effect of different 
polymorphisms located closely in a chromosome in determining disease susceptibility. 
Further functional studies are needed to investigate the role of FcyR haplotypes in 
relation to the handling of periodontopathogenic bacteria.
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6.4.7. Other polymorphisms
As far as the other studied polymorphisms were concerned, none of them showed 
statistically significant associations with the AgP trait. Nonetheless, some of them 
showed trends for association, and deserve a comment.
We observed an increase in the carriage of at least one copy of the allele A at position 
324 in the Fc-a receptor gene in patients compared with controls (47% versus 43% in 
the overall population, 54 versus 46% in Caucasians, and 28 versus 20% in Blacks, see 
table 6.10). Similarly more frequent were A homozygous subjects (8 vs. 6%, 9 vs. 5% 
and 3 vs. 0% respectively in all subjects, Caucasians and Blacks). These differences did 
not reach statistical significance, probably due to a lack of power. Kaneko et al. (2004) 
found an increased prevalence of homozygosity for allele A at position 324 in the Fc-a 
receptor gene in Japanese AgP patients. Individuals homozygous for this allele also 
exhibited decreased phagocytosis of P.gingivalis. Since this FcaR 324 polymorphism is 
synonymous, we conclude that it may be in LD with a polymorphism predisposing to 
AgP. However, this effect is probably limited and larger sample sizes are needed to 
detect its power in the different ethnic groups.
A slight increase in G homozygosity was noted in the FPR 301 polymorphism, 
especially in the Black subgroup (see table 6.10). However, these differences were not 
marked. The frequency of allele A at position 546 in the FPR gene was increased in the 
AgP patient group. In the Caucasian GAgP subgroup (see table 6.14), in particular, 61% 
of patients and 50% of controls carried at least one copy o f the A allele. The C-A 
substitution at nucleotide 546 in the FPR gene is synonymous, and does not change the 
coded amino acid and only slight differences in allele distributions were noted from a 
previous study (Zhang et al. 2003). On the other hand, Zhang et al. (2003) also observed 
a statistically significant increase in the homozygosity for allele A of 568 A-T FPR 
polymorphism in a group of African Americans with AgP. Thirty-seven out o f their 38 
AgP subjects were homozygous for A. In our subgroup o f Black subjects, 22% of 
patients vs. 9% of controls exhibited at least one copy of the rare allele T (see table
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6.10). This genotype distribution failed to show any statistically significant differences 
with AgP when logistic regression analysis was used, but approached statistical 
significance using WHAP analysis. These observations raise doubts over the supposed 
importance of this polymorphism as a risk factor for AgP, given the conflicting evidence 
present.
No substantial differences in genotype distributions were noted for TNF-a -308 
polymorphism.
6.5. CONCLUSIONS
The main finding of this study lies in having detected two genetic polymorphisms which 
seem to modulate the risk to develop Aggressive Periodontitis. As it was discussed in 
chapter 1, whenever a genotype or an allele is found to be associated to a disease in 
case-control genetic association studies there are four possible reasons: i) the genotype 
really increases the risk of developing the disease, ii) the genotype is in linkage- 
disequilibrium with the real predisposing allele, iii) the result is due to population 
stratification or iv) to statistical artefact. With our study design we tried to reduce the 
risks of falling in the last two categories, therefore we have to believe in one of the first 
two options in order to explain our results. The two polymorphisms found to be 
significantly associated with AgP (IL-6 -174 and NADPH oxidase p22phox C242T) are 
functional. IL-6 -174 is thought to increase the IL-6 gene promoter activity, while 
NADPH oxidase p22phox change the coded amino acids. Therefore, every chance exists 
that these polymorphisms may be really predisposing to AgP. Further limited evidence 
for association with AgP was found for FcyRIIIb NA polymorphism in GAgP, FcyR 
haplotype in relation to AgP in Black subjects, and VDR polymorphism in smokers. 
FcyRIIIb NA polymorphisms is functional and changes the coded amino acid, with 
suspected effect on receptor function; FcyR haplotype may have a functional effect too, 
although the presence of another functional SNP in LD cannot be ruled out. The only 
polymorphism we found associated with AgP (in smokers) which is not functional is the 
VDR Taq-I polymorphism, suspected to be in LD with a functional SNP in the gene, still 
to be discovered.
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This study has a larger sample size than any of the previously published case-control 
association studies on Aggressive Periodontitis, and failed to confirm many of the results 
published so far. We embarked on this study with very limited evidence of the 
importance o f genetic factors in AgP. Interpreting these results based on the existing 
literature, we can say that we identified a novel genetic risk factor for AgP (242 T allele 
of NADPH oxidase p22phox CYBA gene) and we confirmed two genetic risk factors that 
have already been shown to be candidates in CP (homozygosity for G of IL-6 -174 and 
VDR Taq-I T allele in smokers). We also produced some evidence in conflict with 
previous reports, but new in Caucasians for the FcyRIIIb NA polymorphism. It is also 
interesting to notice how we identified different risk polymorphisms for different forms 
of disease (GAgP and LAgP). However, in the interpretation o f these results we have to 
acknowledge that only the first two of four possible steps for the inclusion of these SNPs 
as real risk factors for AgP have been accomplished (see paragraph 1.3.2.3). While we 
obtained identification of supposed risk factors, and retention o f significance and 
direction of effect in a multi-factorial model, the validation through studies on 
independent populations and the targeting step have not been achieved. This concept and 
the possible effect o f chance in isolated reports remind us to be cautious in generalising 
these results (Ioannidis 2003, Ioannidis et al. 2003). Furthermore, some other genetic 
polymorphisms, such as FcaR, FcyRIIIa, FcyRIIIb SH may have some importance in 
increasing the AgP risk. Paradoxically, the sample size o f this study was probably 
enough to reduce the effect of chance, but at the same time not large enough to identify 
clear relative risks in polymorphisms that have a subtle but still consistent effect in AgP 
risk.
Functional studies, haplotype analysis and studies with larger sample sizes are 
desperately needed in order to confirm the importance of the observed polymorphisms.
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CHAPTER 7
7. GENETIC INFLUENCE ON DISEASE SEVERITY
7.1. BACKGROUND
It is not clear whether factors which predispose to periodontitis also affect its severity. 
Most previous studies have either focused on the possible effect of a factor in the 
initiation of AgP, CP, or on its effect on severity. In fact, in the particular case of AgP, 
some factors might play a role in the pathogenic mechanism that leads to its initiation, 
while other factors may then intervene in determining its extent and severity. Equally 
unclear and linked to disease severity is the relationship with disease progression 
(Tonetti & Claffey 2005). However, it is reasonable to suspect that if a genetic factor 
predisposes to AgP, subjects who present with this factor should also be prone to have 
more severe disease than others. Based on this concept, we analyzed the clinical data 
described in chapter 5, relating them to the genotypic data we detected in the case- 
control study (see chapter 6). Possible associations between all genetic polymorphisms 
studied in our sample and clinical parameters indicating disease extent and severity were 
investigated. No formal power calculation was performed to identify the number of 
subjects needed to detect if any of the studied SNPs had an effect on disease severity. 
Therefore, we have to consider the analyses presented in this chapter as exploratory 
analyses. Nonetheless, data derived from this chapter might be useful to design more 
focused studies which address the question “Do genetic factors have an effect on disease 
severity?”.
7.2. MATERIALS AND METHODS
All 224 subjects diagnosed with AgP, whose clinical characteristics were presented in 
chapter 5 and whose genetic profile was presented in chapter 6, were included in this 
study (see chapter 4 for inclusion and exclusion criteria). From all the clinical 
information collected the following were deemed to have relevance to the severity of 
disease at subject level: mean probing pocket depth (PPD) and average lifetime 
cumulative attachment loss (LCAL) (data on LCAL were not available for all patients as 
highlighted in chapter 5) and number of pockets > 5 mm. Because of the difficulty in 
comparing the severity of LAgP and GAgP cases, the two forms of disease were
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analyzed separately. Furthermore, measurements of average PPD or LCAL and number 
of pockets above a certain threshold are probably not very good parameters to evaluate 
the severity or extent of periodontitis in general, but especially in a case of LAgP.
7.2.1. Statistical analysis
SPSS 12.0 package was used for statistical analysis. Because of the fact that multiple 
testing can lead to spurious results (Altman 1991), the alpha value was set at 0.01. The 
normality o f distribution of the clinical parameters (av. PPD, av. LCAL and number of 
PPD > 5 mm) was plotted and tested by Kolgomorov- Smirnov and Shapiro-Wilk tests. 
Since average PPD and average LCAL did not show normal distribution, they were log- 
transformed for the analysis. Multivariate analysis was then performed to evaluate the 
association between genotypes and clinical parameters (log av. PPD, log av. LCAL and 
number o f PPD > 5 mm) both in the whole group of GAgP and LAgP, in Caucasian 
GAgP and in Black GAgP. Smoking history, ethnicity, gender and age were entered as 
covariates. Pair wise comparisons tested the magnitude o f the estimated effects 
associated with each genotype (estimated differences adjusted for confounders are 
reported). Box’s M test of the homogeneity of the covariance matrices of the dependent 
variables and Levene’s test for homogeneity o f variance were run to test for 
homogeneity of data. The normality o f distribution of each of the residuals was then 
confirmed by Q-Q plots and by Kolgomorov- Smimov and Shapiro-Wilk tests.
7.3. RESULTS
The mean of the clinical measurements subdivided according to the various genotypes 
for each SNP are presented in appendix XVII. Tables 7.1, 7.2 and 7.3 show the results of 
multivariate analysis for the polymorphisms showing some evidence of association with 
clinical parameters. No statistically significant association with the clinical parameters 
(p < 0.01) were detected. However, some polymorphisms (FcaR, FPR 301 and NADPH 
oxidase p22phox) revealed border-line associations (p<0.05) with disease severity.
Subjects homozygous for both A and G allele of FcaR polymorphism had more severe 
disease compared to heterozygous individuals (see appendix XVII). Multivariate
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analysis showed that FcaR polymorphism was associated with differences in average 
PPD (p=0.037) and number of > 5 mm PPD (p=0.015) (see table 7.1). The general 
models, containing confounders, were statistically significant (p<0.01), but explained 
only a small part o f the overall variation (see model p value and adjusted R squared
values in table 7.1).
Fca All GAgP Caucasian GAgP
Average PPD
Model p 0.001 0.001
Model F 3.437 4.956
Adjusted R squared 0.124 0.213
Fca p 0.037 0.035
Average LCAL
Model p 0.001 0.000
Model F 3.482 5.919
Adjusted R squared 0.126 0.252
Fca p 0.124 0.064
Number of pockets 
> 5 mm
Model p 0.005 0.002
Model F 2.938 4.143
Adjusted R squared 0.101 0.177
Fca p 0.015 0.019
Table 7.1 Results o f  multivariate analysis to analyze the effect o f  genetic polymorphisms on disease 
severity in all GAgP and Caucasian GAgP patients. The p value o f  the model, the F value (indicating 
the ratio o f  the 2 mean squares o f  the analyses) and the adjusted R squared (indicating how much o f  
the variability is explained by the model) are presented, together with the p value for each
polymorphism.
The largest inter- genotype differences adjusted for confounders (data not presented in 
tables) were noted between G homozygous subjects and heterozygous individuals for 
number of > 5 mm PPD (p=0.019, estimated difference = 13.7, 95% C.I.= 2.3- 25.0) 
and between A homozygous and heterozygous subjects for average PPD (p= 0.030, 
estimated difference = 1 .2  mm, 95% C.I.= 1.0- 1.3) and number of > 5 mm PPD 
(p=0.022, estimated difference = 22.6, 95% C.I.= 3.2- 42.0). Among GAgP Caucasians, 
FcaR polymorphism showed some evidence of association with differences in average 
PPD (p=0.035) and number of > 5 mm PPD (p=0.019) (see table 7.1). The largest inter­
genotype differences adjusted for confounders (data not presented in tables) were noted 
between G homozygous subjects and heterozygous individuals for average PPD 
(p=0.028, estimated difference =1.13 mm, 95% C.I = 1.0- 1.3) and number of > 5 mm 
PPD (p=0.014, estimated difference = 19.6, 95% C.I.= 4.1- 35.1) and between A 
homozygous and heterozygous subjects for average PPD (p= 0.046, estimated difference
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= 1.2 mm, 95% C.I.= 1.0- 1.5), average LCAL (p=0.027, estimated difference = 1.3 mm, 
95% C.I.= 1.0- 1.6) and number of > 5 mm PPD (p=0.036, estimated difference = 28.1, 
95% C.I.= 1.8- 54.4).
FPR 301 polymorphism was associated with differences in average PPD (p=0.049) (see 
table 7.2). Although the general models, containing confounders, were statistically 
significant, they explained only a small part of the overall variation (see model p and R 
value in table 7.2). The largest inter- genotype differences adjusted for confounders 
(data not presented in tables) were noted between G homozygous subjects and 
heterozygous individuals for average PPD (p=0.016, estimated difference = 1.1 mm, 
95% C.I.= 1.0- 1.1) and number of > 5 mm PPD (p=0.020, estimated difference = 13.5, 
95% C.I.= 2.1- 24.7). Among GAgP Caucasians, FPR 301 polymorphism did not show 
evidence of association with any of the studied clinical parameters (see table 7.2). In the 
subgroup of Black individuals, FPR 301 was also associated with average PPD 
(p=0.042), although no marked pair wise differences between genotypes were detected.
FPR 301 All GAgP Caucasian GAgP
Average PPD
Model p 0.001 0.003
Model F 3.437 3.979
Adjusted R squared 0.125 0.169
FPR 301 p 0.049 0.222
Average LCAL
Model p 0.003 0.001
Model F 3.094 4.703
Adjusted R squared 0.109 0.202
FPR 301 p 0.477 0.575
Number of pockets 
> 5 mm
Model p 0.013 0.014
Model F 2.502 3.088
Adjusted R squared 0.084 0.125
FPR 301 p 0.061 0.150
Table 7.2 Results o f  multivariate analysis to analyze the relationships between genetic polymorphisms 
on disease severity in all GAgP and Caucasian GAgP patients. The p value o f  the model, the F value 
(indicating the ratio o f the 2 mean squares o f  the analyses) and the adjusted R squared (indicating how 
much o f  the variability is explained by the model) are presented, together with the p value for each
polymorphism.
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In the whole group of subjects of mixed ethnicities, NADPH oxidase 22phox 
polymorphism showed a moderate trend of association with the clinical parameters (see 
table 7.3). The largest differences were noted comparing T homozygous subjects and CC 
subjects for average PPD (p=0.076) and number of > 5 mm PPD (p=0.078). In 
Caucasians with GAgP, multivariate analysis revealed that NADPH oxidase 22phox 
polymorphism was associated with number of > 5 mm PPD (p=0.038) (see table 7.3). 
Comparison between genotypes (data not presented in tables) showed that when T 
homozygous were compared to C homozygous subjects they showed an increase in 
average PPD (p= 0.039, estimated difference = 1 .2  mm, 95% C.I.= 1.1- 1.5), average 
LCAL (p=0.021, estimated difference = 1 .3  mm, 95% C.I.= 1.0- 1.6) and number of 
PPD > 5 mm (p=0.017, estimated difference = 32.0, 95% C.I. = 6.0- 58.0). T 
homozygous subjects had increased average LCAL also when compared to heterozygous 
subjects (p=0.047, estimated difference = 1.2 mm, 95% C.I.= 1.0- 1.5).
No results approaching statistically significance for any polymorphisms were noted in 
the LAgP group.
NADPH oxidase p22phox All GAgP Caucasian GAgP
Average PPD
Model p 0.007 0.003
Model F 2.800 4.115
Adjusted R squared 0.100 0.186
NADPH oxidase p 0.196 0.108
Average LCAL
Model p 0.004 0.000
Model F 3.037 5.641
Adjusted R squared 0.111 0.254
NADPH oxidase p 0.419 0.066
Number of pockets 
> 5 mm
Model p 0.032 0.006
Model F 2.200 3.677
Adjusted R squared 0.069 0.164
NADPH oxidase p 0.146 0.038
Table 7.3 Results o f  multivariate analysis to analyze the relationship between genetic polymorphisms on 
disease severity in all GAgP and Caucasian GAgP patients. The p value o f  the model, the F value 
(indicating the ratio o f  the 2 mean squares o f  the analyses) and the adjusted R squared (indicating how 
much o f the variability is explained by the model) are presented, together with the p value for each
polymorphism.
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7.4. DISCUSSION
FcaR A324G, FPR G301C and NADPH oxidase 22phox C242T polymorphisms showed a 
relation with disease severity in the Generalised Aggressive Periodontitis patients 
included in this study. None of these differences reached the level of statistical 
significance set for this study (p<0.01). However, we presented here an exploratory, 
hypothesis- generating analysis. The observed results, which neared statistical 
significance, may be used to inform a power calculation and allow us to conduct a new 
study to test the hypotheses of association between these polymorphisms and disease 
severity.
FcaR 324 A homozygous GAgP patients had more severe disease in our sample than 
heterozygous individuals. Consistent with this observation, subjects homozygous for the 
A allele have been shown previously to have decreased phagocytosis of P.gingivalis 
(Kaneko et al. 2004) and in the association study presented in the previous chapter there 
was a higher frequency of this genotype in patients compared to controls (see table
6.10). We can therefore speculate that, due to an increased susceptibility to 
periodontopathogenic bacteria, AA individuals may have more severe disease. However, 
we have to bear in mind that we did not observe any statistical relevance when the 
clinical features o f A and G homozygous subjects were compared with each other, but 
only when they were compared to the heterozygous subjects. Hence, these results have 
to be interpreted with caution and require further studies with larger sample size in order 
to be confirmed or rejected.
A relation with disease severity was also noted for individuals homozygous for the FPR 
301 G allele. These subjects had increased average PPD and number of pockets > 5 mm 
compared to the other genotypes, and a gradient effect was observed between G 
homozygous, heterozygous and C homozygous, which suggests a dominant role for 
allele G. This effect did not reach statistical significance in the Caucasian GAgP 
subgroup, but was significant for average PPD in Blacks. Consistent with this was the 
observed increase in G homozygosity in the patient group compared to controls, 
especially in Blacks, in the association study presented in the previous chapter (see table
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6.10). Speculation about a role of this polymorphism in GAgP severity in Blacks should 
be supported by functional data on the effect of this polymorphism.
Presence o f allele T of NADPH oxidase 22phox C242T polymorphism was previously 
associated in our sample with presence of AgP (see chapter 6). T homozygosity was 
particularly enriched in GAgP patients, and in the subgroup of GAgP Caucasians. In 
relation to disease severity, we noted an effect due to T homozygosity rather than to 
carriage of the T allele. In fact, CC and CT individuals had very similar clinical 
parameters, in terms of average probing pocket depth (PPD), average lifetime 
cumulative attachment loss (LCAL) and number of probing pocket depths equal or 
above the 5 mm threshold. However, TT individuals had a considerable increase in PPD, 
which approached statistical significance in the Caucasian GAgP group. In particular, T 
homozygous subjects exhibited an increase in LCAL equal to 1.3 mm on average, and in 
number o f PPD > 5 mm equal to 32 when compared to CC individuals. We can 
therefore suspect that while carriage of the T allele may predispose to GAgP, within 
subjects with this disease, homozygosity for the T allele, probably through an increase in 
the oxidative burst (Shimo-Nakanishi et al. 2004), may be able to predispose to more 
advanced destruction. This is reflected by the increased number of sites with severe 
pocket depths, and by the increased averages of both probing pocket depth and lifetime 
cumulative attachment loss. This result is consistent with our previous findings and 
points to the fact that once GAgP is initiated, T homozygosity may be involved in its 
severity and probably in its progression.
In conclusion, this chapter shows a possible influence of genetic polymorphisms in 
disease severity. These observations, coupled with the evidence gathered from the 
association study previously described, may shed light into the meaning and importance 
of genetic polymorphisms in AgP susceptibility.
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CHAPTER 8
8. F A M IL Y  ST U D Y
8.1. BACKGROUND
As outlined in the general introduction to this thesis (see chapter 1), the observation of a 
familial association of Early Onset Periodontitis dates back many decades (Baer 1971). 
Given the importance attributed to the familial aggregation in the new classification, and 
the possible use of family screening as a preventive tool, it is worth trying to clarify the 
evidence we have to say that early onset cases of periodontitis aggregate in families. The 
studies from Michalowicz et al. (1991, 2000) can be considered milestones of the 
periodontal literature in relation to familial aggregation. They studied monozygous and 
dizygous twins, both reared apart and reared together, and concluded that approximately 
half o f the variance in periodontitis in the population is attributable to genetic factors. 
However, there is a considerable lack of systematic studies aimed at ascertaining the 
prevalence of EOP in families and the mode of transmission.
8.1.1. Disease prevalence in families
A literature search on the familial aggregation of EOP identifies some studies based on 
large pedigrees with high prevalence (Melnick et al. 1976, Hodge et al. 2000, Trevilatto 
et al. 2002), and a few studies on multiple families with results ranging from moderate 
(Saxen et al.1980) or very elevated prevalence of EOP in families of affected individuals 
(Marazita et al. 1994). The largest family study available so far in the periodontal 
literature was conducted by Marazita et al. (1994). They examined relatives from 100 
families (mainly of African - American origin) with at least one individual affected by 
EOP. These families yielded 463 first degree blood-related individuals, of which 118 
(25%) were found positive for a diagnosis of EOP. This means that, according to their 
data, one in every four relatives of an affected proband also has EOP. However, these 
data are likely to represent a considerable overestimation of the real disease prevalence, 
due to the disease definition adopted. Individuals were diagnosed with EOP based on 
age between 13 and 35 years, and > 4 mm attachment loss on at least two first molars or 
one first molar and one incisor (LJP), or > 5 mm attachment loss on at least eight 
permanent teeth (GEOP). This definition can be criticised as it does not take into 
account medical history or presence of local factors. However, what is more striking is
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that the attachment loss threshold was lowered to > 2 mm for diagnosis of EOP to be 
made in the relatives. In practical terms, this means that if a relative presented as a 
diabetic 35 years old with 2 mm of attachment loss on two first molars, he would be 
classified as an EOP case, whereas now we would consider this to be Chronic 
Periodontitis.
An additional difficulty of studies ascertaining the family prevalence of AgP arises from 
the necessity of diagnosing older subjects with multiple missing teeth, without having 
any previous dental records. In these cases, it becomes necessary to rely only on the 
patients’ memory of past dental problems and treatments and on the clinical examination 
at the time of presentation (Hodge et al. 2000). Therefore, a real measure of the 
prevalence of AgP in a large cohort of a considerable number o f families is still lacking.
8.1.2. Mode of transmission
Diseases associated to genes of major effect are transmitted following Mendelian 
inheritance. This is distinguished into X-linked, which means due to the transmission of 
a gene located in the X chromosome, or autosomal. X-linked transmission can be 
recessive (e.g. haematophilia) or dominant (e.g. some inherited forms of rickets). In the 
first case the disease phenotype occurs in homozygous females and males with one copy 
of the allele, and the disease can skip generations thanks to carrier heterozygous females, 
who do not express the disease. X-linked dominant transmission is very easy to identify: 
only one copy of the allele in the X chromosome is necessary to express the disease; 
therefore it is transmitted from affected fathers to all daughters and from mothers to 
sons.
Similarly, autosomal transmission can be either recessive or dominant. In case of an 
autosomal recessive mode of transmission (e.g. cystic fibrosis), the phenotype is present 
only in homozygous subjects; conversely, in case o f dominant transmission, even 
heterozygous subjects express the disease (e.g. Marfan syndrome).
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These are however very simplistic models; in reality, things are complicated by the 
different penetrance of diseases (probability of phenotypic expression of a gene). If for 
example 70% of allele carriers manifest the disease, it means the penetrance is 70%.
Furthermore, not all hereditary phenotypes are due to a single gene. Most diseases are 
controlled by the combined influence of several genes (polygenic heredity), which 
interact between them and with environmental factors to determine the disease 
phenotype.
Different theories have been hypothesized about the transmission of Early Onset forms 
of periodontal disease. A pattern of transmission consistent with Mendelian inheritance 
of a gene o f major effect has been suggested (Saxen et al. 1980, Beaty et al. 1987, 
Boughman et al. 1988, Marazita et al. 1994). X-linked dominant pattern was 
hypothesized (Melnick et al. 1976, Spektor et al. 1985), but later dismissed because of 
probable ascertainment bias (Hart et al. 1991). Segregation analyses show conflicting 
results, some suggesting a possible autosomal dominant mode of inheritance (Boughman 
et al. 1988, Marazita et al.1994), mainly in black African-American populations, and 
some others a recessive one (Saxen 1980). Marazita et al. (1994) performed a 
segregation analysis on the families reported in the previous paragraph and proposed a 
dominant mode of inheritance with 70% of penetrance. These different conclusions may 
be due to different disease definitions, different population and to the heterogeneity of 
AgP. However, they show the lack of evidence on the subject o f transmission of AgP.
8.1.3. Specific aims
Specific objectives of this study were:
• Estimating the percentage of affected first degree blood relatives of AgP patients
• Identifying environmental, demographic or genetic factors able to predict 
familial aggregation of AgP
• Establishing the type of AgP (Localised or Generalised) present in the relatives 
and relating it to the proband diagnosis
These specific aims underlie two more clinically-based general questions:
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• Is the familial aggregation of AgP strong enough to justify its inclusion as a 
principal characteristic of the diagnosis?
• Does the prevalence of AgP in families justify the need to examine first degree 
blood relatives of our AgP patients? Or is this needed just in subgroups of 
subjects?
8.2. MATERIALS AND METHODS
All patients diagnosed with AgP in our Department were given a case presentation and 
the suspected genetic background of their condition was explained to them. In this 
context, the importance of examining their first degree blood relatives was highlighted 
and patients were given a questionnaire to complete. In this questionnaire patients were 
invited to write their relatives’ names and if they knew they had missing teeth, loose 
teeth, bleeding gums or if they had been treated for gum disease. All available first 
degree blood relatives were invited for a specific assessment at the Eastman Dental 
Hospital. The study protocol was approved by the Eastman Joint Research and Ethics 
Committee. The proband and the relatives who were examined provided signed 
informed consent.
No formal power calculation was performed in the design o f this study. Out of a total of 
230 AgP patients examined, relatives from only 54 of them were able to attend for 
examination at the EDH. Many patients excluded themselves because o f poor family 
histories (no contact with family, family living abroad, adopted). Many other relatives 
refused to come for an assessment because they were not interested or did not have the 
possibility to attend. Therefore, no random selection was used to select this population 
of probands and relatives. Hence, we have to consider the analyses presented in this 
chapter as exploratory analyses and be cautious with the interpretation of the results. 
Nonetheless, data derived from this chapter might be useful to design more focused 
studies in order to answer the question: “Do genetic factors have an effect on 
susceptibility to AgP?”.
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8.2.1. Relatives’ examination
Relatives who attended for examination were given a medical history form to complete 
and were asked questions about their dental health and their previous dental treatments, 
with particular regards to periodontal treatment. Clinical screening involved assessment 
of gingival appearance and oral hygiene and a Community Periodontal Index of 
Treatment Needs (CPITN) examination, using a WHO probe. Whenever probing pocket 
depths (PPD) or lifetime cumulative attachment loss (LCAL) > 4 mm were noted, full 
mouth measures of PPD and LCAL were obtained using a UNC 15 periodontal probe. 
Radiographic assessment included panoramic or long cone periapical radiographs. Once 
a diagnosis was made, a letter describing the diagnosis and, if necessary, the treatment 
plan was sent to their general dentists and copied to the patient. If the patients consented, 
a blood sample was collected and stored at -70° C.
8.2.2. Relatives’ diagnosis
Authors of previous reports investigating the family history of AgP adopted
heterogeneous disease criteria, sometimes different even within the same study between
probands and relatives (Marazita et al. 1994, Hodge et al. 2000). We chose to apply the 
same diagnostic criteria to our probands and relatives, and the 1999 Consensus 
Classification was used (see chapter 1). All subjects were diagnosed as healthy or with 
either gingivitis, chronic periodontitis (CP) or AgP. The only difference between the 
diagnosis of probands and relatives was that at the time of examination, for the relatives 
we already had certainty of their family history of AgP.
All available fathers, mothers and siblings of our probands, above the age limit of 12 
years old were invited for examination. We are aware that patients as young as 13 years 
old may still be too young to manifest the disease phenotype. However, only 5 subjects 
(5.2%) were younger than 20 years old. In instances where patients had experienced 
multiple tooth loss, an attempt was made to understand the cause for tooth loss, and to 
obtain old dental records. Whenever, because of the patient age and the lack of previous 
records, there were uncertainties, a diagnosis of AgP was dismissed.
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8.2.3. Statistical analysis
SPSS 12.0 package was used for statistical analysis. Continuous, normally distributed 
variables are reported as means ± standard deviations (SD). The percentage of relatives 
affected by CP and AgP was calculated considering the total of relatives examined. As 
we had not managed to examine all the possible relatives, another percentage was 
calculated to reflect all the possible relatives of the 54 probands, assuming that none of 
the relatives we had not examined would actually have AgP. Comparisons of continuous 
and categorical data between groups were analyzed with ANOVA and Chi-square test 
respectively. In an exploratory analysis, the demographic characteristics of each relative 
(gender, age, smoking, and ethnicity) and the genetic polymorphisms of the 
correspondent probands were entered as variables, in order to detect possible risk 
indicators for positive diagnosis.
WHAP analysis (see chapter 6) was performed in order to detect if  any FcyR and FPR 
haplotypes were able to predict the familial aggregation of AgP.
8.3. RESULTS
Fifty four probands had at least one relative who volunteered for examination. Table 8.1 
reports the demographic and clinical characteristics of the probands. Most of them were 
females, Caucasians, and almost half of them had never smoked. These characteristics 
mirror the gender, ethnic and smoking status of the whole group of 224 AgP included in 
the association study (see table 6.4). These 54 patients had a total of 224 first degree 
blood relatives, including fathers, mothers, brothers and sisters. Ninety nine of them 
(almost two per proband) agreed to take part in the study and attended for examination. 
Most probands (53.7%) yielded just one relative each; two relatives each were examined 
from 14 probands, 3 relatives each from 7 probands, four from 1, five from 2 and seven 
relatives were examined from 1 single proband. Table 8.2 reports the characteristics of 
the 99 relatives examined. As it is evident from the table, the majority o f relatives who 
attended were females: more mothers than fathers, and more sisters than brothers were 
examined. Ten subjects (10.1%) were diagnosed with AgP (7 GAgP and 3 LAgP), 40 
(40.4%) with CP, 29 (29.3%) presented with gingivitis, while 20 (20.2%) were
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periodontally healthy. A conservative estimate of the prevalence of AgP in these 
families, including the total of relatives not-examined (assuming none of them to be 
affected by AgP) was 4.5%.
PROBANDS (n=54) 
PARAMETER MEAN
AGE (Mean ± S.D.) 28.1 ±6.7
FEMALES (percentage) 39(72.2%)
Current heavy ( > 2 0  
cigarettes/day) 6(11.1%)
SMOKERS (percentage) Current light 8 (14.8%)
Former 16(29.6%)
Never 24 (44.4%)
Caucasians 32 (59.3%)
ETHNICITY (percentage)
Blacks 12 (22.2%)
Asians 6(11.1%)
Others 4 (7.4%)
TEETH AT BASELINE (Mean ± S.D.) 27.9 ±2 .7
NUMBER OF POCKETS > 5 mm (Mean ± S.D.) 54.3 ±33.6
PROBING POCKET DEPTH (mm) 
(Mean ± S.D.) 3.9 ±1.1
LIFETIME CUMULATIVE ATTACHMENT LOSS (LCAL) 
(mm)
(Mean ± S.D.)
4.5 ± 1.4
Table 8.1: Demographic and clinical characteristics o f  AgP patients who had at least one relative
examined as part o f  the study
153
RELATIVES (n=99) 
PARAMETER M E A N
AGE (Mean ± S.D.) 38.7 ± 15.2
FEMALES (percentage) 61 (61.6%)
SMOKERS (percentage)
Current heavy (>20 
cigarettes/day) 5 (5.0%)
Current light 16(16.1%)
Former 12(12.1%)
Never 66 (66.7%)
ETHNICITY (percentage)
Caucasians 66 (66.7%)
Blacks 15(15.2%)
Asians 13 (13.1%)
Others 5(5.1%)
RELATION TO PROBAND 
(percentage)
Fathers 13 (13.1%)
Mothers 23 (23.2%)
Brothers 26 (26.3%)
Sisters 37 (37.4%)
DIAGNOSIS (percentage)
Healthy 20 (20.2%)
Gingivitis 29 (29.3%)
Chronic Periodontitis 40 (40.4%)
Aggressive Periodontitis 10(10.1%)
Table 8.2: Demographic characteristics and diagnosis o f  relatives o f  AgP patients examined
8.3.1. Association between diagnosis and relative characteristics
Table 8.3 shows that out of the 10 relatives diagnosed with AgP, 1 was a father, 1 a 
mother, 4 were brothers and 4 sisters of the original probands. Gender, ethnicity and 
smoking were not associated with the diagnosis. The relation to the proband was not 
associated with the diagnosis of AgP but had an effect on the diagnosis of destructive 
periodontitis (AgP+ CP): respectively 85%, 56%, 38% and 43% of fathers, mothers, 
brothers and sisters were diagnosed with CP (Pearson’s Chi square p=0.034).
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RELATIVES No AgP AgP
PEA R SO N ’S
CHI
SQUARE
AgP+
CP
PEARSO N’
S C H I
SQUARE
GENDER
Female 
(n= 61)
56
(91.8%)
5
(8.2%) 0.426
30
(49.2%) 0.837
Male 
(n=38)
33
(86.8%)
5
(13.2%)
20
(52.6%)
ETHNICITY
Caucasian 
(n= 66)
61
(92.4%)
5
(7.6%)
0.665
32
(48.5%)
0.819
Black 
(n= 15)
13
(86.7%)
2
(13.3%)
9
(60.0%)
Asian 
(n= 13)
11
(84.6%)
2
(15.4%)
6
(46.2%)
Others
(n=5)
4
(80.0%)
1
(20.0%)
3
(60.0%)
SMOKING
Current 
heavy’ (n= 5)
4
(80.0%)
1
(20.0%)
0.560
4
(80.0%)
0.566
Current 
light (n = 16)
14
(87.5%)
2
(12.5%)
7
(43.8%)
Former 
(n= 12)
12
(100.0%)
0 6(50.0%)
Never 
(n= 66)
59
(89.4%)
7
(10.6%)
33
(52.4%)
RELATION
TO
PROBAND
Fathers 
(n= 13)
12
(92.3%)
1
(7.7%)
0.628
1 1
(84.6%)
0.034
Mothers 
(n= 23)
22
(95.7%)
1
(4.3%)
13
(56.5%)
Brothers 
(n= 26)
22
(84.6%)
4
(15.4%)
10
(38.5%)
Sisters 
(n= 36)
33
(89.2%)
4
(10.8%)
16
(43.2%)
TOTAL (n= 99) 89(89.9%)
10
(10.1%)
50
(50.5%)
Table 8.3: Relationships between demographic characteristics o f relatives and periodontal diagnosis
with relative Chi-squared results
8.3.2. Association between diagnosis and proband characteristics
Ten out of 54 probands (18.5%) had at least one blood relative affected by AgP. In 35 
of the examined families (64.8%) there was at least one relative with destructive 
periodontitis (CP or AgP).
Table 8.4 shows that each relative diagnosed with AgP had the same diagnosis as his 
related proband: all probands of the 7 GAgP relatives were diagnosed with GAgP and
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all probands of the 3 LAgP relatives were diagnosed with LAgP. Clinical and 
radiographic images of two of the probands and their affected relative with AgP are 
presented here.
PRO BAND RELA TIVE
G ender A ge
Dx Sm oking Ethnicity Dx
Rel. to 
proband
G ender Age
Dx Sm oking
Dx
F 29 Form er Cauc. GAgP M other F 50 Current GAgP
F 34 Form er Other GAgP Brother M 29 Never GAgP
F 31 Current Cauc. GAgP
Twin
sister
F 31 Never GAgP
M 14 Current Cauc. LAgP Brother M 14 Never LAgP
F 27 Never Asian GAgP Sister F 33 Never GAgP
F 36 Current Cauc. GAgP Father M 40 Current GAgP
F 31 N ever Asian GAgP Sister F 29 Never GAgP
F 18 Current Black LAgP Brother M 20 Never LAgP
M 31 C urrent Cauc. GAgP Brother M 39 Never GAgP
F 14 Never Black LAgP Sister F 15 N ever LAgP
Table 8.4: Demographic characteristics and diagnosis o f probands and correspondent relatives affected
by AgP
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Figure 8.1 represents the case of a 14-year old Black Caribbean (already described in 
paragraph 5.2.2), while figure 8.2 relates to her 15-year old sister. They both had a 
similar pattern of localised disease, although the sister only had the left first molars 
affected.
Figure 8.1. Frontal intraoral picture and orthopantomograph of the 14-year old Black- Caribbean female 
patient described in paragraph 8.4.2. Localised vertical bone defects are present around all first molars 
and 11 (UR1). A diagnosis of LAgP was made.
___
Figure 8.2. Frontal intraoral picture and orthopantomograph of the 15-year old Black- Caribbean female 
patient, sister of the patient shown in figure 8.1. Localised vertical bone defects are present around 26 
(UL6) and 36 (LL6). A diagnosis of LAgP was made.
Figures 8.3 and 8.4 represent orthopantomographs of a female Caucasian patient (the 
proband) and of her father. The proband (figure 8.3) was 30 years old at the time of 
diagnosis and was a light smokers (10 cigarettes/day for 16 years). She presented with 
excellent standards of oral hygiene, generalised attachment and bone loss and was 
classified as GAgP. Her father was a 50 year-old former smoker. He reported a history 
of periodontal problems since his early twenties, with extraction of a number of teeth 
due to excessive mobility. Clinical examination revealed moderate amounts of plaque,
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localised marginal inflammation and moderate to severe periodontal probing pocket 
depths. He had attended for a visit at the EDH 10 years before, therefore we were able 
to retrieve previous radiographic records (see figure 8.4), which show generalised bone 
loss, affecting most of the remaining dentition. Anamnestic, clinical and radiographic 
findings were consistent with a diagnosis of GAgP.
Figure 8.3. Orthopantomograph of the 30-year old Caucasian female patient described in paragraph 
8.4.2. A generalised pattern of alveolar bone loss is present both in the maxilla and in the mandible.
Figure 8.4. Ortpantomograph o f the 50-year old father of the patient shown in figure 8.3 (the radiograph 
was taken when the patient was 40 years old). A generalised pattern of alveolar bone loss is present
both in the maxilla and in the mandible.
Table 8.5 reports the relatives’ diagnosis in relation to proband characteristics, such as 
gender, diagnosis, ethnicity and genotypes (described in chapter 6). The proband of one
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of the 10 affected relatives is among the 6 out of 230 probands who did not have a 
blood sample taken, therefore genetic SNP results are available from just 9 probands of 
AgP relatives. Probands’ gender, ethnicity and age of diagnosis were not associated 
with relatives’ diagnosis. The proband genotype for Fey Ha was significantly associated 
with diagnosis of AgP in the correspondent relative (Pearson’s Chi square p=0.003). 
However, some cells of the Chi-squared table would have expected values less than 5 - 
which make this result not very reliable, probably for a lack of power. Tendencies for 
association were also noted for FcyRIIIa (which is in linkage disequilibrium with the 
FcyRIIa gene, as assessed in chapter 6) and IL-6 polymorphisms.
RELATIVES no AgP AgP PEARSON’S CHI SQUAREProband characteristics
Gender Female (n= 61) 56(91.8%) 5 (8.2%) 0.426Male (n=38) 33 (86.8%) 5 (13.2%)
Diagnosis LAgP (n= 33) 30 (90.9%) 3 (9.1%) 1.000GAgP (n= 66) 59 (89.4%) 7 (10.6%)
Ethnicity
Caucasian (n=66) 61 (92.4%) 5 (7.6%)
0.665Black (n=15) 13 (86.7%) 2(13.3% )Asian (n=13) 11 (84.6%) 2(15.4% )
Others (n=5) 4 (80.0%) 1 (20.0%)
Fca -324
AA (n=7) 6 (85.7%) 1 (14.3%)
0.890AG (n=39) 35 (89.7%) 4(10.3% )
GG (n=46) 42 (91.3%) 4 (8.7%)
Fcylla 494
HH (n=18) 17 (94.4%) 1 (5.6%)
0.003HR (n=54) 52 (96.3%) 2 (3.7%)
RR (n=20) 14(70.0%) 6 (30.0%)
Fcyllb 232
CC (n=6) 6(100%) 0
0.430CT (n=T8) 15(83.3%) 3 (16.7%)
TT (n=68) 62 (91.2%) 6 (8.8%)
F cyllla  559
VV (n=10) 9 (90.0%) 1 (10.0%)
0.176VF (n=46) 44 (95.7%) 2 (4.3%)
FF (n=36) 30 (83.3%) 6 (16.7%)
Table 8.5: Relatives’ diagnosis in relation to correspondent probands’ demographic characteristics and
genetic profile
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RELATIVES no AgP AgP PEARSON’S CHI SQUAREProband c laracteristics
Fcylllb NA
NA2/NA2 (n=43) 38 (88.4%) 5 (11.6%)
0.617NA1/NA2 (n=34) 32 (94.1%) 2 (5.9%)
NA1/NA1 (n=15) 13 (86.7%) 2(13.3% )
Fcylllb SH
SH+/SH+ (n=2) 2 (100.0%) 0
0.663SH-/SH+ (n=5) 5 (100.0%) 0
SH-/SH- (n=85) 76 (89.4%) 9(10.6% )
FPR 301
CC (n=9) 8 (88.9%) 1 (11.1%)
0.647CG (n=43) 40 (93.0%) 3 (7.0%)
GG (n=38) 33 (86.8%) 5 (13.2%)
FPR 546
AA(n=15) 14 (93.3%) 1 (6.7%)
0.771AC (n=36) 33 (91.7%) 3 (8.3%)
CC (n=41) 36 (87.8%) 5 (12.2%)
FPR 568
AA(n=71) 63 (88.7%) 8(11.3% )
0.679AT (n=21) 20 (95.2%) 1 (4.8%)
TT (n=0) 0 0
VDR Taq-I
tt (n=2) 2(100.0%) 0
0.288Tt (n=60) 52 (86.7%) 8 (13.3%)
TT (n=30) 29 (96.7%) 1 (3.3%)
TNF- a -308
AA (n=68) 61 (89.7%) 7(10.3% )
1.000AG (n=24) 22 (91.7%) 2 (8.3%)
GG (n=0) 0 0
IL-6 -174
CC (n=7) 6 (85.7%) 1 (14.3%)
0.268CG (n=19) 19(100.0%) 0
GG (n=66) 58 (87.9%) 8(12.1%)
NADPH 
p22phox 242
CC (n=19) 18 (94.7%) 1 (5.3%)
0.580CT (n=61) 54 (88.5%) 7(11.5% )
TT (n=4) 4(100.0%) 0
Total (n= 99) 89 (89.9%) 10(10.1%)
Table 8.5 continued
8.3.3. Haplotype analysis
WHAP analysis confirmed the association between FcRylla and the presence of AgP in 
the family (p=0.001, adjusting for gender, ethnicity and smoking). The haplotype 
association between all five studied Fc receptor polymorphisms was still associated with 
AgP (p=0.014), but the extent of this association was smaller than for FcRylla only.
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8.4. DISCUSSION
A small subset of AgP patients examined in our Department provided relatives who 
lived in the UK and were willing to volunteer for a specific periodontal examination. 
The demographics of this group with respect to ethnic origin, gender and smoking status 
mirrored the characteristics of the 224 AgP patients included in the case-control genetic 
association study. Therefore, although no data regarding the socio-economic status of 
these patients have been examined, it seems reasonable to assume that they broadly 
represent the whole group of AgP patients described in this thesis.
Eighteen per cent of the families of AgP patients included in the study had at least one 
additional individual affected. The prevalence of AgP in first degree blood relatives of 
AgP patients that we managed to examine was found to be equal to 10%. This 
prevalence is considerably lower than has been reported in most previous studies 
(Spektor et al. 1985, Marazita et al. 1994, Trevilatto et al. 2002). This discrepancy is 
likely to be due to the fact that most studies focused just on one family with multiple 
subjects affected (Trevilatto et al. 2002), or to the excessively lenient definition often 
adopted for the diagnosis of AgP in relatives (Marazita et al. 1994). However, our 
findings are more in agreement with the report from Saxen (1980), who examining 127 
subjects from 33 Finnish families of AgP patients found AgP in 11 siblings (9%) from 8 
families (24%). In Saxen’s study, most of the existing relatives (94%) were examined. In 
our study, on the other hand, only 99 out of 224 possible relatives were examined (44%), 
which carries the risk of possible self- selection bias. In other words, less than half of the 
relatives accepted our invitation to be examined. Out of the 224 first degree blood 
relatives, some were deceased, some lived abroad, and some of them were odontophobic 
or simply did not care to have a dental examination. This has led to an increased 
female/male ratio in relatives, as expected from previous similar studies (Hart et al. 
1991) and might also have led to over- or under- estimation of AgP prevalence in these 
families. Considering the total number of relatives of our probands, we can say that at 
least 10 out of 224 (4.5%) were affected by AgP. Even this conservative prevalence is 
higher than the prevalence of AgP in the population as described in epidemiological 
studies (see chapter 1). Moreover, 65% of the examined relatives were found to be
161
affected by Chronic Periodontitis, a higher percentage than what would be expected in a 
random adult population (Kelly et al. 1999). Therefore, this study supports the concept 
o f familial aggregation in AgP and suggests the employment o f routine examination of 
first degree blood relatives of AgP patients as a useful preventive tool. Moreover, an 
observation on a subset of our patients revealed that the proband report about their 
relatives’ periodontal condition was reasonably reliable (Gozalbo & Griffiths 2005), and 
effective in the selection of risk families to examine. Nonetheless, the extent of this 
familial aggregation is probably not large enough to justify its inclusion criteria as one 
of the principal features of the diagnosis.
Hart et al. (1991) reported that the supposed increased prevalence of AgP in female 
relatives was probably due to ascertainment bias. Our data seem to support this 
statement: 13% of male relatives and 8% of female relatives had AgP. Ethnicity and 
smoking habits were not associated with AgP in the relatives. More siblings than parents 
were found to be affected by AgP.
Further analysis was conducted to detect if any proband characteristic (gender, ethnicity, 
genetic polymorphisms) could represent a risk predictor for familial aggregation. Within 
the limitations o f a small sample size, Fcylla polymorphism was a significant risk 
predictor for presence of AgP in the family. 30% of relatives o f RR homozygous 
probands and only 4% of heterozygous and HH homozygous had AgP. Considering the 
families rather the number of examined relatives as the unit for statistical analysis, AgP 
was found in 60% of families o f Fey I la R homozygous and 7% of heterozygous and H 
homozygous subjects. Interestingly, other risk polymorphisms observed in the 
association study (IL-6 and NADPH oxidase) showed trends of association with familial 
aggregation. O f the relatives of either IL-6 -174 C homozygous and heterozygous 
probands, only 1/26 (4%) had AgP, compared to 8/66 (12%) of the relatives of G 
homozygous probands. Similarly for the NADPH p22phox polymorphism, 1/19 (5%) of 
relatives of C homozygous probands and 7/61 (11%) of relatives of T allele carriers 
were found to have AgP. These preliminary data point towards the importance of genetic 
predisposition to AgP in families. The same genotypes predisposing the probands to
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AgP, may also be present in the relatives of these probands, thus predisposing them to 
AgP also. Only a genetic polymorphism study on affected and non affected relatives, 
and a larger sample size could clarify and confirm these observations.
It is interesting to observe the exact correspondence of diagnosis between probands and 
relatives affected by AgP. A diagnosis of LAgP was made in 3 relatives of LAgP 
patients, and GAgP was diagnosed in 7 relatives of GAgP patients. A similar 
observation was noted by Saxen (1980) and suggests that LAgP and GAgP might have 
different genetic predisposing factors.
We have not tested any hypothesis for the mode of inheritance in our sample. However, 
according to our female/male ratios and to the observation of the absence of 
periodontitis in some of the daughters of an affected father, the likelihood of an X-linked 
transmission seems to be small. In autosomal dominant mode of transmission, the 
disease will tend to appear in successive generations. Although we managed to examine 
only 9 complete couples of parents in this study, none of them were affected by AgP. 
Furthermore, only 2 out of the other 18 parents were affected. This does not seem to 
support an autosomal dominant mode of transmission. The remaining possibilities are 
autosomal recessive mode of inheritance, supposing the existence of a gene of major 
effect, or complex polygenic and multifactorial inheritance. In an autosomal recessive 
mode of inheritance, the phenotype is present only in homozygous subjects. The parents 
are usually carriers (heterozygous) and there is 25% chance for the offspring to be 
affected.
On the other hand, AgP may behave like many common acquired diseases, such as 
diabetes, asthma, Parkinson disease, rheumatoid arthritis, which do not conform to any 
recognized pattern of Mendelian inheritance, and show multifactorial inheritance 
(Hansen & Pedersen 2005). This means that several genes contribute to disease 
susceptibility, each exerting additive effects, which interact with environmental factors 
to determine disease onset. For example, type I diabetes is now recognized as a 
multifactorial disease with polygenic susceptibility consisting of one major locus and up
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to 20 modifying loci. The extent of familial heritability of multifactorial diseases is 
calculated by dividing the incidence in families of affected individuals by the incidence 
in the population (ratio = I) (Khouri et al. 1993). Type I diabetes has an incidence of 
0.4% in UK population and about 6% in affected families. The X for type I diabetes is 
therefore equal to 15. The corresponding figure for AgP, assuming that the overall 
prevalence in the population is about 1% (see chapter 1) and the family prevalence is 
10% would be equal to 10.
Considering the importance of environmental factors such as bacteria and smoking, and 
the supposed importance of multiple genes as risk factors for periodontitis, this 
polygenic model seems a more likely mode of inheritance for AgP. Nonetheless, the 
very strong familial aggregation encountered in some cases (Spektor et al. 1985), raises 
doubts about a polygenic nature of transmission.
A consistent finding of most studies, confirmed by this report, is the increased 
prevalence of destructive periodontitis in families, irrespective of the difference in 
diagnosis between CP and AgP. This has probably led to the concept of autosomal 
dominant transmission, but may be masked by the rather high prevalence of CP in the 
normal population. This concept points in two directions: i) AgP and CP may indeed 
have similar pathogenesis, or be different manifestations of the same disease, which 
would not justify a subdivision in the classification; ii) there might be similar polygenic 
background to CP and AgP, and some genes may have an additive effect resulting in the 
more severe form of the disease. Alternatively there may be environmental factors which 
can increase the susceptibility of a subject who has a genetic background which is 
already prone to AgP.
The overall impression, taking together literature reports and data from the present 
investigation, is that AgP is genetically very heterogeneous and has a whole spectrum of 
different possible modes of transmission. It may be the result of various pathogenic 
pathways, and susceptibility to AgP may lie in different defects and different genes in 
each population and even in each family. These genes may be of major effect (capable
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of causing the disease in both dominant and recessive manners) or just predisposing, and 
lead all to a similar disease phenotype, which we are not able to differentiate.
In conclusion, this study suggests the employment of routine examination o f first degree 
blood relatives of AgP patients as a useful preventive tool and supports the use o f family 
history as an easily accessible genetic tool for individual disease prevention in AgP 
(Guttmacher et al. 2004).
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CHAPTER 9
9. MICROBE-GENETIC INTERACTIONS
9.1. INTRODUCTION
Response to infection varies enormously between individuals and genetic factors may 
explain these individual variations (Wang 2005). This concept has led to a growing 
interest in the genetic predisposing factors for life-threatening infectious diseases such as 
malaria, tuberculosis, hepatitis and AIDS. It has been shown recently that genetic 
variants in the promoter region of the CC chemokine receptor 5 gene confer protection 
against HIV infection (Cooke & Hill 2001). A recent review (Schroder & Schumann 
2005) underlined how SNPs in Toll-like receptors (TLR) loci may affect the ability to 
respond to infectious agents. Moreover, genetic polymorphisms of inflammatory 
markers have recently been associated with the prevalence of bacterial infections in 
patients in intensive care units (Sutherland et al. 2005), and polymorphisms in Fey 
receptors have been suspected to have an effect on host defence against malaria infection 
(Omi et al. 2002). Understanding the molecular basis for these different responses may 
improve our understanding of infectious disease pathogenesis and help in the treatment 
and control of these infections (Cooke & Hill 2001).
The pathogenesis of AgP is considered to be due to a shift in the homeostasis existing 
between the bacteria present in the subgingival plaque and the host response. Thus in 
AgP, host responses (genetically determined) and microbiological factors seem to be 
deterministic components which, even in the absence of conspicuous amounts of 
subgingival plaque or other local factors, may trigger or cause the onset o f this disease 
(Kinane & Hart 2003).
Actinobacillus actinomycetemcomitans, Tannerella forsythensis (previously Bacteroides 
forsythus) and Porphyromonas gingivalis were officially designated as being among the 
aetiological agents o f periodontitis in 1996 (Consensus Report 1996) and in the majority 
of populations, AgP has been associated with a mixed infection with these 
microorganisms (Mombelli et al. 2002). The presence of elevated proportions of A. 
actinomycetemcomitans and, in some populations, of P. gingivalis, is now considered 
one of the laboratory diagnostic features of AgP (Armitage 1999). A.
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actinomycetemcomitans is a small, non-motile, Gram-negative, saccharolytic, 
capnophilic, round-ended rod. The proportion of subjects who carry this bacterium 
varies from 20% to 90% in AgP cases (Mombelli et al. 2002). It has also been 
demonstrated that most AgP cases have elevated serum antibodies against A. 
actinomycetemcomitans (Kinane et al. 1999b). P. gingivalis is a Gram-negative, 
anaerobic, non-motile, asaccharolytic rod. It is one of the most prevalent bacteria 
isolated from AgP lesions and may be detected from 60-90% of generalised cases. T. 
forsythensis is a Gram-negative, anaerobic rod, which may be detected in 70-100% of 
patients with Generalised AgP (GAgP) (Mombelli et al. 2002).
A range of different genetic deficiencies or variations in the host response are considered 
to predispose to AgP and several genetic polymorphisms have been associated with 
susceptibility to this infection, with particular regards to neutrophil receptors and 
cytokines (Kinane & Hart 2003). In the study presented in chapter 6 we have detected 
associations between AgP and two genetic polymorphisms (IL-6 -174 and NADPH 
oxidase p22phox C 242 T) and tendencies for association with AgP for two other 
polymorphisms (FcyRIIIb and VDR Taq-I) and a haplotype (FcyR). The mechanisms of 
this supposed genetic predisposition are still not clearly elucidated, and may involve 
interactions with periodontal bacteria.
In the present study, we hypothesized that the host genotype can influence the 
composition of the subgingival microbiota. Evidence which supports the hypothesis that 
a particular genotype could render host defence mechanisms more selectively active 
against specific periodontal pathogens is very limited (Socransky et al. 2000), and there 
are no previous studies investigating these possible interactions in patients diagnosed 
with GAgP. The aim of this study was to investigate whether genetic polymorphisms of 
inflammatory markers may influence the presence of A. actinomycetemcomitans, P. 
gingivalis and T. forsythensis in a population diagnosed with GAgP.
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9.2. MATERIALS AND METHODS
9.2.1. Study population
Out of all the subjects included in the genetic association study, 45 consecutive subjects 
diagnosed with Generalised AgP were identified and included in the study. All o f the 
patients gave written informed consent and the study had been reviewed and approved 
by the Eastman/UCLH joint ethics committee.
Inclusion and exclusion criteria were described in chapter 4. Furthermore, subjects were 
excluded from the study if: i) they were pregnant or lactating females, ii) they suffered 
from any other systemic diseases (cardiovascular, pulmonary, liver, cerebral diseases or 
diabetes); iii) they had received systemic or local antibiotic treatment in the previous 3 
months; iv) they were taking long-term anti-inflammatory or immunosuppressive drugs; 
v) they had received a course of periodontal treatment within the last 6 months. The 
demographic and clinical characteristics of the 45 patients are presented in table 9.1.
■■ ' - ■ 1.. —................
PARAMETER MEAN
AGE (Mean ± S.D.) 29.9 ±5.5
FEMALES (percentage) 30 (66.7%)
SMOKERS (percentage) 9 (20.0%)
ETHNICITY
(percentage)
Caucasians 27 (60.0%)
Blacks 7(15.6%)
Asians 10 (22.2%)
Others 1 (2.2%)
TEETH AT BASELINE (Mean ± S.D.) 28.5 ±2.7
NUMBER OF POCKETS > 5 mm (Mean ± S.D.) 64.0 ±30.8
PROBING POCKET DEPTH (mm) 
(Mean ± S.D.)
4.2 ± 1.0
LIFETIME CUMULATIVE ATTACHMENT LOSS 
(LCAL) (mm)
(Mean ±  S.D.)
4.8 ± 1.3
Table 9.1. Demographic characteristics o f the patients
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9.2.2. Clinical examination
All of the patients with a suspected diagnosis of AgP were examined by a single 
experienced clinician. As described in chapter 4, full mouth measures o f probing pocket 
depth (PPD), recession and lifetime cumulative attachment levels (LCAL) were 
obtained. Six sites were measured for each natural tooth, one each at the mesiobuccal, 
mid-buccal, distobuccal, distolingual, mid-lingual and mesiolingual sites encircling the 
tooth. Full mouth long cone periapical radiographs were also obtained for each patient.
Patients were diagnosed with Generalized AgP (GAgP) when presenting with 
generalized interproximal PPD and LCAL > 5 mm and radiographic bone loss o f > 
30% of root length affecting at least three permanent teeth other than first molars and 
incisors. Once the eligibility criteria had been fulfilled, consent was taken for blood and 
subgingival plaque sampling and patients were entered into the study. The blood 
samples were collected via venipuncture and stored at -70° C until the genetic analysis 
was performed.
9.2.3. Plaque sampling
The plaque samples were collected from the 4 deepest sites in each quadrant (Mombelli 
et al. 1991). The supragingival portion o f the root surface of the site was carefully 
cleaned with a curette and isolated from saliva by a gentle air spray and by positioning a 
cotton roll in proximity of the tooth. A sterile curette was then inserted to the bottom of 
the pocket and the microbiological sample was collected with a single apical-coronal 
stroke. Samples were then immediately placed in a sterile container with 1 ml of reduced 
transport fluid (Syed & Loesche 1972) before periodontal probing.
9.2.4. DNA extraction and genotyping
Genetic procedures applied in this study have been described in chapter 6.
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9.2.5. Microbiological analysis
The samples were processed immediately on arrival at the Department o f Microbiology 
of the Eastman Dental Hospital. Samples were vortex mixed for 30 seconds (or until the 
plaque had been dispersed) and subsequently diluted in reduced transport fluid to a 
dilution factor of 10'6. Duplicate 50pl aliquots of the sample at each dilution were then 
plated on the following media: (a) Fastidious anaerobic agar (FAA) containing 5% 
defibrinated horse blood (for the total anaerobic count) and all black-pigmented colonies 
were counted and subcultured for identification o f P. gingivalis, (b) A.
actinomycetemcomitans was isolated on tryptone soya agar (Oxoid Ltd, Basingstoke, 
UK) containing 0.1 % yeast extract, 10 % horse serum (E & O Laboratories, 
Bonnybridge, UK), bacitracin (75 mg/L; Sigma, Poole, UK) and vancomycin (5mg/L; 
Sigma; Slots, 1982) and incubated at 37°C for 5 days in air supplemented with 5% CO2 . 
(c) FAA containing 7% defibrinated horse blood and 10 mg/L N-acetyl muramic acid 
(colonies with the appropriate morphology were counted and subcultured for 
identification of T. forsythensis). All FAA plates were incubated in an anaerobic 
environment (10 % hydrogen, 10 % carbon dioxide, balanced with nitrogen) in an 
anaerobic cabinet at 37°C for 5 days. The identity of isolates was determined by partial 
sequencing of the 16S rRNA gene amplified by PCR. The whole genomic DNA was 
extracted from cultures of presumptive A. actinomycetemcomitans, P. gingivalis and T. 
forsythensis using the Puregene™ DNA isolation Kit, (Gentra Systems, Minneapolis, 
USA). The extracted DNA was then used as a template for species confirmation via 
PCR, which targeted specific regions within the 16S rRNA gene. The nucleotide 
sequences for the primers were as follows: P. gingivalis specific forward primer (PgF), 
5’-TGTAGATGACTGATGGTGAAAACC-3’; A. actinomycetemcomitans specific 
forward primer (AaF), 5 ’-ATTGGGGTTTAGCCCTGGTG-3 ’; T. forsythiensis specific 
forward primer (TfF), 5 ’ -T AC AGGGG AAT AA AAT GAG AT ACG- 3 ’ and a conserved 
reverse primer (ConR), 5’-ACGTCATCCCCACCTTCCTC-3’ (Genosys, 
Cambridgeshire, UK). The expected product lengths were 197 bp for P. gingivalis, 360 
bp for A. actinomycetemcomitans and 745 bp for T. forsythensis (13). The PCR results 
were confirmed by DNA sequencing of the amplicons which was carried out using an 
ABB 10 Genetic Analyser (PE Biosystems, Warrington, U.K.). Sequences were analysed
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using the Ribosomal Database project II (Maidak et al. 2000) and BLAST at the 
National Centre for Biotechnological Information (Altschul et al. 1997). The detection 
limit for each of the studied bacteria was 10 cells/ml.
9.2.6. Statistical analysis
The SPSS 12.0 package was used for statistical analysis and the alpha value was set at 
0.01, because of the problem of multiple variable testing (Altman 1991). Continuous, 
normally distributed variables are reported as means ± standard deviations (SD). 
Comparisons of continuous and categorical data between groups were analyzed with 
ANOVA and Chi-square test respectively, on all tested polymorphisms. Associations 
between genotype and the presence of periodontopathogenic bacteria (A. 
actinomycetemcomitans, P. gingivalis and T. forsythensis) were screened by Chi-square 
test. Whenever p values < 0.2 were detected, multiple logistic regression analysis was 
performed. A backward likelihood- ratio elimination algorithm was used entering age, 
smoking, ethnicity, number of periodontal pockets > 5 mm and genotype as variables. 
SLE (significance level for entry into the model) e SLS (significance level to stay in the 
model) were set at 0.05 and 0.1 respectively. The results of the final models are reported. 
Further analysis was performed to investigate the prevalence of concomitant detection of 
A. actinomycetemcomitans and P. gingivalis, and A. actinomycetemcomitans, P. 
gingivalis and T. forsythensis together. Multivariate analysis was performed in positive 
subjects for each of the studied bacteria in order to investigate relation between 
genotypes and log counts of detected bacteria. WHAP analysis (see chapter 6) was 
performed to detect possible FcR and FPR haplotype associations able to predict the 
presence o f the studied bacteria or the concomitant presence of the different species.
9.3. RESULTS
The allele distributions of all studied polymorphisms satisfied the Hardy-Weinberg 
equilibrium. A. actinomycetemcomitans, P. gingivalis and T. forsythensis were detected 
in 23 (51.1%), 23 (51.1%) and 29 (64.4%) subjects respectively. A.
actinomycetemcomitans and P. gingivalis were concomitantly detected in 16 subjects
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(35.6%), while all three bacteria were present together in 10 subjects (22.2%). No 
statistically significant differences were observed in bacterial detection for age, gender, 
ethnicity, smoking and disease severity, indicated by the number o f probing pocket 
depths > 5 mm (data not presented). Average log counts for A. actinomycetemcomitans, 
P. gingivalis and T. forsythensis were respectively 4.43 ± 1.18, 6.02 ± 1 .3 4  and 6.23 ± 
0.48 cfu/ml. Out of all the candidate polymorphisms studied, Fcylllb receptor and 1L-6 
polymorphisms showed association with the presence o f A. actinomycetemcomitans, P. 
gingivalis and T. forsythensis. Distributions of all polymorphisms in relation to detection 
rates of the above mentioned bacteria are reported in table 9.2.
Poly­
morphism
Geno­
type patient#
A.a.
detected
Pg.
detected
T.f.
detected
A.a. + 
Pg- 
detected
A.a. + P.g.
+ T.f. 
detected
FcaR
AA 6 2(33.3%)
3
(50.0%)
4
(66.7%)
1
(16.7%)
1
(16.7%)
AG 18 10(55.6%)
9
(50.9%)
14
(77.8%)
7
(38.9%)
4
(22.2%)
GG 21 10(47.6%)
10
(47.6%)
11
(52.4%)
8
(38.1%)
5
(23.8%)
FcyRIIa
HH 13 3(23.1%)
5
(38.5%)
9
(69.2%)
3
(23.1%)
1
(7.7%)
HR 18 10(55.6%)
8
(44.4%)
10
(55.6%)
6
(33.3%)
13
(16.7%)
RR 13 8(61.5%)
8
(24.7%)
9
(69.2%)
6
(46.2%)
5
(38.5%)
FcyRIIb
CC 1 0 0 0 0 0
CT 12 6(50.0%)
6
(50.0%)
7
(58.3%)
4
(33.3%)
3
(25.0%)
TT 32 16(50.0%)
16
(50.0%)
22
(68.8%)
12
(37.5%)
7
(21.9%)
FcyRIIIa
VV 6 1(16.7%)
1
(16.7%)
2
(33.3%)
1
(16.7%)
0
(0%)
VF 19 9(47.4%)
9
(47.4%)
11
(57.9%)
7
(36.8%)
3
(15.8%)
FF 20 12(60.0%)
12
(60.0%)
16
(80.0%)
8
(40.0%)
7
(35.0%)
FcyRIIIbNA
NA2/
NA2 17
6
(35.3%)
7
(41.2%)
8
(47.1%)
4
(23.5%)
1
(5.9%)
NA1/
NA2 18
9
(50.0%)
9
(50.0%)
14
(77.8%)
7
(38.9%)
6
(33.3%)
NA1/
NA1 10
7
(70.0%)
6
(60.0%)
7
(70.0%)
5
(50.0%)
3
(30.0%)
Table 9.2 Detection rates o f  periodontopathogenic bacteria by genotype
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Poly­
morphism
Geno­
type
patient
#
A.a.
detected
Pg.
detected
T.f.
detected
A.a. + 
Pg. 
detected
A.a. + P.g. 
+ T.f.
detected
FcylllbSH
SH+/
SH+ 0 0 0 0 0 0
SH-/
SH+ 8
7
(87.5%)
6
(75.0%)
5
(62.5%)
6
(75.0%) 4 (50.0%)
SH-/
SH- 37
15
(40.5%)
16
(43.2%)
24
(64.9%)
10
(27.0%) 6 (16.2%)
FPR 301
CC 3 1(33.3%)
1
(33.3%)
2
(66.7%) 0 (0%) 0 (0%)
CG 15 8(53.3%)
7
(46.7%)
8
(53.3%)
6
(40.0%) 3 (20.0%)
GG 25 13(52.0%)
13
(52.0%)
17
(68.0%)
10
(40.0%) 7 (28.0%)
FPR 546
AA 5 2(40.0%)
5
(100.0%) 4 (80.0)
2
(40.0%)
1
(20.0%)
AC 25 12(48.0%)
9
(36.0%)
18
(72.0%)
8
(32.0%)
7
(28.0%)
CC 14 7(50.0%)
7
(50.0%)
7
(50.0%)
5
(35.7%)
2
(14.3%)
FPR 568
AA 33 15(45.5%)
14
(42.4%)
20
(60.6%)
11
(33.3%)
7
(21.2%)
AT 12 7(58.3%)
8
(66.7%)
9
(75.0%)
5
(41.7%)
3
(25.0%)
TT 0 0 0 0 0 0
VDR
tt 5 3(60.0%)
3
(60.0%)
2
(40.0%)
3
(60.0%)
2
(40.0%)
Tt 24 12(50.0%)
9
(37.5%)
15
(62.5%)
6
(25.0%)
3
(12.5%)
TT 15 7(46.7%)
10
(66.7%)
11
(73.3%)
7
(46.7%)
5
(33.3%)
TNF-a
AA 34 18(52.9%)
19
(55.9%)
22
(64.7%)
14
(41.2%)
9
(26.5%)
AG 9 4(44.4%)
3
(33.3%)
6
(66.7%)
2
(22.2%)
1
(11.1%)
GG 2 0 0 1(50.0%) 0 0
1L-6
CC 7 3(42.9%)
3
(42.9%)
3
(42.9%)
2
(28.6%)
1
(14.3%)
CG 12 2(16.7%)
4
(33.3%)
7
(58.3%) 1 (8.3%) 0
GG 26 17(65.4%)
15
(57.7%)
19
(73.1%)
13
(50.0%)
9
(34.6%)
NADPH
CC 22 10(45.5%)
8
(36.4%)
13
(59.1%)
6
(27.3%)
4
(18.2%)
CT 17 10(58.8%)
11
(64.7%)
10
(58.8%)
8
(47.1%)
4
(23.5%)
TT 5 2(40.0%)
3
(60.0%)
5
(100.0%)
2
(40.0%)
2
(40.0%)
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Logistic regression revealed that homozygosity for G allele of IL-6 -174 polymorphism 
was associated with detection of A  actinomycetemcomitans (p=0.003, O.R. =13.7, 95% 
C.I. =2.4-77.1 adjusting for age and smoking) (see table 9.3), and approached statistical 
significance for combined detection of A. actinomycetemcomitans and P. gingivalis 
(p=0.019, O.R. = 7.86, 95% C.I. =1.4- 44.1 adjusting for age and ethnicity) and 
combined detection of all three studied pathogens (p=0.042, O.R. = 9.53, 95% C.I. =1.1- 
83.4).
B S.E. Wald df Sig. O.R.
95,0% C.I.for 
EXP(B)
Lower Upper
IL-6GG 2.604 0.938 7.703 1 0.006 13.522 2.149 85.073
Age 0.168 0.094 3.196 1 0.074 1.183 0.984 1.423
Ethnicity 2.763 0.430
Ethnicity (I) 2.246 1.458 2.373 1 0.123 9.446 0.543 164.468
Step 1 Ethnicity(2) 1.020 0.946 1.163 1 0.281 2.773 0.435 17.691
Ethnicity(3) -19.500 40192.97 0.000 1 1.000 0.000 0.000
Smoking(l) 1.942 1.135 2.930 1 0.087 6.976 0.754 64.502
5mm PPD 0.009 0.012 0.508 1 0.476 1.009 0.985 1.034
Constant -8.086 3.545 5.203 1 0.023 0.000
IL-6GG 2.538 0.922 7.570 1 0.006 12.650 2.075 77.116
Age 0.166 0.094 3.125 1 0.077 1.180 0.982 1.419
Ethnicity 2.581 0.461
Step 2
Ethnicity (1) 2.153 1.420 2.300 1 0.129 8.613 0.533 139.257
Ethnicity(2) .896 0.921 0.946 1 0.331 2.449 0.403 14.887
Ethnicity(3) -19.653 40192.97 0.000 1 1.000 0.000 0.000
Smoking(l) 2.095 1.109 3.568 1 0.059 8.128 0.924 71.482
Constant -7.404 3.370 4.827 1 0.028 0.001
IL-6GG 2.617 0.882 8.812 1 0.003 13.695 2.433 77.086
Step 3
Age 0.138 0.082 2.817 1 0.093 1.148 0.977 1.348
Smoking(J) 1.800 0.973 3.426 1 0.064 6.051 0.899 40.709
Constant -6.098 2.868 4.522 1 0.033 0.002
Table 9.3. Results o f  backwards logistic regression analysis for detection o f  A.actinomycetemcomitans 
The variables entered on step 1 were IL6GG, age, ethnicity, smoking, and number o f  PPD> 5 mm. B 
indicates the set o f coefficients estimated for the model, S.E. is the standard error, W ald’s test indicates 
the significance o f the parameters, df indicates the degrees o f freedom and O.R. indicated the odds 
ratios for each parameter. The last two columns show the 95% confidence intervals. Step 3 is the most 
significant one, indicating the importance o f  IL-6 genotype, age and smoking.
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Fcylllb NA polymorphism showed some evidence for association with detection rates o f 
A. actinomycetemcomitans (p=0.038, O.R. = 6.84, 95% C.I. =1.1- 42.0 adjusting for 
ethnicity). Tendencies for association, although not statistically significant, were also 
observed for Fcylllb SFI antigen and Fcylla polymorphisms (see table 9.2).
WHAP analysis revealed that FcyR haplotypes were associated with presence of 
A.actinomycetemcomitans (p=0.010 adjusting for gender, smoking and ethnicity). The 
highest p values were observed for constrained models including Fcylla and Illb NA (p= 
0.013 and 0.016 respectively for A. actinomycetemcomitans and combined presence of 
all three bacteria), Fcylla, Illb NA and Illb SH (p=0.003 and 0.006 respectively for A. 
actinomycetemcomitans and combined presence of all three bacteria) and Illb NA and 
Illb SH (p^O.008, 0.006 and 0.02 respectively for A.a., A.a. and P.g. and all three 
studied bacteria).
Logarithmic conversions of counts of anaerobic and aerobic bacteria, and 
A.actinomycetemcomitans, P.gingivalis and T.forsythensis obtained by the cultural 
method described above in positive individuals for each of these bacteria were analyzed 
by genotypes. No statistically significant associations were detected between total log 
counts and genetic polymorphisms (data not presented). This may be partially due to the 
small number of positive subjects for each o f the three bacteria, which reduced the 
power to detect any association. Appendix XVIII shows the total of each log count of 
studied bacteria computed in the table by different genotypes.
9.4. DISCUSSION
This is the first study to investigate the association between neutrophil receptors, 
NADPH oxidase p22phox, IL-6, TNF-a and VDR single nucleotide polymorphisms and 
the detection of periodontopathogenic bacteria in patients with AgP. Socransky et al. 
(2000) suggested that differences in genetic background o f the host may influence the 
composition o f the subgingival microbiota. They observed an association between the
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IL-1 genotype and the levels o f suspected periodontal pathogens in a population with 
Chronic Periodontitis.
The results of this study show that polymorphisms of genes encoding for neutrophil 
receptors (Fcylllb) and pro inflammatory cytokines (IL-6) are associated with the 
presence of pathogenic bacteria in the periodontal pockets of Aggressive Periodontitis 
subjects. This finding was independent of other risk factors such as age, smoking, ethnic 
origin and disease severity. Therefore, these results reinforce the hypothesis that the host 
genotype can influence the composition of the subgingival microbiota and support data 
from previous studies which suggest that individual genetic susceptibility may influence 
the host response to infections (Sutherland et al. 2005).
In particular, our findings suggest that Interleukin-6 -174 polymorphism may be 
important in determining susceptibility to colonization with periodontopathogenic 
bacteria, especially A.actinomycetemcomitans. Interleukin 6 (IL-6) is a multifunctional 
cytokine with a central role in host defence (Terry et al. 2000), produced by 
monocytes/macrophages, fibroblasts, endothelial cells, adipocytes, T cells and mast 
cells. Dysregulation of IL-6 production has been associated with a number of systemic 
diseases such as plasmacytosis, juvenile chronic arthritis, rheumatoid arthritis, 
osteoporosis, Paget disease and psoriasis (Terry et al. 2000). IL-6 has been shown to 
have a crucial role in the inflammatory response to infectious agents (especially Gram- 
negative bacteria), which is necessary in order to control the infection (Dalrymple et al. 
1996, Remick et al. 2005). Homozygosity for the G allele at position -174 in the 
promoter region has been linked to increased serum concentration of IL-6 and increased 
construct expression upon stimulation with LPS (Fishman et al. 1998, Terry et al. 2000) 
and suspected as a susceptibility factor for periodontitis (Trevilatto et al. 2003). 
Furthermore, we have shown in the case-control study described in chapter 6, an 
association between G homozygosity and AgP. Recently, a complex regulatory 
haplotype has been discovered in a region extending upstream of the previously known 
promoter region. This haplotype might have a more pronounced functional effect than 
the -174 polymorphism alone (Fife et al. 2005). In our study, -174 G homozygous
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subjects exhibited higher detection rates of periodontopathogenic bacteria. If the 
supposed increased activity associated with the G allele is confirmed, the reason why 
patients with increased IL-6 activity are more prone to carriage of the periodontal 
pathogens A. actinomycetemcomitans and P. gingivalis remains to be explained A 
possible explanation could be that G homozygosity may predispose to periodontal 
disease through stimulation of an excessive inflammatory cascade, which increases the 
risk for tissue destruction. Bacteria such as A. actinomycetemcomitans and P. gingivalis 
are known to stimulate the inflammatory cascade and the production o f IL-6 from 
gingival fibroblasts (Belibasakis et al. 2005, Bodet et al. 2005). Therefore, the presence 
of periodontopathogenic bacteria in IL-6 -174 G homozygous individuals may act over 
an already ‘primed’ substrate and excessively amplify the local inflammatory response 
in these subjects, and this may result in the characteristic tissue destruction seen in AgP. 
Consequently, detection rates of these pathogenic bacteria and G homozygosity cluster 
in the same group of AgP patients.
The other finding of the study is in relation to Fc-y receptor polymorphisms. Neutrophils 
recognize bacteria opsonized by Immunoglobulins (Ig) through specific Fc receptors and 
their binding activates important effector functions such as phagocytosis, superoxide 
production, cellular cytotoxicity, antigen presentation, cytokine release, degranulation 
and regulation of antibody synthesis (van Sorge et al. 2003). The Fc-ylllb bears the 
neutrophil antigen (NA) polymorphism, implicated in autoimmune neutropenia and 
transfusion reactions. This antigen is determined by five nucleotide substitutions, which 
result in two isoforms (NA1 and NA2) differing by 4 amino acids (at position 36, 65, 82 
and 106) in an Ig domain. NA1 and NA2 have been shown to have different 
glycosylation and therefore different ligand affinity. The NA1 allotype exhibits higher 
affinity for immune-complexed IgG3, and therefore increased phagocytosis (Salmon et 
al. 1990). Kobayashi et al. (2000b) showed Fc-ylIIb-NA2-carrying PMN from both 
patients with chronic periodontitis and healthy controls to be less efficient in 
phagocytosis upon interaction with IgGl- and IgG3-opsonized P. gingivalis. The Fc­
ylllb NA2 allotype has been shown to be involved in susceptibility to periodontitis by 
several investigators (Kobayashi et al. 2000a, Fu et al. 2002, Yasuda et al. 2003).
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However, in the case-control study reported in chapter 6 we showed an association 
between the NA1 homozygous allotype and Generalised AgP in Caucasians. Bux et al. 
(1997) identified another antigen (SH) located on the Fc-ylllB, determined by a single 
base C-A mutation at nucleotide 266, which results in an Ala78Asp amino acid 
substitution. SH+ individuals are rare and seem to be always accompanied by the NA2 
allotype, either because of close homology or because of linkage. This new antigen may 
have functional influences, still to be elucidated (Koene et al. 1998). Fc-ylla is 
polymorphic in at least two sites, one of which (at position 131) codes for amino acids 
located in spots involved in IgG-binding. The histidine (H) at position 131 has been 
shown to increase receptor affinity and specificity, while the presence of an arginine (R) 
results in PMN with reduced ability to phagocytose IgG2-opsonized particles (Bredius et 
al. 1994). In conflict with the literature data, in this report Fc-ylllb NA1 positive 
individuals had higher detection rates o f A. actinomycetemcomitans than NA2 subjects. 
However, among NA2 subjects, SH positive individuals exhibited very high detection 
rates of the studied bacteria. Therefore in our sample, while results from Fc-ylla R 
confirmed a decreased capacity for phagocytosis and killing linked to this genotype, the 
same did not apply to the Fc-ylllb NA2 allele. Nonetheless, as already hypothesized 
(Koene et al. 1998), the SH antigen might have masked some o f the functional results 
previously observed in relation to the NA2 allotype. Furthermore, the highest association 
with carriage of A.a., A.a. and P.gingivalis and all three bacteria were observed for 
haplotype combinations between Fcylla, Illb NA and Illb SH, pointing towards the 
importance of the interaction between these three FcR loci.
The same considerations proposed for the IL-6 polymorphism may apply to the 
interpretation of this finding for the Fc-ylllb NA1 allele. NA1 homozygous individuals 
are likely to have a neutrophil hyperactivity (Kobayashi et al. 2000b); therefore, NA1 
homozygosity and presence of A. actinomycetemcomitans may cluster together in AgP 
patients, and their combination may trigger the excessive immune response leading to 
AgP onset.
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The results of this study suggest microbe-genetic interactions in Aggressive 
Periodontitis. Fc-ylllb receptor and IL-6 polymorphisms were found to be associated 
with the presence of periodontopathogenic bacteria. This stimulates speculation about 
the possible role o f these polymorphisms both in the defence against bacterial infections 
and in the pathogenesis of periodontal disease. Further studies with larger sample size 
are now required to test these hypotheses. Periodontal disease, being one o f the most 
common multibacterial diseases in developed countries, may represent a useful model to 
study pathways and mechanisms of microbe-genetic interactions.
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CHAPTER 10
10.SUPEROXIDE PRODUCTION
10.1. BACKGROUND
The results described in chapter 6 show a skewed distribution for NADPH oxidase 
p22phox C242T polymorphism between our patient and control groups. This SNP is 
supposed to be involved in superoxide production within neutrophils (Shimo-Nakanishi 
et al. 2004). The results we observed led to the hypothesis that this polymorphism might 
increase the risk of developing AgP through an excessive production of superoxide by 
neutrophils. Moreover, it has been widely demonstrated that PMN from AgP 
individuals, especially LAgP, release under stimulation more superoxide than matched 
controls (Shapira et al. 1991, Leino et al. 1994). A neutrophil hyperactivity has therefore 
been suspected as a possible pathogenic mechanism leading to AgP (Kantarci et al. 
2003).
The aim of this study was to measure the superoxide production from PMNs in a subset 
of AgP patients and relate it to their NADPH oxidase p22phox C242T polymorphism. The 
null hypothesis is that NADPH oxidase p22phox C242T polymorphism has no effect on 
PMN superoxide production.
10.2. MATERIALS AND METHODS
10.2.1. Patient recruitment and examination
A subset of patients with AgP who took part in the genetic case-control association 
study described in chapter 6 (see chapter 4 for inclusion and exclusion criteria) was 
recruited to have an assessment of their superoxide production. In order to have an 
ethnically homogeneous group of subjects, only Caucasians were recruited. All 
Caucasian subjects scheduled to attend a recall examination were asked to participate in 
this study. Twenty-eight AgP patients attended the Early Onset clinic at the Department 
of Periodontology, EDH, during the two months when the study took place; only one of 
the patients declined participation in the study.
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Therefore, a total of 27 Caucasians diagnosed with AgP agreed to have a blood sample 
taken for functional analysis of superoxide production. Their demographic 
characteristics are presented in table 10.1. Only one of these patients had been diagnosed 
with LAgP; all the others were affected by GAgP. None of these subjects were using 
concomitant medications at the time of examination.
10.2.2. Blood sample
A blood sample was drawn from each subject as described in chapter 4. Twenty 
millilitres of blood were collected in one 10 ml- EDTA tube and transferred to the 
laboratory for examination immediately after collection.
10.2.3. Neutrophil isolation
One ml of dextran was added to 10ml of blood in a universal. The tube was inverted and 
left to stand at room temperature for 30-45 minutes. During this time the erythrocytes 
settled to the bottom of the universal. Using a pipette, the supernatant was removed and 
gently added on the top of 10ml of Ficoll-Paque in a labelled tube, which was then 
centrifuged for 10 minutes at 2000rpm, 20°C. The remaining supernatant after 
centrifugation was removed, leaving the whitish/reddish pellet (mainly neutrophils) at 
the bottom of the tube. In order to lyse the red blood cells, first 10 ml of water and then 
immediately 10 ml 2x saline were added to the cell pellet. The cells were centrifuged 
again at 1200rpm for 7 minutes. The supernatant was then again discarded, leaving a 
white neutrophil pellet at the bottom, which was re-suspended in 5ml of PBS/glucose 
buffer. A cell count was performed using a haematocytometer. A concentration of lx l0 6 
cells/ ml o f PBS/glucose buffer was required; therefore, if  the estimated concentration 
was higher, additional PBS/glucose buffer was added until the right concentration was 
reached. If, on the other hand, the measured concentration was lower, the tube 
containing the neutrophils was centrifuged again and the pellets re-suspended in the 
appropriate volume o f PBF/glucose buffer.
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10.2.4. Superoxide measurement from neutrophils
Several different methodologies are used to measure the production o f superoxide, 
including cytochrome c reduction, adrenochrome formation, cyanide-resistant oxygen 
consumption, hydroethidine oxidation, electrochemical detection, chemiluminescence 
reactions, aconitase inhibition, hydrogen peroxide production (Tarpey & Fridovich 
2001). All these methods have advantages and disadvantages. The method used in this 
study was the cytochrome c reduction assay. This method uses the reduction rates of 
ferricytochrome c to evaluate the amount o f oxygen released by PMN following 
stimulation with 4B-phorbol 12-mystrate 13-acetate (PMA). The reduction reaction 
happens mainly thanks to oxygen, but also to compounds such as ascorbate and 
glutathione. This reaction produces a colour change that can be measured by a 
spectrophotometer. Suda et al. (2005) reported a maximum level o f 02* release within 
the first five minutes of stimulation. Therefore, in order to be able to detect the 
immediate response to PMA and its time pattern, we did not incubate and centrifuge the 
samples after stimulation with PMA, as described previously by Shimo-Nakanishi et al. 
(2004). However, we incubated some duplicate samples and did not notice significant 
variations in O2’ production compared to the non incubated ones (data not presented). 
For technical reasons, we also did not use superoxide dismutase (SOD) as a negative 
control. SOD can be added to increase the specificity of the reaction since it catalyses 
the conversion of superoxide to oxygen and hydrogen peroxide allowing the estimation 
of reduction due to superoxide alone and correcting for the effects of other reductants.
In brief, the spectrophotometer was switched on and set at 550nm. Two cuvettes for 
each subject were filled with 1 ml of PBS/glucose buffer containing lxlO 6 cells and 100 
pi o f cytochrome C. Each cuvette was then positioned in the spectrometer for at least 1 
minute, and the absorbance rate before the addition of PMA was read, and used as a 
baseline reference. Respectively 1 and 2 pg/ml of PMA were added to each of the two 
cuvettes and the absorbance rates were read and recorded every 15 seconds up to 5 
minutes. The Beer-Lambert law (Sassaroli & Fantini 2004) was used to calculate the 
number nmol of superoxide produced by lxlO6 cells:
A= 21.1 x C x D,
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where:
A is the measured absorbance, 21.1 is the absorption coefficient, C is the concentration 
in M, and D the light path of the cuvette in cm. Considering this last measure was equal 
to 1 cm, the molarity was calculated as follows:
C (mMol) = A x 1000/21.1.
10.2.5. Statistical analysis
The SPSS 12.0 package was used for statistical analysis. All recorded measures were 
entered in a spreadsheet and proofed for entry errors. The normality of distribution of the 
superoxide production measures was plotted and tested by Kolgomorov- Smirnov and 
Shapiro-Wilk tests. Since they did not show normal distribution, they were log- 
transformed for the analysis. Repeated ANOVA analysis was used to account for the 
differences in superoxide production between the different genotypes in time. The 
residuals of log- transformed values were again plotted (Q-Q plot) and showed a better 
pattern of distribution (see figure 10.1), although Kolgomorov- Smirnov and Shapiro- 
Wilk test still showed non normal distribution, albeit relating to extreme measures only.
Normal Q-Q Plot of Residual for 2 m icrogram s of PMA
Normal Q-Q Plot of Residual for 1 microgram of PMA
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Figure 10.1: Q-Q plot of residuals of repeated ANOVA analysis for NADPH genotypes after stimulation
respectively with 1 and 2 pg o f PMA
In order to assess clear-cut genetic-driven effects, data from homozygous subjects for 
the suspected risk allele (T allele of NADPH oxidase p22phox 242 polymorphism) were
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compared to data from patients carrying at least one copy of the other allele. The effects 
of confounders such as smoking and gender were also assessed.
10.3. RESULTS
The patients’ demographic and clinical characteristics were comparable with those of the 
whole AgP population (see table 10.1 and 6.5).
| AgP PATIENTS (n=27) MEAN
AGE (Mean ± S.D.) 31.6 ± 6.5
FEMALES (percentage) 16(59.3%)
SMOKERS Current smokers 4(14.8% )
(percentage) Non smokers 23 (85.2%)
TEETH AT BASELINE (Mean ± S.D.) 28.3 ±2 .7
NUMBER OF POCKETS > 5 mm 
Mean ± S.D. 63.2 ±38.7
PROBING POCKET DEPTH (mm) 
Mean ± S.D. 4.2 ± 1.2
LIFETIME CUMULATIVE ATTACHMENT LOSS (LCAL) 
(mm)
Mean ± S.D.
4.8 ± 1.6
Table 10.1: Demographic and clinical characteristics o f patients included in the study on superoxide
production
The addition of PMA was followed by a considerable increase in the production of 
superoxide by PMNs. This increase reached its climax in most patients at the first 
reading (after 15 seconds), after which there was a continuous very slow decrease. 
Figures 10.2 and 10.3 show the time patterns of superoxide production after stimulation 
respectively with 1 and 2 pg of PMA. In the x axis, fifteen time points from 0 
(stimulation with PMA) to 5 minutes (300 seconds) are shown. The time points from 0 
to 2 minutes are separated by 15 seconds intervals, while from 2 to 5 minutes the 
intervals are 30 seconds. In the y axis, log- transformed estimated marginal means of Cfi' 
production are shown (with standard errors), as assessed by repeated ANOVA analysis.
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The time patterns of superoxide production were similar for both PMA concentrations, 
but the magnitude of the response was approximately 3x with 2 pg compared to 1 pg.
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Figure 10.2: Average superoxide production (mMol) on all patients after stimulation with 1 pg o f  PMA
up to 5 minutes
Stimulation with 2 micrograms of PMA
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Figure 10.3: Average superoxide production (mMol) on all patients after stimulation with 2 pg o f  PMA
up to 5 minutes
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Repeated ANOVA analysis revealed that smoking and gender did not have a significant 
effect on superoxide production (data not presented). Therefore, these two parameters 
were not included as covariates in the analysis.
Figures 10.4 and 10.5 report the time patterns of O2’ production after stimulation 
respectively with 1 and 2 pg o f PMA when patients are clustered by their NADPH 
oxidase p22phox C242T genotypes. Subjects are divided into T homozygous and C allele 
positive individuals (including heterozygous and C homozygous). No statistically 
significant differences were detected after addition of 1 pg o f PMA for NADPH oxidase 
p22phox C242T genotypes (p= 0.477) (figure 10.4).
Stimulation with 1 microgram of PMA
a>oo©
X
T“
o
2
E,
co
'■5o
3"Oo1-a.a>■oxol_a>Q.
3
</)
4
3
CC-CT (N=22) 
TT (N=5)
T
0 15 30 45 60 75 90 105 120 150 180 210 240 270 300
Time (sec.)
Figure 10.4: Average superoxide production (mMol) on all patients by NADPH genotypes after 
stimulation with 1 pg of PMA up to 5 minutes
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Upon stimulation with 2 pg of PMA, however, the model was statistically significant 
(p<0.001, adjusted R squared = 0.404) and the TT genotype was significantly associated 
with an increase in superoxide production (p<0.001). This increase appeared at the first 
time point after stimulation and remained constant up to the last measurement (5 
minutes).
Stimulation with 2 micrograms of PMA
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Figure 10.5: Average superoxide production (mMol) on all patients by NADPH genotypes after 
stimulation with 1 pg o f PMA up to 5 minutes
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10.4. DISCUSSION
The results observed in this study show that NADPH oxidase p22phox C242T 
polymorphism was associated with superoxide generation from neutrophils in our 
patients. PMNs from T homozygous individuals for the NADPH oxidase polymorphism 
exhibited an increase in the release o f O2 ' after stimulation with 2 pg o f PMA. 
Stimulation with a smaller concentration of PMA (1 pg) did not show any differences.
The observations relative to the NADPH oxidase p22phox C242T polymorphism are in 
agreement with a report from Japanese individuals (Shimo-Nakanishi et al. 2004). They 
observed an increase in PMA-stimulated superoxide production in CT compared to CC 
individuals, suggesting an effect given by the presence o f the T allele. No T 
homozygous subjects were included in their study. In our study, the observed increase in 
superoxide production was linked to T homozygosity, while no difference was present 
between CT and CC individuals. On the other hand, a study conducted on Caucasian 
subjects detected the opposite result (Wyche et al. 2004), showing a reduction in 
superoxide production in T homozygous individuals. These differences in the outcome 
are likely to be due to the different methods used, to the small number of participants 
and maybe to the different types o f patients included. Our methods were similar to those 
described by Shimo-Nakanishi et al. (2004). However, we did not compare basal 
oxidative burst between subjects, but just increases relative to a stable basal level, using 
individual resting values as baselines. Our results lack the inhibitory effect given by the 
use of superoxide dismutase (SOD) on superoxide production. This means we have 
measured the total amount o f superoxide produced by PMNs after stimulation with 
PMA. A percentage of this oxidative burst may be due to other factors (such as 
ascorbate and glutathione) other than NADPH oxidase. However, independently of the 
source, all produced O2’ initiates and promotes a series of reactions which can lead to 
tissue damage. TT individuals in our study had an increase in the total oxidative burst 
upon stimulation with PMA, therefore are likely to be predisposed to more tissue 
damage than the other subjects. Having observed differences between genotypes for the 
whole amount of superoxide produced, it is likely to mean that excluding the effect of
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other oxidative sources will increase the magnitude of the effect on NADPH oxidase 
production.
The p22phox is one of the subunits forming the NADPH oxidase system. As described in 
chapter 7, the C to T mutation at position 242 in the gene coding for the p22phox causes 
an amino acid substitution at position 72 (histidine to tyrosine). This substitution 
involves a potential heme-binding site, which can have as a consequence an increase in 
superoxide production. Moreover, the presence o f the T allele is also supposed to be 
involved in up-regulation of p22phox mRNA and protein (Shimo-Nakanishi et al. 2004). 
It is still not clear whether this polymorphism has a direct effect on NADPH oxidase 
function or is in linkage disequilibrium with a functional SNP elsewhere in the gene. 
However, this is the first study to show an effect of this polymorphism on oxidative 
bursts in patients with Aggressive Periodontitis. This effect was consistent with time but 
was observed only upon a strong stimulation (high concentrations of PMA). It is 
difficult to relate the used concentration of PMA to in vivo reality, as PMA is an 
artificial system not naturally present in inflamed periodontal tissues. In the case-control 
study described in chapter 6 we observed an increase in the prevalence of carriage of the 
T allele in AgP patients compared to controls. T homozygous subjects had a particularly 
high frequency in the GAgP group, and were found to have more severe disease (see 
chapter 7). The finding of increased oxidative burst in T homozygous subjects confirms 
that the pathogenic mechanism of tissue damage in these subjects is likely to be 
mediated by a hyper activation of neutrophils upon stimulation.
Further studies with larger sample sizes and including also healthy subjects as controls 
are needed to confirm the role of this polymorphism on neutrophil function.
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CHAPTER 11
11.GENERAL DISCUSSIONS
The series of studies presented in this PhD thesis aimed at detecting genetic factors 
associated with Aggressive Periodontitis. Despite the efforts made in recent years, which 
led to the conclusion of a strong role of genetics in AgP onset, the genetic nature o f AgP 
is still somehow mysterious. Despite numerous efforts and dozens of genetic 
polymorphisms being studied, none have been singled out as real risk factors for AgP 
(Kinane et al. 2005). This PhD provided a complete analysis o f the largest group o f AgP 
patients so far described in the literature. Stringent inclusion criteria and the dedication 
of years o f research resulted in the identification of 224 subjects suffering from a disease 
with severe signs of periodontal attachment and bone loss at early age, which we now 
call Aggressive Periodontitis (Armitage 1999). We applied stringent inclusion criteria, 
which allowed us to select a population of subjects suffering from very advanced disease 
at an early age, highlighted by the numbers of sites affected and the average age o f the 
subjects (see table 5.1 and 5.2 for description o f clinical parameters). Many o f these 
subjects were ‘dentally-crippled’ because through this aggressive disease they had lost 
or were about to lose several teeth at a very early age, with substantial negative 
repercussions on their lives. The severity and apparent lack of a clear aetiologic factor 
led years ago to the understanding of this disease as a degenerative condition of the 
periodontium (Baer et al. 1971). However, we now know that Aggressive Periodontitis 
is an infectious disease, due to microbes present in the bacterial plaque, which take 
advantage of the unique anatomy of the periodontium to invade the host. The teeth are 
the only mineralised tissues directly in contact with both the outside environment (oral 
cavity) and the most inner tissue of the human body (the bone). This atypical anatomic 
structure makes the tissues surrounding the teeth (the periodontium) an attractive way 
for pathogenic bacteria to colonize and develop in the human host. While this infectious 
process, which starts from the crevice between teeth and gingival epithelium, takes 
decades to cause minimal damage in most of the human population, a subset of subjects 
(those suffering from AgP) show a dramatic predisposition to it. Therefore, they exhibit 
considerable periodontal attachment loss and bone damage which lead to tooth mobility 
and eventually tooth exfoliation. This process is accompanied by the development of an 
inflammatory infiltrate in the periodontal crevice, which is probably to be held
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responsible for the characteristic tissue damage of AgP (Gemmell et al. 2002, Bosshardt 
& Lang 2005).
This PhD consisted of a study on the effect of several genetic polymorphisms (SNPs) 
regulating the host response on the Aggressive Periodontitis (AgP) trait. A specific panel 
of SNPs was selected based on the literature and on their possible functional importance. 
The relation between these SNPs and AgP was investigated in a case-control association 
study (chapter 6). The associations between the studied SNPs and common features of 
AgP, as defined by the current classification (see chapter 1) were then examined: disease 
severity (chapter 7), familial aggregation (chapter 8), presence o f known 
periodontopathogenic bacteria (chapter 9) and phagocyte abnormalities (chapter 10). 
Most previous association studies on AgP included relatively small numbers o f subjects 
and investigated one or two SNPs (Kinane et al. 1999a, Kobayashi et al. 2000a). We 
included in this study 224 AgP patients and 231 controls, and investigated a large range 
of SNPs (13). This gives the advantage of being able to look at relative effects and 
interactions between different SNPs; on the other hand, because of the multiple testing, 
looking at many SNPs has an effect on the confidence of the observed results (Altman 
1991). The conclusions drawn from the studies described in the previous chapters will 
be discussed as a whole in this chapter, and related to the literature evidence. First of all, 
each of the different SNPs will be discussed separately, and then an overview and 
general discussion and conclusions will be presented.
11.1. FcRa -324 polymorphism
The FcRa gene codes for Fc receptors a  (CD89), present on PMN, 
monocytes/macrophages and eosinophils. These receptors bind IgA coated on the 
surface of invading bacteria, and mediate several immunologic defence processes such 
as phagocytosis, antibody-dependent cell-mediated cytotoxicity, and release of 
inflammatory mediators (Monteiro & van de Winkel 2003). IgA - mediated phagocytosis 
in periodontitis is thought to be more effective than that mediated by IgG (Mazengera & 
Kerr 1990) and PMN in the apical portion of periodontal pockets express a large number 
o f Fca recptors for interaction with IgA- coated bacteria (Yuan et al. 2000). An A-G
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substitution at position 324 in the Fca gene, 114 base pairs upstream of the transcriptory 
region, is suspected of having a bearing on the activity of the receptors. In particular, 
Kaneko et al. (2004) observed decreased phagocytosis of Actinobacillus 
Actinomycetemcomitans in vitro in PMN from subjects homozygous for the rare allele 
(A). The A homozygous genotype was also increased in prevalence in Japanese AgP 
patients compared with controls (Kaneko et al. 2004). In our sample, we observed a 
slightly increased carriage of the A allele and of A homozygosity in Caucasians and 
Blacks with AgP compared with controls (see table 6.10). Furthermore, A homozygous 
AgP patients had more severe disease than heterozygous individuals (see table 7.1), 
while no differences were noted for presence of periodontopathogenic bacteria. Among 
relatives o f allele A- carrying AgP a slight increase in AgP prevalence was found (see 
table 8.5). Taking all these findings as a whole, a role for the A allele of this SNP in the 
expression of the AgP phenotype seems to emerge. The 324 polymorphism may be in 
linkage disequilibrium with a predisposing gene, whose effects translate into a less 
effective PMN response. Therefore, further studies should aim at detecting this supposed 
predisposing polymorphism and elucidate its functions, and studies on larger samples 
should be conducted before we can draw definitive conclusions on the susceptibility 
effect of this SNP towards AgP.
11.2. FcyR polymorphisms
The Fc y receptors include a family o f receptors for IgG. These immunoglobulins play 
an important role in the binding of periodontopathogenic bacteria and have been found 
at increased levels in diseased periodontium (Tew et al. 1985). IgG-bound bacteria are 
recognized by Fey receptors, stimulating a series of reactions aimed at eliminating the 
invading parasites (van Sorge et al. 2003). Specific Fey receptors exist for different 
classes of IgG: FcyRI (CD64), FcyRII (CD32, subdivided in Ha and lib), FcyRIII 
(CD 16, subdivided in Ilia and Illb). FcyRI are expressed in myeloid cells and 
neutrophils, FcyRIIa in myeloid cells, neutrophils, platelets and T cells, FcyRIIb in B 
cells, monocytes, macrophages and neutrophils, FcyRIII in neutrophils and eosinophils. 
All these classes have different affinities to IgG, diverse signal transduction activity and 
are present in different cells. Their genes have a common location on the long arm of
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chromosome 1. SNPs in these genes have been associated with influence on receptor 
function, which might predispose to autoimmune and infectious diseases. The analysis 
of five different FcyR SNPs in this study revealed considerable linkage disequilibrium 
between them. In other words, the interpretation of the results relative to association 
with AgP in our study cannot leave aside the relationship between all these 
polymorphisms and the fact that they are closely associated with each other. Moreover, 
there are strong suggestions for an interplay and overlap in the functions of Fey 
receptors. FcyRIIlb, for example, lacks intrinsic signalling capacity, and is likely to 
interact with FcyRI la to determine leukocyte responses. Indeed, even a synergistic 
activity o f these two receptor types has been hypothesized (van der Pol & van de Winkel 
1998). In our sample, a possible role emerged for FcyRIIa R/H and FcyRIIlb NA 
polymorphisms in susceptibility to AgP.
A G to A nucleotide substitution at position 494 in the gene coding for FcyRIIa 
determines an arginine (R) to histidine (H) amino acid change in a IgG- ligand binding 
domain. The presence of this arginine has been shown to reduce ligand interaction. Since 
interaction with IgG2 depends almost entirely on FcyRIIa activity, R homozygosity 
results in deficient phagocytosis o f IgG2- opsonized particles (van Sorge et al. 2003). In 
our group of Caucasians, we found an increase of R homozygosity among patients 
(especially GAgP) (see tables 6.10 and 6.14). R homozygous subjects also had increased 
detection rates of Actinobacillus actinomycetemcomitans in their periodontal pockets 
(see table 9.2). However, whilst showing interesting trends, neither of these results 
reached statistical significance. The most striking result with this polymorphism was in 
relation to familial aggregation: relatives of R homozygous subjects were found to have 
an increased risk of having AgP compared to H- carrying individuals (see table 8.5). 
Taken together, these results suggest that R homozygosity may have a predisposing 
effect on AgP, probably through an impaired bactericidal activity versus 
A.actinomycetemcomitans. We can speculate that relatives o f R homozygous subjects, 
being more likely to be R homozygous themselves, have an increased risk of having 
AgP probably through the same mechanism of increased susceptibility to 
periodontopathogenic bacteria. It is interesting to note how most previous studies
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detected no associations between this polymorphism and periodontitis (Colombo et al. 
1998, Kobayashi et al. 2000a, Fu et al. 2002), while some studies showed increased risk 
for disease onset and severity linked with the H allele, mainly in Caucasians with CP 
(Loos et al. 2003, Yamamoto et al. 2004). Generalising our results to other ethnic groups 
is complicated if  not impossible, considering that in our sample of AgP Black patients 
the opposite tendency towards increased H homozygosis was noted.
A polymorphism in the FcyRIIlb gene determines four amino acid substitutions, 
responsible for allelic differences in receptor glycosylation. The two deriving allotypes 
are called NA (neutrophil antigen) 1 and 2. The NA2 allotype has been shown to be less 
effective in binding IgG3 and phagocytosing IgG3-coated particles (Salmon et al. 1990). 
A decrease in ability to phagocytose P.gingivalis has been shown more recently 
(Kobayashi et al. 2000b). A C-A substitution located at nucleotide 266 in the same gene 
determines an amino acid change responsible for the SH antigen (Bux et al. 1997), in 
linkage disequilibrium with the NA allotype (all SH positive individuals are also NA2 
positive). In our sample, the NA1 allotype showed some evidence of association with the 
GAgP trait (see table 6.14) and increased detection of periodontopathogenic bacteria 
(see table 9.2). This is in conflict with previous studies, where the NA2 antigen was 
associated with AgP (Kobayashi et al. 2000a, Fu et al. 2002), or where no association 
with AgP or CP was detected (Colombo et al. 1998, Meisel et al. 2001, Chung et al. 
2003). Hence, this study supports the theory of the NA1 allotype as a genotype 
predisposing to GAgP, especially in Caucasians. A possible mechanism of action 
involves an excessive superoxide production, which would be responsible for the 
periodontal tissue damage. This would also explain why the NA1/NA1 genotype was 
associated with detection of A.actinomycetemcomitans in our sample. Intuitively, based 
on its supposed reduced phagocytic activity, we would expect the NA2 to be associated 
with increased bacterial presence in the periodontal pockets. However, more NA1 than 
NA2 GAgP subject are positive to A.a., probably because the persistence of this 
bacterial insult in these subjects stimulates an excessive neutrophil response and leads to 
AgP. Therefore, NA1 and A.a. cluster in the same group of AgP patients. In fact, among 
A.actinomycetemcomitans positive individuals, slightly increased counts of A.a. were
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detected in NA2 patients (see appendix XVIII), suggesting that when A.a. infects the 
periodontal pockets, the increased effiency of NA1 individuals may be able to improve 
phagocytosis and limit the numbers of this bacterium, but at the same time stimulates 
host defensive tissue-damaging reactions leading to AgP. The role o f the SH antigen 
also has to be investigated further. This was the first study to report frequencies o f this 
polymorphism in a periodontitis population. Despite the fact that SH homozygous 
individuals were found only among AgP patients, their number was too small to draw 
any conclusions. However, some of the observed results related to the NA2 allotype in 
other studies on non Caucasian population may be influenced by the potential effects of 
this allotype (Koene et al. 1998). Further studies about FcyRIIIb NA polymorphism have 
to include haplotype analysis including the Ha and lib SH loci, in order to clarify 
possible mechanisms of action.
Fc-y lib receptors are present in B cells, monocytes, macrophages, and neutrophils 
(Ravetch & Bolland 2001). Since they are involved in IgG interactions and in the 
regulation of Fc-y R inflammatory responses, they have been studied in relation to 
periodontal disease. Yasuda et al. (2003) identified the T allele at position 695 in the Fc- 
y RHb gene as a risk indicator for AgP in Japanese individuals. No association was 
noted in our study between this polymorphism at position 695 (Yasuda et al. 2003) and 
the presence or severity of AgP, presence of periodontopathogens and familiarity of 
AgP. Furthermore, significant linkage disequilibrium was noted with the Fc-yRIIIb NA 
locus, which might have caused a positive association in Yasuda’s study.
A similar LD phenomenon may be at the basis of the supposed importance of a 559 SNP 
in the Fc-yRIIIa gene. This polymorphism has been studied in relation to periodontitis, 
because o f the higher affinity of the V allotype (determined by the presence of allele G) 
compared to the F allotype, for IgG 1, 3 and 4. In a study of Caucasians, Loos et al. 
(2003) associated the V allele to periodontitis risk, while Meisel et al. (2001) associated 
it with disease severity. We observed decreased detection of periodontopathogenic 
bacteria in the pockets of VV homozygous subjects (see table 9.2), while no difference 
was observed in terms of polymorphism distribution in the whole group of patients and
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controls. Interestingly, however, Black AgP patients had an increased prevalence o f  V 
homozygosity compared with Black controls (see table 6.10). Any conclusion about the 
possible effect of this polymorphism has to take into account the very strong linkage 
disequilibrium shown with the Fc-ylla HR and Fc-yR Illb polymorphisms, which might 
influence the magnitude of Fc-yR Ilia disease-association (van Sorge et al. 2003). If an 
effect on disease susceptibility exists, it is at best very limited and probably acting just in 
some populations.
11.3. Formy 1-peptide receptors (FPR) polymorphisms
The constant finding of reduced chemotaxis in patients suffering from AgP (Van Dyke 
et al. 1985) has led to the search for a genetic reason for it. The main culprit is the gene 
coding the formyl peptide receptors (FPR), which are expressed in PMN and recognize 
and bind N-formyl peptide, a chemotactic factor derived from human mitochondrial 
proteins and bacterial products. Multiple domains of the FPR seem to be required for 
high-affinity ligand binding. FPR is encoded by the FPR1 gene, located on chromosome 
19. We screened 31 LAgP patients and 28 controls, by DNA sequencing for a region of 
the FPR1 gene encompassing all the SNPs described in the periodontal literature. Our 
results confirm that the associations reported by Gwinn et al. (1999) were probably due 
to population stratification and that the polymorphisms at position 329, 378 and 306, 
cannot be realistic markers o f disease because o f extreme rarity of the uncommon allele. 
Three out o f the other SNPs described by Zhang et al. (2003) appeared to have 
promising relationships with the AgP trait and were analyzed on all patients.
The 301 G-C polymorphism determines a substitution of a valine with a lysine in a site 
not known to be important for ligand affinity. We detected a slight, not statistically 
significant, increase in the prevalence of the G allele in patients compared with controls 
(see table 6.10). In addition, G homozygous AgP patients had more severe disease when 
compared with C homozygous patients (see table 7.2).
The allele A at nucleotide 546, and A homozygosity were increased in prevalence in the 
patient group (see table 6.10). A homozygous subjects showed a tendency for increased
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attachment loss (see appendix XVII) and for increased detection o f Porphyromonas 
gingivalis (see table 9.2). None of these observations reached statistical significance, but 
showed a consistent trend. Functionally, however, there is no reason to believe that this 
polymorphism is a real marker of disease, since it is synonymous, and does not change 
the coded protein. The observed tendencies may be the reflection of linkage 
disequilibrium with a functional gene and stimulates further research in order to detect 
the functional gene.
The 568 polymorphism is determined by a A-T nucleotide substitution, resulting in a 
change from a basic to an acid amino acid (Arginine to Tripsine) at codon 190 (Zhang et 
al. 2003) in the second extracellular loop of the receptor, believed to have functional 
relevance on ligand affinity. Zhang et al. (2003) detected an increased prevalence o f A 
homozygosity in African Americans with LAgP. On the other hand, we found the T 
allele increased in prevalence in Black patients (see table 6.10), although this did not 
reach statistical significance. Subjects with the T allele showed slight increases in the 
detection of all studied bacteria (see table 9.2).
Considering the close genetic linkage between FPR polymorphisms, we cannot exclude 
the possibility that the tendencies for association seen in this study may reflect a real 
effect on disease susceptibility. Speculation points towards a minor effect linked to the 
568 polymorphism, mainly in Blacks, but conflicting literature evidence and lack of a 
large sample of Black AgP subjects, leave doubts about the interpretation of these data. 
The real polymorphism able to modify AgP susceptibility may lie somewhere else in the 
gene, and may be just in LD with the studied polymorphisms.
11.4. NADPH p22phox polymorphism
One of the main findings of this PhD is the effect of this polymorphism on AgP 
phenotype. A C-T substitution at position 242 in the CYBA gene, coding for the p22phox 
subunit of the NADPH oxidase has recently been identified and studied, with conflicting 
results, in relation to cardiovascular disease susceptibility (Inoue et al. 1998). This was 
the first study to aim at investigating a possible effect of this SNP on AgP risk. In our
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sample the T allele was associated with the AgP phenotype, with particular enrichment 
of T homozygosity in GAgP Caucasians (see tables 6.10 and 6.14). T homozygosity was 
also associated with increased disease severity in GAgP (see table 7.3) and with 
increased release of superoxide from neutrophils (see figure 10.5). The family study 
revealed a slight increase in family predisposition in T allele carriers (see table 9.2). 
These results taken together indicate that the C242T p22phox polymorphism is a novel 
genetic risk factor for Aggressive Periodontitis. This is a functional polymorphism, 
causing a histidine to tyrosine change at position 72 in the p22phox protein. This 
substitution involves a potential haem-binding site, which can have an effect on 
superoxide production. Consistent with data from Shimo-Nakanishi et al. (2004), our 
results support the hypothesis that T homozygosity increases the release of superoxide, 
determining a cascade of oxygen metabolites and the activation of proteases. This leads 
to increased tissue damage on the periodontium, where the effect of the neutrophil in 
response to periodontal bacteria is particularly important. Therefore, if  the bacterial 
stimulus is not eliminated, the excessive neutrophil stimulation becomes chronic and it 
leads to a constant release of toxic metabolites and to continuous chronic damage. This 
response is probably hyperactivated in T positive subjects and even more so in TT 
homozygous subjects. From our data, it seems that the T allele is important in 
determining disease susceptibility and, among AgP patients, having two copies of this 
allele increases the susceptibility to more severe disease.
However, the effect of the increased superoxide production may not be due only to 
neutrophils, but also to osteoclasts, which use a NADPH oxidase system to produce 
ROS, thought to be important in bone resorption (Yang et al. 2001). Osteoclasts have 
been shown to secrete hydrogen ions, proteinases and supeoxide in order to excavate a 
resorption pit or lacuna in the bone surface. Superoxide may stimulate bone resorption 
by activating collagenases and by participating in fragmentation of matrix proteins. The 
p22phox subunit has been shown to be indispensable in the osteoclastic Nox 4 superoxide 
production (Yang et al. 2004). Therefore, we can hypothesise that the combined 
hyperactivity of neutrophils and osteoclasts linked with the T allele or T homozygosity 
interact to predispose to periodontal destruction and, as a consequence, to AgP.
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Neutrophils and osteoclasts can play a role in different steps of disease pathogenesis: 
while neutrophils-derived ROS may be more important in the initiation o f the disease, 
osteoclasts-driven superoxide production may be involved in the progression and in the 
chronic damage.
The C242T p22phox polymorphism has also been linked with increased lipid oxidation, 
which may have importance as a risk factor for cardiovascular disease. Furthermore, 
Nakano et al. (2003) found that circulating concentrations of HDL were 1.5-fold lower 
and oxidized LDL were higher in diabetes patients with T allele compared to CC 
homozygous subjects. Considering the hyper inflammatory metabolic status o f severe 
periodontitis patients (Nishimura & Murayama 2003, D’Aiuto et al. 2005), the possible 
role of C242T p22phox polymorphism as a link between periodontitis and cardiovascular 
disease deserves further attention and investigation.
11.5. Interleukin-6 polymorphism
A C-G polymorphism at position -174 in the promoter region o f the Interleukin-6 gene 
has been linked to regulation o f IL-6 activity (Fishman et al. 1998). This has been 
implicated in several diseases and conditions, such as juvenile rheumatoid arthritis, 
systemic arthritis and cardiovascular disease (Fife at al. 2005). The effect seems to be 
mediated by an excessive IL-6 release linked with G homozygosity, which would 
amplify the pro-inflammatory functions of this cytokine. Among other functions, IL-6 
stimulates the hepatic acute phase response to infection and injury, stimulates the 
osteoclasts, activates macrophages, neutrophils and T cells along with the growth and 
differentiation of B cells (Lotz et al. 1988, Revel 1989). IL-6 knockout mice (Terry et al. 
2000) have a compromised response to infections and tissue damage. IL-6 production is 
induced by a number of inflammatory stimuli such as IL-1, platelet-derived growth 
factor, tumor necrosis factor a  (TNF-a), bacterial products such as endotoxin, and viral 
infections (Terry et al. 2000). Monocytes/macrophages, fibroblasts, endothelial cells, 
adipocytes, T cells and mast cells are among the cells able to produce IL-6. The presence 
and supposed importance of IL-6 in periodontal disease, especially in stimulating bone 
resorption (Ota et al. 1999, Todhunter et al. 2005), has led to an interest in this -174
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polymorphism. G homozygosity was suspected as a risk factor for periodontitis in a 
Brazilian population (Trevilatto et al. 2003). The results presented in the context o f this 
PhD show that -174 G homozygous was a risk indicator for AgP in our population, with 
a very strong relation with LAgP (see table 6.10 and 6.16). Moreover, G homozygous 
subjects had increased detection rates of periodontopathogenic bacteria (see table 9.2) 
and increased familial aggregation of AgP (see table 8.5). These findings strongly 
support a genuine role for this polymorphism in inducing AgP. Given the lack of robust 
data and the conflicting evidence regarding the effect of this polymorphism on IL-6 
concentrations in serum (Fishman et al. 1998, Endler et al. 2004), we can only speculate 
that the GG genotype is associated with an increased IL-6 release and function in the 
periodontal tissues. G homozygous subjects might have an increased IL-6 function and 
osteoclastic activity. This would justify the increased detection of periodontopathogenic 
bacteria, whose presence, coupled with the ‘ hyperstimulated ’ genotype, may predispose 
to an excessive and continuous IL-6 production with consequent tissue damage. 
Alternatively, G homozygosity, for some reason yet to be made clear, may actually 
decrease the ability to face the microbial challenge and therefore predispose to AgP. 
However, given the similar observations on the FcyRIIIb NA polymorphism and 
bacterial detection, the first supposed mechanism (site-specific increased IL-6 activity) 
seems a more feasible explanation. As observed for the FcyRIIa genotype, the increased 
familial aggregation may reflect the increased likelihood of relatives o f G homozygous 
individuals to be homozygous themselves, and to have a similar disease pathogenesis. 
Moreover, considering that relatives are also more likely to share the same subgingival 
micro flora (Petit et al. 1994, Haubek et al. 2005), the pathogenic combination of IL-6 G 
homozygosity and periodontopathogenic bacteria seems to offer a very reasonable 
explanation for the pathogenic pathway leading to AgP in our probands and relatives.
11.6. Vitamin D receptor polymorphism
We examined in our sample Taq-I, one of the known polymorphism of the VDR gene. 
VDR is a nuclear receptor, and modulates gene expression once complexed with the 
active form of vitamin D. Because of its role in bone metabolism, immune modulation, 
regulation of cell growth, differentiation and induction of apoptosis o f a variety of cells,
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such as osteoblasts (Dusso et al. 2005), it has been suspected of playing a role in 
periodontal disease pathogenesis. However, conflicting results arise from studies on the 
relationship between TaqI, BsmI and FokI polymorphisms of the VDR gene and 
periodontal disease (Hennig et al. 1999, Yoshihara et al. 2001, Tachi et al. 2003, Nibali 
et al. 2005). Results from this study (see figures 6.1 and 6.2) confirm the importance of 
the interaction between Taq-I polymorphism and smoking in the pathogenesis of 
periodontitis, that we had described previously (Nibali et al. 2005). Due to a possible 
common mechanism o f action on immune modulation or bone metabolism, this VDR 
polymorphism and smoking seem to have an additive effect in increasing the AgP 
burden. However, functional studies are needed to explore the mechanisms of this 
association, considering that the Taq-I polymorphism is synonymous, and does not 
change the coded amino acid. Linkage disequilibrium with a functional polymorphism 
somewhere else in the gene is suspected. No effects on carriage o f periodontopathogenic 
bacteria and familial aggregation were detected.
11.7. Tumor necrosis factor a polymorphism
TNF-a production has been described as being dependent upon a polymorphism in the 
TNF- a  gene at nucleotide -308. Higher transcriptional levels are associated with the 
presence of allele A rather than G (Wilson et al. 1997) and supposed to contribute to the 
periodontitis burden. No evidence for any effect of this polymorphism on AgP risk has 
been produced so far (Kinane et al. 1999a, Soga et al. 2003). No associations were noted 
in our study with presence of AgP, disease severity, detection of periodontopathogenic 
bacteria and familial aggregation.
204
11.8. Overall conclusions
We can summarise the results presented in the different chapters o f this study as follows:
• Smoking, age and male gender are associated with more advanced disease
• Periodontal lesions in AgP tend to affect more molars and maxillary teeth
• The current diagnosis based on the number of affected teeth is probably not 
accurate in distinguishing localised and generalised cases
• IL-6 -174 GG genotype and carriage of NADPH oxidase p22phox 242 T allele are 
associated with AgP
• FcyRIIIb NA1/NA1 genotype is associated with GAgP
• FcyR haplotypes are associated with AgP in Blacks
• The vitamin D receptor Taq-I polymorphism is associated with AgP in smokers
• FcaR, NADPH oxidase p22phox 242 TT and FPR 301 GG genotypes showed 
tendencies for association with disease severity in GAgP
• 10% of examined first-degree blood relatives of AgP patients (at least 4.5% of 
the total relatives) suffer from AgP
• FcyRIIa RR genotype is associated with familial aggregation of AgP
• FcyR haplotypes and IL-6 -174 GG genotype are associated with detection of 
periodontopathogenic bacteria
• NADPH oxidase p22phox 242 TT genotype is associated with increased 
neutrophil oxidative burst.
The overall results of this study point towards the importance of genetic polymorphisms 
regulating the immune response to periodontopathogenic bacteria in the onset of AgP. In 
particular, genotypes which are believed to indicate an increased activity of neutrophils 
(NADPH oxidase p22phox and FcyR) and cytokines (IL-6) were enriched in AgP patients 
compared with controls. This supports the hypothesis that it is not the bacteria 
themselves, but the host reactions triggered by bacteria that causes the classical tissue 
damages of AgP (Gemmell et al. 2002). Both the T allele of NADPH oxidase p22pll0x 
242 polymorphism and the NA1 allele of FcyRIIIb polymorphism, which were enriched 
in patients, have been linked with increased release of superoxide from neutrophils.
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Kobayashi et al. (2000b) showed increased phagocytosis o f P.gingivalis in PMN from 
NA1 positive individuals, while Shimo-Nakanishi et al. (2004) found an increase in 
superoxide production in T allele positive subjects. This increase was also observed in 
the AgP patients included in our study: T homozygous patients showed increased 
oxidative burst upon stimulation with 2 rjg of PMA. Therefore, it seems that subjects 
whose neutrophils are hyperactive are more prone to develop AgP. This is consistent 
with the hypotheses postulated by Van Dyke et al. (2003), who supports the idea that 
hyperactive neutrophils may determine AgP damage. It is known that impaired PMN 
function, characteristic of diseases such as cyclic neutropenia or Chediak-Higashi 
syndrome have as a consequence increased susceptibility to infections and one of the 
sites affected is the periodontium. Patients affected by these diseases present with severe 
periodontal destruction at a very early age and healthy periodontal conditions are very 
difficult to achieve and maintain in such cases. Hence, the concept arose that AgP could 
be caused by more subtle PMN defects and impairments, whose only manifestation was 
at periodontal level. However, research into the function of neutrophils o f AgP subjects 
has produced evidence that PMN from these subjects are not hypo- but hyper-active, and 
an excessive activity, coupled with the presence of specific microbes, as well an 
impaired activity, may lead to periodontal tissues damage (Kantarci et al. 2003). Several 
investigators have demonstrated an amplified PMN superoxide production in AgP 
patients (Van Dyke et al. 1985, Leino et al. 1994) compared with healthy subjects. 
Nonetheless, the mechanisms leading to this hyperactivity remain unknown. The data 
presented in this PhD thesis suggest that the host genetic background leads to this 
hyperactivity. In particular, PMN hyperactivation may be mediated by NADPH oxidase 
p22phox and FcyR polymorphisms. This excessive PMN activity may be balanced by 
feedback mechanisms in normal conditions. On the other hand, bacteria such as 
A.actinomycetemcomitans in the periodontal crevice stimulate PMN recruitment and 
migration towards the periodontium, where they act as the first line o f defence against 
the invading organisms. Through the presence o f local factors, particularly virulent and 
leukotoxic bacterial strains, or other underlying genetic factors, the resolution of the 
infection may not be achieved. In this event, the constant presence of A. 
actinomycetemcomitans induces the establishment of a chronic inflammatory process,
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with the involvement of the immune system and the production of antibodies. As a 
result, PMN of these subjects will be continuously called into the inflamed area to exert 
their defensive functions such as phagocytosis and oxidative burst. It is known that the 
superoxide anion (O2 ) is released both inside PMN and outside, leading to possible 
tissue damage through a cascade of oxidative species and the stimulation o f the release 
of proteases (Rada et al. 2004). In PMN carriers of the p22phox T allele, the potential to 
cause tissue damage may be augmented, because this polymorphism codes for an amino 
acid in a haem-binding region of the NADPH oxidase. Therefore, in these individuals 
the risk of evolving from a simple gingival inflammation (gingivitis) to a more serious 
irreversible periodontal destruction is increased. One of the stimulatory mechanisms for 
superoxide production comes from the recognition of the presence of bacteria. In PMN 
this happens, among other mechanisms, thanks to a family o f transmembranous 
receptors, called Fc receptors, which recognize bacteria bound to Immunoglobulins 
(IgG). Once the recognition has taken place, bacteria are internalized in the phagocytes 
and the killing mechanism starts. Polymorphisms in the genes encoding for these 
receptors determine different receptor abilities and therefore different signal 
transmission. Individuals with the NA1 allotype for FcyRIIIb express a glycosylation 
pattern in their receptors which increases the ability to recognize and phagocytose 
bacteria, including the periodontopathogenic ones (van Sorge et al. 2003). One of the 
increased activities in NA1 subjects is again the oxidative burst, with consequent risk of 
tissue damage. Among the Caucasian subjects described in this thesis, having at least 
one copy of the p22phox T allele gave a relative risk of about 2 to have GAgP; similarly, 
the risk o f having GAgP for NA1 homozygous individuals was equal to 2. The relative 
risk for subjects with both these risk genotypes to have GAgP was equal to 34, which 
suggests an additive effect due to a common mechanism of action. It is worthy to 
mention that the measure of superoxide production is just an indicative measure of a 
hyperactive status of PMN and may not be the only pathway through which these 
polymorphisms predispose to AgP. Equally important to mention is that the p22phox is a 
fundamental component of the NADPH oxidase in osteoclasts as well, and it has been 
shown to be important in bone resorption. Hence, together with the increased PMN 
activity, osteoclasts have the potential to cause more tissue damage in T carriers, and
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this mechanism might be responsible for the continuation of the tissue-damaging effect 
and lead to a more severe bone loss in subjects with this polymorphism. In fact, T 
homozygous GAgP Caucasian patients had considerably more advanced attachment loss 
(1.2 mm more than C allele carriers, see paragraph 7.3), which is likely to be associated 
with alveolar bone loss.
This scenario describing a primed, ‘aggressive’ PMN defensive phenotype becomes 
even more suggestive when the other important finding of this study is considered: the 
role of Interleukin-6. The cytokine network has a determinant function in the 
coordination o f the inflammatory process, and IL-6 is one o f its pro-inflammatory 
players. Among IL-6 activities, bone resorption and neutrophil stimulation stand out. 
The finding that G homozygous individuals for the -174 polymorphism had increased 
risk of having AgP in our sample, especially the Localised form, and also had more 
A.actinomycetemcomitans detected and more relatives affected by AgP, leads to 
speculation about its pathogenic activity. The particular enrichment of G homozygosity 
in LAgP suggests that the effect of this polymorphism is particularly linked with 
A.actinomycetemcomitans, the bacterium most consistently associated with LAgP 
(Mombelli et al. 2002). This is indeed confirmed by the findings from the family study 
presented in chapter 8, which shows that siblings, who share the same genetic 
background and most likely a similar bacterial microflora (Zambon et al. 1983, Petit et 
al. 1994, Haubek et al. 2005), end up having a similar disease. As observed in relation to 
the neutrophil polymorphisms, a possible explanation is that the presence of certain 
bacteria such as A.actinomycetemcomitans in the periodontium of G homozygous 
subjects leads to the establishment of a chronic inflammatory lesion, which results in an 
enhanced and rapid bone resorption and AgP onset at an early age. Since we have 
evidence to say that A.a. stimulates gingival fibroblast to produce IL-6 (Belibasakis et al. 
2005), we can speculate that in G homozygous subjects, this increase brings an 
excessive tissue-damaging inflammatory response mediated by fibroblasts and/or other 
cell types (including PMN). This PhD thesis therefore shifts the attention of periodontal 
cytokine research onto the role of IL-6, which could reveal much more functional 
significance than most of the other cytokines extensively studied so far. New research
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should be designed to study the effect of IL-6 genotypes on the presence o f 
periodontopathogenic bacteria, and emphasis has to be placed on the role IL-6 genetic 
haplotype may play in periodontal pathogenesis. As a matter o f fact, different research 
groups have already pointed out the importance of haplotype analysis in association 
studies for other diseases, especially with regards to IL-6 (Terry et al. 2000, Fife et al. 
2005). Figure 11.1 reports a schematic diagram of the complex interactions that may 
exist between Interleukin-6, NADPH oxidase and Fc receptors of neutrophils and 
periodontopathogenic bacteria. These interactions form the basis of the excessive 
response seen in AgP, especially with regard to the effect on bone resorption.
The hypothesis regarding the ‘aggressive’ status of the host response in AgP patients is 
however complicated by some other findings of this study. The results relative to the 
FcyRIIa polymorphism point towards the ‘impaired’ response theory, because R 
homozygous individuals were more common among patients and, similar to the IL-6 
polymorphism, they had more bacteria detected and more relatives affected. Since R 
homozygosity has been shown to confer reduced ability to recognize and phagocytose 
IgG2-opsonized particles (van Sorge et al. 2003), it looks in this case as though not 
being able to face the bacterial challenge can also result in increased disease 
predisposition. This is of course plausible, if we consider that FcyRIIa are the only 
receptors able to bind IgG2, which are the predominant Immunoglobulins in the 
periodontium. An impaired function of these receptors probably has a more evident 
repercussion on the disease risk than reduced function of the FcyRIIIb might have. 
Furthermore, FcyRIIIb are the most numerous receptors expressed in PMN, so they may 
have more potential than others to stimulate tissue damage. Moreover, in certain 
populations other hypoactive genotypes, such as FcyRIIIb NA2/NA2 or FcyRIIIa FF 
have been associated with periodontitis (Loos et al. 2005). In our sample, for example, a 
supposedly hypoactive genotype (Kaneko et al. 2004), FcaR -324 A homozygosity, 
showed a tendency towards increased risk o f AgP. Moreover, in the Black 
subpopulations, FcyRIIIb NA2 homozygosity was enriched in patients. In general, a 
consistent difference was noted between Caucasians and Blacks: among Caucasians, 
FcyRIIa R and FcyRIIIb NA1 alleles were more frequent in patients, whilst the opposite
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was observed in the Black subgroup, which is more in agreement with the previous 
literature, predominantly based in Black and Japanese populations (Loos et al. 2005).
Interleukin-6
Produce
IL-6
Stimulate IL-6 
production (Belibasakis e 
al. 2005, Bodet et al. 2005)
Protective role in 
response to infections 
(e.g. E.coli) (Dalrymple et 
al. 1996)
Periodontopathogenic 
bacteria (A.a., P.g.)
Induces 
neutrophilia during 
infections 
Increases PMN 
activity (Borish et Cleave Fc receptors 
Inhibit PMN activity 
(Wilton et al. 1990)
Phagocytosis and 
killing through 
oxidative and non 
oxidative 
pathways (Rada et 
al. 2004)
Neutrophils
Figure 11.1 Relationships between IL-6, PMN and periodontopathogenic bacteria, with a potential role
on periodontal disease pathogenesis.
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Therefore, the impression is that two completely diverse pathways may lead to AgP: one 
characterized by the primed or ‘aggressive’ genotype, with hyper activation of the host 
response, and another one characterized by hypo functional (‘impaired’) genotypes. 
Probably they can both predispose to AgP, the first by mounting an excessive chronic 
inflammatory response (this seems to be the most common pathway), the second by 
being more prone to bacterial toxic products. These two pathways may be characteristic 
of different populations (the primed genotype seems to fit better for Caucasians) or 
could indeed coexist in the same subpopulations or even in the same subject. As a matter 
of fact, paradoxically both Fca A and G homozygous subjects, and Fcylla H and R 
homozygous subjects had more advanced disease compared with heterozygous subjects 
for the same polymorphisms. Both pathways converge to the hypothesis that AgP 
originates from an inability of the host to resolve the inflammatory processes triggered 
by the presence of bacteria (Van Dyke et al. 2003). This inability has genetic reasons, 
either because the host is not able to eliminate the insulting bacteria, or because it 
excessively amplifies the inflammatory response with consequent tissue damage.
Parallel to these findings, great attention has to be attributed to the importance of 
detecting of an interaction between Vitamin D receptor polymorphism and smoking in 
the pathogenesis of AgP. Speculation about a functional role of this polymorphism are 
hampered by the lack of understanding about its functions. However, combined effects 
on bone metabolism or on the immune system can be suspected. The confirmation of the 
role of this polymorphism in determining AgP in smokers may have important 
repercussions in prevention strategies in smokers with the Taq-I risk allele.
All the evidence produced by this study and by previous studies suggests that 
Aggressive Periodontitis is a very complex, heterogeneous disease which can be caused 
by several genetic defects. For example, cases of pre-pubertal periodontitis have been 
associated with a defect in cathepsin C (CTSC), a neutrophil protease, responsible for 
the Papillon-Lefevre syndrome (PLS) (Hart et al. 2000, Hewitt et al 2004). Mutations in 
the CTSC gene were detected in families with pre-pubertal periodontitis; although the 
affected subjects suffered from periodontitis, they did not have the palmo-plantar
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keratosis typical of PLS. Subjects affected by these mutations have minimal or 
undetectable activity of the cathepsin C protease, and develop severe forms of 
periodontitis in their deciduous and permanent dentition (Hewitt et al. 2004). Other 
single gene defects may exist which can cause a clinical phenotype which we classify as 
AgP, either alone or as part of a syndrome. Subtle differences in genetic polymorphisms 
regulating Fc receptors or cytokines are probably irrelevant in such cases. This example 
testifies the genetic heterogeneity o f AgP which can probably be due to single gene 
defects or to a combined genetic profile including for instance T homozygosity for 
NADPH p22phox or G homozygosity fro IL-6 -174 polymorphisms. With routine clinical 
diagnostic tools we would not be able to discriminate different phenotypes caused by 
different multiple or single genetic defects. Indeed, this thesis shows how we are 
currently not even able to accurately distinguish some cases o f LAgP from GAgP.
The genetic polymorphisms detected as risk factors for AgP in this thesis deserve further 
investigation to elucidate mechanisms of action and to test and confirm their importance 
in different populations. This ‘aggressive’ genotype we propose as a possible genetic 
background of AgP cases may have developed through the years by a mechanism of 
selective pressure. AgP of course is not a life-threatening disease able to exert selection 
in the population. However, other lethal diseases might have helped selecting this hyper- 
responsive genotype throughout centuries (Cooke & Hill 2001). In other words, diseases 
which have a significant effect on mortality before reproductive age cause a natural 
selection in the population. This is the case of some infectious diseases, resistance to 
which may be genetically determined (Cooke & Hill 2001). Resistant subjects, who have 
a decreased risk of contracting the infectious disease in question and o f dying from it, 
will have more chance of leaving offspring and their genetic patrimony is more likely to 
be transmitted throughout generations. At the same time, however, such genetic 
background might predispose to other diseases. An explicative example is represented 
by malaria, an infectious disease caused by Plasmodium falciparum. Individuals 
heterozygous for the HbS variant o f haemoglobin are protected against P.falciparum 
infection and have a decreased risk of contracting malaria, because their erythrocytes 
offer a less suitable growth environment for this parasite. Therefore, selective pressure
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has occurred throughout generations and led to a very high prevalence of this HbS 
variant in areas where malaria was endemic. As a consequence, HbS homozygosity, 
which leads to thalassaemia, is dramatically increased in prevalence in those areas. 
Selective pressure is also suspected to be able to represent the basis for diffusion not 
only o f single-gene disorders, but also of complex diseases, such as Crohn’s disease. 
The florid inflammatory status which characterizes this gastrointestinal disorder might in 
fact represent a protective factor against certain infections (Cooke & Hill 2001). 
Recently, infectious diseases such as Black Death plague and smallpox epidemics have 
been suspected as possible selective pressure agents, especially in European populations 
(Galvani & Slatkin 2003). Plague epidemics have been very frequent in Europe for at 
least 400 years and had a mortality rate of up to 40%. Smallpox, on the other hand, was 
endemic in Europe for hundreds o f years and its mortality rates, although smaller than 
plague, were very high among children, removing a large number of individuals o f 
reproductive potential (Galvani & Slatkin 2003). Both these infectious diseases resulted 
in a selection of resistant individuals, who survived because of specific genetically- 
driven host response mechanisms and produced offspring. A mutation in the chemokine 
receptor CCR5, which confers protection against HIV infection, is thought to have 
developed from one of these epidemics, most likely smallpox. This is reinforced by the 
fact that this mutation is virtually absent in extra-European populations, where no 
smallpox epidemic was recorded (Galvani & Slatkin 2003). In this context, the 
‘aggressive’ genotype we observed in the AgP patients included in this study may have 
been the result o f selective pressure from some infectious agents. In particular, 
considering the very high prevalence of the NADPH p22phox oxidase 242 T allele and 
IL-6 -174 G allele in Black populations, infectious diseases relevant especially in Black 
African populations might have selected this hyper-responsive genotype. These alleles 
could have been protective versus life-threatening infectious diseases because of the 
strong oxidative burst and inflammatory response linked with them, but at the same time 
might give origin to significant tissue damage, for example in the periodontium. This is 
coherent with the fact that AgP seems to be more common in Black populations, who 
have increased frequencies of these risk alleles.
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In conclusion, this thesis produces evidence consistent with a multifactorial polygenic 
nature o f AgP, even if some cases may be caused by single gene defects. Thus, similar to 
the situation for other chronic diseases, like diabetes or cardiovascular disease, there 
might be some main modifying genes and several others with a small effect on disease 
susceptibility (Hansen & Pedersen 2005). The combination o f main and minor risk 
alleles with environmental factors and, most of all, periodontopathogenic bacteria able to 
trigger an inflammatory response, may lead to AgP. The example o f another oral 
disease, Amelogenesis imperfecta (Al), can be used to examine the prospective benefit 
o f a better understanding of AgP genetics. The Al trait can be acquired, X-linked, 
autosomal dominant or autosomal recessive. Clinical characteristics have been detected, 
which allow a sub classification of Al into pitted hypoplastic, rough hypoplastic, 
hypocalcified etc. (Aldred et al. 2003). All these forms correspond to different known 
genetic defects. In AgP, a similar ability to clinically discern phenotypic characteristics 
due to specific genotypic factors would help achieve a better diagnosis. Some clinical 
features could for example be linked with increased familial aggregation, or with a 
different response to conventional treatment. While the prospect of a better clinical 
diagnosis seems difficult to achieve in AgP, the possibility of a genetic diagnosis with an 
impact on management may soon become a reality.
The work included in this PhD identified genetic polymorphisms as risk factors for 
onset, severity and familial aggregation of AgP. It also suggested possible mechanisms 
of association between genetic risk factors and AgP. I hope this thesis can contribute to 
the continuous research aimed at understanding genetic risk factors for AgP. The 
identification of the risk genotypes we performed should be followed by haplotype 
studies, family studies, functional analyses and studies on the effects of these genotypes 
on disease progression. Once clear mechanisms of disease susceptibility are confirmed 
in different populations, the management of AgP can enter a new dimension, with the 
prospect for more specific treatments. Being able to detect the different defects leading 
to AgP in each family and each individual, will help inform preventive strategies and 
new treatment modalities directed at modulating the activity of the hypo- or hyper­
functioning genes (Van Dyke et al. 2003). New techniques which are rapidly becoming
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available, such as wide genome screening and gene therapy, may change in the near 
future the approach to AgP.
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LIST OF ABBREVIATIONS
AgP: Aggressive Periodontitis 
GAgP: Generalised Aggressive Periodontitis 
LAgP: Localised Aggressive Periodontitis 
CP: Chronic Periodontitis 
LJP: Localised Juvenile Periodontitis 
GJP: Generalised Juvenile Periodontitis 
L-EOP: Localised Early Onset Periodontitis 
G-EOP: Generalised Early Onset Periodontitis 
RPP: Rapidly Progressive Periodontitis 
PPD: Probing Pocket Depth 
REC: recession
LCAL: Lifetime Cumulative Attachment Loss
CEJ: cement- enamel junction
FGM: free gingival margin
FMBS: full mouth bleeding score
FMPS: full mouth plaque score
CPITN: Community Periodontal Index for Treatment Needs
WHO: World Health Organization
GDP: General Dental Practitioner
EDH: Eastman Dental Hospital
Aa: Actinobacillus actinomycetemcomitcins
Pg : Porphyromoncis gingivalis
Tf: Tannerella forsythensis
PGE: Prostaglandin E
IL: Interleukin
TNF: Tumor Necrosis Factor 
TLR: Toll-like receptor 
FPR: formyl peptide receptor
FMLP: N-formyl peptide formyl-methionine-leucyl-phenylalanine 
NA: neutrophil antigen
PMN: polymorphonuclear leukocytes (neutrophils) 
MMP: matrix metalloproteinases 
LPS: lipopolysaccharide 
ROS: reactive oxygen species
NADPH: nicotinamide adenine dinucleotide phosphate
NOX: NADPH oxidase
PMA: 4B-phorbol 12-mystrate 13-acetate
SOD: superoxide dismutase
Ig: Immunoglobulin
DNA: deoxyribonucleic acid
RNA: ribonucleic acid
SNP: single nucleotide polymorphism
RFLP: restriction fragment length polymorphism
ANOVA: analysis of variance
LD: linkage disequilibrium
PCR: polymerase chain reaction
LRT: likelihood- ratio test
ETOH: ethanol
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APPENDIX I. Example of probing sheet used to collect the clinical 
measurement. PD indicates probing pocket depth, R indicates recession, FI 
stands for furcation involvement and M for mobility
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APPENDIX II. Average probing pocket depths reported for jaw, tooth 
surface and tooth type
AVERAGE PPD (mm) Tot. AgP (mm)
GAgP
(mm)
LAgP 1 
(mm)
JAW
Maxilla 4.03 4.39 2.94
Mandible 3.68 3.98 2.74
SURFACE
Interproximal 4.44 4.83 3.24
Mid 2.75 2.96 2.11
TOOTH
TYPE
Second molars 4.49 4.86 3.37
First molars 4.70 4.90 4.16
Second
premolars 3.78 4.11 2.80
First premolars 3.55 3.90 2.41
Canines 3.44 3.82 2.24
Second incisors 3.46 3.82 2.36
First incisors 3.46 3.79 2.44
APPENDIX III. Scatter plots showing the distribution of the FcaR 324 genotypes as plotted 
by the 7300/7500 SDS software. The red balls indicate samples homozygosous for allele A, 
the green triangles heterozygous samples and the blue rhombi samples homozygous for the 
G allele. The squares indicate controls which do not contain DNA. Crosses indicate 
samples whose genotype was undetermined.
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APPENDIX IV. Scatter plots showing the distribution of the FcyRIIa 494 genotypes as 
plotted by the 7300/7500 SDS software. The red balls indicate samples homozygosous for 
allele A, the green triangles heterozygous samples and the blue rhombi samples 
homozygous for the G allele. The squares indicate controls which do not contain DNA. 
Crosses indicate samples whose genotype was undetermined.
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APPENDIX V. Scatter plots showing the distribution of the FcyRIIa 494 genotypes as 
plotted by the 7300/7500 SDS software. The red balls indicate samples homozygosous for 
allele T, the green triangles heterozygous samples and the blue rhombi samples 
homozygous for the C allele. The squares indicate controls which do not contain DNA. 
Crosses indicate samples whose genotype was undetermined.
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APPENDIX VI. Scatter plots showing the distribution of the FcyRIIb 695 genotypes as 
plotted by the 7300/7500 SDS software. The red balls indicate samples homozygosous for 
allele G, the green triangles heterozygous samples and the blue rhombi samples 
homozygous for the T allele. The squares indicate controls which do not contain DNA. 
Crosses indicate samples whose genotype was undetermined.
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APPENDIX VII. Scatter plots showing the distribution of the FcyRIIIb NA (141) 
genotypes as plotted by the 7300/7500 SDS software. The red balls indicate samples 
homozygosous for allele G (NA2), the green triangles heterozygous samples and the blue 
rhombi samples homozygous for the C allele (NA1). The squares indicate controls which 
do not contain DNA. Crosses indicate samples whose genotype was undetermined.
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APPENDIX VIII. Scatter plots showing the distribution of the FcyRIIIb SH (266) 
genotypes as plotted by the 7300/7500 SDS software. The red balls indicate samples 
homozygosous for allele A (SH+), the green triangles heterozygous samples and the blue 
rhombi samples homozygous for the C allele (SH-). The squares indicate controls which do 
not contain DNA. Crosses indicate samples whose genotype was undetermined.
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APPENDIX IX. Scatter plots showing the distribution of the FPR 301 genotypes as plotted 
by the 7300/7500 SDS software. The red balls indicate samples homozygosous for allele G, 
the green triangles heterozygous samples and the blue rhombi samples homozygous for the 
C allele. The squares indicate controls which do not contain DNA. Crosses indicate 
samples whose genotype was undetermined.
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APPENDIX X. Scatter plots showing the distribution of the FPR 546 genotypes as plotted 
by the 7300/7500 SDS software. The red balls indicate samples homozygosous for allele C, 
the green triangles heterozygous samples and the blue rhombi samples homozygous for A 
allele. The squares indicate controls which do not contain DNA. Crosses indicate samples 
whose genotype was undetermined.
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APPENDIX XI. Scatter plots showing the distribution of the FPR 568 genotypes as plotted 
by the 7300/7500 SDS software. The red balls indicate samples homozygosous for allele A, 
the green triangles heterozygous samples and the blue rhombi samples homozygous for T 
allele. The squares indicate controls which do not contain DNA. Crosses indicate samples 
whose genotype was undetermined.
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APPENDIX XII. Scatter plots showing the distribution of the IL-6 -174 genotypes as 
plotted by the 7300/7500 SDS software. The red balls indicate samples homozygosous for 
allele G, the green triangles heterozygous samples and the blue rhombi samples 
homozygous for allele C. The squares indicate controls which do not contain DNA. Crosses 
indicate samples whose genotype was undetermined.
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APPENDIX XIII. Scatter plots showing the distribution of the TNF-a -308 genotypes as 
plotted by the 7300/7500 SDS software. The red balls indicate samples homozygosous for 
allele G, the green triangles heterozygous samples and the blue rhombi samples 
homozygous for allele A. The squares indicate controls which do not contain DNA. Crosses 
indicate samples whose genotype was undetermined.
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APPENDIX XIV. Scatter plots showing the distribution of the VDR Taq-I (1056) 
genotypes as plotted by the 7300/7500 SDS software. The red balls indicate samples 
homozygosous for allele T (TT), the green triangles heterozygous samples and the blue 
rhombi samples homozygous for allele C (tt). The squares indicate controls which do not 
contain DNA. Crosses indicate samples whose genotype was undetermined.
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Appendix XV. Visualization under UV light of the PCR products of the NADPH p22phox 
C242T polymorphism. Digestion of the PCR product (348 bp) by Rsal enzyme makes 160- 
bp and 188-bp fragments in the T mutation, while the same enzyme does not cut the PCR 
product in the wild type (C allele). The 7 samples shown in the picture were respectively 
classified as follows starting from the first on the left: CC, TT, CT, CT, CT, CT, CT. The
last column shows a size marker.
348 bp
188 bp
--------------- ►
160 bn
Appendix XVI. Allele distributions in patients and controls for all studied SNPs.
Polymorphism Allele
All subjects Caucasians Blacks
Patients
(n=224)
Controls
(n=231)
Patients
(n=106)
Controls
(n=I44)
Patients
(n=59)
Controls
(n=45)
Fca
A 1 22
(2 7 .8 % )
114
(2 4 .7 % )
7 0
( 3 1 .5 % )
7 4
(2 5 .7 % )
18
(1 5 .8 % )
9 ( 1 0 .0 % )
G 3 1 6
(7 2 .1 % )
3 4 8
( 7 5 .3 % )
152
(6 9 .5 % )
2 1 4
(7 4 .3 % )
9 6
(8 4 .2 % )
81
(9 0 .0 7 c )
tot 4 3 8 4 6 2 2 2 2 2 8 8 114 9 0
Fcylla
H 2 1 9
( 5 0 .2 % )
2 3 5
(5 0 .8 % )
104
( 4 6 .8 % )
145
(5 0 .3 % )
59
(5 2 .7 % )
4 0
(4 4 .4 7 c )
R 2 1 7
( 4 0 .8 % )
2 2 7
(4 9 .2 % )
118
( 5 3 .2 % )
143
(4 9 .7 % )
53
(4 7 .3 % )
5 0
(5 5 .6 7 c )
tot 4 3 6 4 6 2 2 2 2 2 8 8 112 9 0
Fcyllb
C 7 3
( 1 6 .6 % )
7 4
( 1 6 .0 % )
2 6
(1 1 .6 % )
3 9
(1 3 .5 % )
25
(2 1 .9 % )
18
(2 0 .0 7 c )
T 3 6 7
(8 3 .4 % )
3 8 8
(8 4 .0 % )
198
( 8 8 .4 % )
2 4 9
(8 6 .5 % )
89
(7 8 .1 % )
7 2
(8 0 .0 7 c )
tot 4 4 0 4 6 2 2 2 4 2 8 8 114 9 0
FcyHIa
V 151
( 3 4 .6 % )
1 59
(3 4 .7 % )
8 2
( 3 6 .9 % )
103
(3 6 .2 % )
3 9
(3 4 .2 % )
27
(3 0 .0 7 c )
F 2 8 5
(6 3 .4 % )
2 9 9
(6 5 .3 % )
140
( 6 3 .1 % )
181
(6 3 .8 % )
75
(6 5 .8 % )
63
(7 0 .0 7 c )
tot 4 3 6 4 5 8 2 2 2 2 8 4 114 9 0
FcylllbN A
NA2 2 4 6
(5 5 .6 % )
2 7 6
(5 9 .7 % )
134
(5 9 .8 % )
177
(7 7 .6 % )
62
(5 3 .4 % )
4 6
(5 1 .1 7 c )
NA1 196
(4 4 .4 % )
186
(4 0 .3 % )
9 0
( 4 0 .2 % )
111
(2 2 .4 % )
5 4
(4 6 .6 7 c )
4 4
(4 8 .9 % )
tot 4 4 2 4 6 2 2 2 4 2 8 8 116 9 0
FcylllbSH
SH+ 32
(7 .2 % )
2 2  (4 .7 % ) 6  (2 .7 % ) 3 (1 .0 % )
22
(1 8 .9 7 c )
13
(1 4 .4 % )
SH- 4 1 2
(9 2 .8 % )
4 4 0
(9 5 .3 % )
2 1 8
(8 7 .3 % )
2 8 5
(9 9 .0 % )
94
(8 1 .1 7 c )
77
(8 5 .6 7 c )
tot 4 4 4 4 6 2 2 2 4 2 8 8 116 9 0
Appendix XVI continued.
Poly­
morphism Allele
All subjects Caucasians Blacks
Patients
(n=224)
Controls
(n=231)
Patients
(n=106)
Controls
(n=144)
Patients
(n=59)
Controls
(n=45)
FPR 301
C 134
(31.6%)
157
(34.2%)
70
(31.8%)
98
(34.5%) 29 (25.4%) 28 (31.1%)
G 290(68.4%)
301
(65.8%)
150
(68.2%)
186
(65.5%) 83 (74.6%) 62 (68.9%)
tot 424 458 220 284 114 90
FPR 546
A 156(35.4%)
145 
(31.4%)
76
(33.9%)
87
(30.2%) 33 (28.9%) 29 (32.2%)
C 284(64.6%)
317
(68.6%)
148
(66.1%)
201
(69.8%) 81 (81.1%) 61 (67.8%)
tot 440 462 224 288 114 90
FPR 568
A 384(87.2%)
409
(88.5%)
193
(86.9%)
255
(89.1%)
102
(87.9%) 86 (95.5%)
T 56(12.8%)
53
(11.5%)
29
(13.1%)
31
(10.9%) 14(12.1%) 4 (4.5%)
tot 440 462 222 286 116 90
VDR
t 161(35.9%)
186
(40.2%)
82
(36.6%)
119
(41.3%) 40 (33.9%) 29 (32.2%)
T 287(64.1%)
276
(59.8%)
142
(63.4%)
169
(58.7%) 78 (66.1%) 61 (67.8%)
tot 448 462 224 288 118 90
TNF-a
A 375(84.4%)
383
(83.2%)
176
(78.6%)
231
(80.8%) 99 (85.3%) 74 (82.2%)
G 69(15.6%)
77
(16.8%)
48
(21.4%)
55
(19.2%) 17 (14.7%) 16 (17.8%)
tot 444 460 224 286 116 90
IL-6
C 100(22.5%)
151
(32.7%)
77
(34.4%)
130
(45.1%) 6 (5.3%) 7 (7.7%)
G 344(77.5%)
311
(67.3%)
147
(65.6%)
158
(54.9%)
108
(94.7%) 83 (92.3%)
tot 444 462 224 288 114 90
NADPH
C 230(57.8%)
308
(68.7%)
123
(61.5%)
199
(71.1%) 50 (46.3%) 52 (57.8%)
T 168(42.2%)
140
(31.3%)
77
(38.5%)
81
(28.9%) 58 (53.7%) 32 (42.2%)
tot 398 448 200 280 108 84
Appendix XVII. Clinical data recorded in GAgP patients, divided by genotypes for all 
polymorphisms.
All
patients
GAgP
Genotype no. Av.PPD
Av.
LCAL
no. > 5 
mm PPD
no. > 10 
mm PPD
AA 14 4.4±1.4 5.4±2.0 70.5±38.7 5.2±8.0
Fca AG 64 4.0±1.0 4.6±1.5 55.3±29.6 2.7±6.0
GG 84 4.3±1.0 5.0±1.4 69.4±31.6 3.3±5.0
HH 41 4.3±0.9 5.0±1.4 68.7±33.6 3.0±4.2
Fcylla HR 78 4.1 ±0.9 4.7±1.3 60.0±29.8 3.0±6.0
RR 42 4.3±1.2 5.1 ± 1.8 65.9±34.5 3.8±6.6
CC 4 3.8±0.5 4.4±1.2 52.0±21.5 1.2±1.5
Fcyllb CT 45 4.3±1.2 5 .1±1.6 67.2±37.0 4.0±7.2
TT 113 4.2±0.9 4.9±1.5 61.7±34.3 2.9±5.1
VV 20 4.2±1.0 4.9±1.5 61.7±34.3 2.9±4.2
Fey Ilia VF 69 4.2±1.2 5 .1±1.7 64.8±34.3 3.9±7.1
FF 72 4.1 ±0.9 4.7± 1.3 63.4±29.7 2.7±4.6
NA2/NA2 51 4.2±1.0 4.8±1.5 62.6±32.1 3.8±7.1
FcylllbNA NA1/NA2 74 4.2±1.1 4.9±1.6 64.8±34.6 3.2±5.5
NA1/NA1 37 4.3±0.8 4.9±1.4 64.0±27.1 2.3±3.8
SH+/SH+ 3 3.3±0.9 3.7±0.4 34.3±4.9 0.7±1.1
FcylllbSH SH-/SH+ 17 4.4±1.1 5.2±1.6 71.3±34.6 4.2±6.5
SH-/SH- 144 4.2±1.0 4.9±1.5 63.7±31.6 3.1±5 7
CC 16 3.9±0.9 4.6±1.6 55.5±33.6 2.2±4.6
FPR 301 CG 60 4.0±1.1 4.8±1.5 58.7±35.0 3.1 ±6.5
GG 79 4.4±0.9 5.0±1.5 70.0±28.8 3.5±5.3
AA 19 4.5±1.4 5.3±1.7 71.7±40.6 6.0±10.6
FPR 546 AC 79 4.0±0.9 4.8±1.6 58.6±30.6 2.5±4.1
CC 64 4.4±l.O 4.8±1.3 68.2±30.4 3.3±5.3
AA 123 4.2±1.0 4.8±1.5 62.4±33.2 3.2±6.1
FPR 568 AT 39 4.3±0.9 5.1 ±1.7 68.4±28.0 3.4±4.8
TT 1 4.7 4.5 76.0 5.0
tt 23 4.3±1.1 4.9±1.7 65.1±36.4 4.3±7.2
VDR Tt 72 4.2±1.0 4.9±1.6 65.9±30.7 2.7±5.5
TT 69 4.1 ± 1.0 4.9±1.4 61.5±31.8 3.4±5.6
AA 113 4.3±1.0 4.8±1.5 64.4±32.4 3.3±0.5
TNF-a AG 45 4.2±1.0 5 .1±1.5 65.9±31.5 3.1 ±0.9
GG 4 3.3±0.3 3.8±1.0 39.2±13.1 0
CC 14 4.4±1.2 4.7±1.7 68.6±37.3 4.3±7.7
IL-6 CG 53 4.2±1.0 5.0±1.7 65.0±31.0 2.6±5.4
GG 96 4.2±1.0 4.9±1.4 62.8±32.0 3.5±5.7
CC 50 4.2±1.0 4.8±1.6 61.7±32.6 3.4±5.4
NADPH CT 73 4.1 ±0.9 4.8±1.3 63.0±30.7 3.0±6.0
TT 31 4.4±1.2 5.2± 1.8 67.1 ±33.7 3.7±6.5
Appendix XVIII. Log counts of periodontopathogenic bacteria by genotype
Log counts of bacteria 
by genotypes Tot
Tot an­
aerobes 
log
Tot
aerobes
log
A.a. 
log
Pg.
log
T.f.
log
AA 6 6.7±0.4 5.7±0.4 4.8±1.2 5.6±0.5 5.9±0.4
Fca AG 18 7.4±0.7 6.2±0.8 4.5±1.3 6.6±0.8 6.4±0.4
GG 21 7.1 ±0.5 6.1±0.8 4.3±1.1 6.1 ±0.6 6.1 ±0.5
HH 13 7.1±0.5 6.3±0.6 4.5±0.6 5.7±0.4 6.1 ±0.4
Fcylla HR 18 7.2±0.7 6.0±0.9 4.4±1.2 6.3±0.9 6.4±0.6
RR 13 7.1 ±0.6 6.1 ±0.8 4.4±1.5 6.4±0.8 6.1 ±0.3
CC 1 6.8 4.1 0 0 0
Fcyllb CT 12 7.1 ±0.5 6.0±0.8 4 .1±1.2 6.0±0.6 6.2±0.3
TT 32 7.2±0.7 6.1 ±0.7 4.5±1.2 6.4±0.8 6.2±0.5
VV 6 7.1 ±0.7 6.1 ± 1.1 4.7 5.7 5.9±0.5
Fey Ilia VF 19 7.0±0.5 6.0±0.6 4.4±1.1 6.0±0.6 6.3±0.3
FF 20 7.3±0.7 6.1 ±0.8 4.4±1.3 6.5±0.8 6.2±0.6
NA2/NA2 17 7.1 ±0.6 5.9±1.0 4.8±1.4 6.3±0.8 6.1 ±0.4
FcylllbNA NA1/NA2 18 7.2±0.7 6.2±0.6 4.5±1.3 6.2±0.6 6.2±0.4
NA1/NA1 10 7.2±0.5 6.1 ±0.5 4.0±0.9 6.4±1.0 6.4±0.7
SH+/SH+ 0 0 0 0 0 0
FcylllbSH SH-/SH+ 8 6.9±0.4 5.6±0.6 4.6±1.2 5.9±0.6 6.1 ±0.3
SH-/SH- 37 7.2±0.6 6.1 ±0.8 4.3±1.2 6.4±0.8 6.2±0.5
CC 3 6.9±0.5 4.9±0.7 5.6 5.7 5.7±0.6
FPR 301 CG 15 7.2±0.8 6.1 ±0.7 4.1 ±1.2 6.0±0.7 6.1 ±0.3
GG 25 7.2±0.5 6.2±0.8 4.6±1.2 6.4±0.8 6.4±0.5
AA 5 7.0±0.6 6.1 ±1.1 4.4±0.6 6.0±1.1 6.0±0.5
FPR 546 AC 25 7.1 ±0.5 6.1 ±0.6 4.6±1.3 6.2±0.6 6.1 ±0.4
CC 14 7.3±0.8 6.1 ±1.0 4.0±1.0 6.4±0.8 6.5±0.6
AA 33 7.1 ±0.5 6.0±0.8 4.4±1.1 6.2±0.9 6.2±0.5
FPR 568 AT 12 7.2±0.8 6.4±0.7 4.4±1.3 6.3±0.6 6.3±0.4
TT 0 0 0 0 0 0
tt 5 7.2±0.7 5.9±0.3 4.2±2.3 7.0±0.7 7.0±0.8
VDR Tt 24 7.1 ±0.6 5.9±0.7 4.6±1.0 6.0±0.6 6.2±0.4
TT 15 7.2±0.6 6.4±0.2 4.3±1.1 6.2±0.8 6.2±0.3
AA 34 7.2±0.6 6.1±0.8 4.2±1.2 6.3±0.8 6.2±0.5
TNF-a AG 9 7.1 ±0.4 6.1 ±0.6 5.2±0.7 6.1 ±0.4 6.1 ±0.4
GG 2 6.8±1.1 5.9±0.7 0 0 6.3
CC 7 7.1 ±0.4 5.8±0.4 3.9±1.1 6.1 ±0.9 5.9±0.7
IL-6 CG 12 7.1 ±0.6 6.1 ± 1.0 4 .1±1.1 6.3±1.0 6.2±0.4
GG 26 7.2±0.7 6.2±0.7 4.5±1.2 6.3±0.7 6.3±0.5
CC 22 7.3±0.7 6.1±0.8 4.0±1.1 6.6±0.4 6.3±0.3
NADPH CT 17 7.0±0.6 6.0±0.9 5.0±l.l 6.2±0.9 6.3±0.6
TT 5 6.9±0.5 6.3±0.5 3.5±0.3 5.5±0.3 6.1 ±0.6
